
<html lang="en"     class="pb-page"  data-request-id="f69fc663-b9c3-4626-aaf7-6411bbcf0684"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;article:article:10.1021/jm501262q;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2014.57.issue-22"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Triazolopyridines as Selective JAK1 Inhibitors: From Hit Identification to GLPG0634" /></meta><meta name="dc.Creator" content="Christel J.  Menet" /></meta><meta name="dc.Creator" content="Stephen R  Fletcher" /></meta><meta name="dc.Creator" content="Guy  Van Lommen" /></meta><meta name="dc.Creator" content="Raphael  Geney" /></meta><meta name="dc.Creator" content="Javier  Blanc" /></meta><meta name="dc.Creator" content="Koen  Smits" /></meta><meta name="dc.Creator" content="Nolwenn  Jouannigot" /></meta><meta name="dc.Creator" content="Pierre  Deprez" /></meta><meta name="dc.Creator" content="Ellen M.  van der Aar" /></meta><meta name="dc.Creator" content="Philippe  Clement-Lacroix" /></meta><meta name="dc.Creator" content="Liên  Lepescheux" /></meta><meta name="dc.Creator" content="René  Galien" /></meta><meta name="dc.Creator" content="Béatrice  Vayssiere" /></meta><meta name="dc.Creator" content="Luc  Nelles" /></meta><meta name="dc.Creator" content="Thierry  Christophe" /></meta><meta name="dc.Creator" content="Reginald  Brys" /></meta><meta name="dc.Creator" content="Muriel  Uhring" /></meta><meta name="dc.Creator" content="Fabrice  Ciesielski" /></meta><meta name="dc.Creator" content="Luc  Van Rompaey" /></meta><meta name="dc.Description" content="Janus kinases (JAK1, JAK2, JAK3, and TYK2) are involved in the signaling of multiple cytokines important in cellular function. Blockade of the JAK-STAT pathway with a small molecule has been shown ..." /></meta><meta name="Description" content="Janus kinases (JAK1, JAK2, JAK3, and TYK2) are involved in the signaling of multiple cytokines important in cellular function. Blockade of the JAK-STAT pathway with a small molecule has been shown ..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="November 17, 2014" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm501262q" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2014 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm501262q" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm501262q" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm501262q" /></link>
        
    
    

<title>Triazolopyridines as Selective JAK1 Inhibitors: From Hit Identification to GLPG0634 | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm501262q" /></meta><meta property="og:title" content="Triazolopyridines as Selective JAK1 Inhibitors: From Hit Identification to GLPG0634" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm501262q/20141120/images/large/jm-2014-01262q_0020.jpeg" /></meta><meta property="og:description" content="Janus kinases (JAK1, JAK2, JAK3, and TYK2) are involved in the signaling of multiple cytokines important in cellular function. Blockade of the JAK-STAT pathway with a small molecule has been shown to provide therapeutic immunomodulation. Having identified JAK1 as a possible new target for arthritis at Galapagos, the compound library was screened against JAK1, resulting in the identification of a triazolopyridine-based series of inhibitors represented by 3. Optimization within this chemical series led to identification of GLPG0634 (65, filgotinib), a selective JAK1 inhibitor currently in phase 2B development for RA and phase 2A development for Crohn’s disease (CD)." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm501262q"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm501262q">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm501262q&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm501262q&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm501262q&amp;href=/doi/10.1021/jm501262q" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2014</span><span class="cit-fg-volume">, 57</span><span class="cit-fg-issue">, 22</span><span class="cit-fg-pageRange">, 9323-9342</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/57/22" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm500692u" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm500613m" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Triazolopyridines as Selective JAK1 Inhibitors: From Hit Identification to GLPG0634</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christel+J.++Menet">Christel J. Menet</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stephen+R++Fletcher">Stephen R Fletcher</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Guy++Van+Lommen">Guy Van Lommen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Raphael++Geney">Raphael Geney</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Javier++Blanc">Javier Blanc</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Koen++Smits">Koen Smits</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nolwenn++Jouannigot">Nolwenn Jouannigot</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Pierre++Deprez">Pierre Deprez</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ellen+M.++van+der+Aar">Ellen M. van der Aar</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Philippe++Clement-Lacroix">Philippe Clement-Lacroix</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Li%C3%AAn++Lepescheux">Liên Lepescheux</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ren%C3%A9++Galien">René Galien</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=B%C3%A9atrice++Vayssiere">Béatrice Vayssiere</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Luc++Nelles">Luc Nelles</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Thierry++Christophe">Thierry Christophe</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Reginald++Brys">Reginald Brys</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Muriel++Uhring">Muriel Uhring</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Fabrice++Ciesielski">Fabrice Ciesielski</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Luc++Van+Rompaey">Luc Van Rompaey</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Galapagos NV, Generaal de Wittelaan L11A3, 2800 Mechelen, Belgium</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">BioFocus, Chesterford Research Park, Saffron Walden, Essex CB10 1XL, United Kingdom</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Galapagos SASU, 102 Avenue Gaston Roussel, 93230 Romainville, France</span></div><div class="aff-info" id="aff4"><span class="aff-symbol">∥</span> <span class="aff-text">NovAliX, Boulevardd Sébastien Brant, BP 30170, F-67405 Illkirch CEDEX, France</span></div><div class="corresp-info"><strong>*</strong>Phone: +32 15 342 938. E-mail: <a href="/cdn-cgi/l/email-protection#2f4c475d465c5b4a4301424a414a5b6f48435f48014c4042"><span class="__cf_email__" data-cfemail="22414a504b5156474e0c4f474c475662454e52450c414d4f">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm501262q&amp;href=/doi/10.1021%2Fjm501262q" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2014</span></span><span class="cit-volume">, 57</span><span class="cit-issue">, 22</span><span class="cit-pageRange">, 9323–9342</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">November 4, 2014</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>2 April 2014</li><li><span class="item_label"><b>Published</b> online</span>17 November 2014</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 26 November 2014</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm501262q" title="DOI URL">https://doi.org/10.1021/jm501262q</a></div><div class="article_header-article-copyright"><strong>Copyright © 2014 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D9323%26pageCount%3D20%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DChristel%2BJ.%2BMenet%252C%2BStephen%2BR%2BFletcher%252C%2BGuy%2BVan%2BLommen%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D57%26issueNum%3D22%26contentID%3Djm501262q%26title%3DTriazolopyridines%2Bas%2BSelective%2BJAK1%2BInhibitors%253A%2BFrom%2BHit%2BIdentification%2Bto%2BGLPG0634%26numPages%3D20%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D9342%26publicationDate%3DNovember%2B2014">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm501262q"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">5402</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">59</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm501262q" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Triazolopyridines as Selective JAK1 Inhibitors: From Hit Identification to GLPG0634&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Christel&quot;,&quot;last_name&quot;:&quot;J. Menet&quot;},{&quot;first_name&quot;:&quot;Stephen&quot;,&quot;last_name&quot;:&quot;R Fletcher&quot;},{&quot;first_name&quot;:&quot;Guy&quot;,&quot;last_name&quot;:&quot;Van Lommen&quot;},{&quot;first_name&quot;:&quot;Raphael&quot;,&quot;last_name&quot;:&quot;Geney&quot;},{&quot;first_name&quot;:&quot;Javier&quot;,&quot;last_name&quot;:&quot;Blanc&quot;},{&quot;first_name&quot;:&quot;Koen&quot;,&quot;last_name&quot;:&quot;Smits&quot;},{&quot;first_name&quot;:&quot;Nolwenn&quot;,&quot;last_name&quot;:&quot;Jouannigot&quot;},{&quot;first_name&quot;:&quot;Pierre&quot;,&quot;last_name&quot;:&quot;Deprez&quot;},{&quot;first_name&quot;:&quot;Ellen&quot;,&quot;last_name&quot;:&quot;M. van der Aar&quot;},{&quot;first_name&quot;:&quot;Philippe&quot;,&quot;last_name&quot;:&quot;Clement-Lacroix&quot;},{&quot;first_name&quot;:&quot;Liên&quot;,&quot;last_name&quot;:&quot;Lepescheux&quot;},{&quot;first_name&quot;:&quot;René&quot;,&quot;last_name&quot;:&quot;Galien&quot;},{&quot;first_name&quot;:&quot;Béatrice&quot;,&quot;last_name&quot;:&quot;Vayssiere&quot;},{&quot;first_name&quot;:&quot;Luc&quot;,&quot;last_name&quot;:&quot;Nelles&quot;},{&quot;first_name&quot;:&quot;Thierry&quot;,&quot;last_name&quot;:&quot;Christophe&quot;},{&quot;first_name&quot;:&quot;Reginald&quot;,&quot;last_name&quot;:&quot;Brys&quot;},{&quot;first_name&quot;:&quot;Muriel&quot;,&quot;last_name&quot;:&quot;Uhring&quot;},{&quot;first_name&quot;:&quot;Fabrice&quot;,&quot;last_name&quot;:&quot;Ciesielski&quot;},{&quot;first_name&quot;:&quot;Luc&quot;,&quot;last_name&quot;:&quot;Van Rompaey&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2014&quot;,&quot;month&quot;:&quot;11&quot;,&quot;day&quot;:&quot;17&quot;,&quot;issue&quot;:&quot;22&quot;,&quot;volume&quot;:&quot;57&quot;,&quot;pages&quot;:&quot;9323-9342&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm501262q&quot;},&quot;abstract&quot;:&quot;Janus kinases (JAK1, JAK2, JAK3, and TYK2) are involved in the signaling of multiple cytokines important in cellular function. Blockade of the JAK-STAT pathway with a small molecule has been shown to provide therapeutic immunomodulation. Having identified JAK1 as a possible new target for arthritis at Galapagos, the compound library was screened against JAK1, resulting in the identification of a triazolopyridine-based series of inhibitors represented by 3. Optimization within this chemical series led to identification of GLPG0634 (65, filgotinib), a selective JAK1 inhibitor currently in phase 2B development for RA and phase 2A development for Crohn’s disease (CD).&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm501262q&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm501262q" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm501262q&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm501262q" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm501262q&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm501262q" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm501262q&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm501262q&amp;href=/doi/10.1021/jm501262q" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm501262q" /></input><a href="/doi/pdf/10.1021/jm501262q" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm501262q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm501262q%26sid%3Dliteratum%253Aachs%26pmid%3D25369270%26genre%3Darticle%26aulast%3DMenet%26date%3D2014%26atitle%3DTriazolopyridines%2Bas%2BSelective%2BJAK1%2BInhibitors%253A%2BFrom%2BHit%2BIdentification%2Bto%2BGLPG0634%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D57%26issue%3D22%26spage%3D9323%26epage%3D9342%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/57/22" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jmcmar.2014.57.issue-22/20141126/jmcmar.2014.57.issue-22.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm501262q/20141120/images/medium/jm-2014-01262q_0020.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm501262q/20141120/images/large/jm-2014-01262q_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501262q&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Janus kinases (JAK1, JAK2, JAK3, and TYK2) are involved in the signaling of multiple cytokines important in cellular function. Blockade of the JAK-STAT pathway with a small molecule has been shown to provide therapeutic immunomodulation. Having identified JAK1 as a possible new target for arthritis at Galapagos, the compound library was screened against JAK1, resulting in the identification of a triazolopyridine-based series of inhibitors represented by <b>3</b>. Optimization within this chemical series led to identification of GLPG0634 (<b>65</b>, filgotinib), a selective JAK1 inhibitor currently in phase 2B development for RA and phase 2A development for Crohn’s disease (CD).</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_74365" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_74365" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Janus kinases (JAKs) are cytoplasmic nonreceptor tyrosine kinases. Four human JAK family members are known: JAK1, JAK2, JAK3, and TYK2 (tyrosine kinase 2). It is well documented that JAK kinases play a central role in cytokine receptor signaling through phosphorylation and activation of signal transducer and activator of transcription (STAT) proteins.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> JAKs are constitutively bound to the cytoplasmic tail of the cytokine receptors. Upon binding of the cytokine, JAK family members auto- and/or trans-phosphorylate, leading to phosphorylation of the receptors at specific tyrosine (Tyr) residues. The resulting activated STATs migrate to the nucleus and modulate transcription. JAK1, JAK2, and TYK2 kinases are ubiquitously expressed, whereas JAK3 is limited to the lymphoid lineage. Many cytokines relying on JAKs for intracellular signal transduction have key pathophysiological roles in autoimmune and inflammatory diseases. Such cytokines include IL-2 (interleukine), IL-6, IL-12, IL-23, IFN-α, IFN-γ (interferon), and GM-CSF (granulocyte macrophage colony-stimulating factor).<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Therapeutic benefit from JAK kinase inhibition has been established in rheumatoid arthritis (RA) with tofacitinib, <b>1</b> (Xeljanz) and in the treatment of myelofibrosis with ruxolitinib, <b>2</b> (Jakafi). Tofacitinib generally reported as a JAK1/JAK3 inhibitor is found in-house (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) to have a JAK1/2/3 selectivity profile. Ruxolitinib, <b>2</b> (Jakafi), generally known as a JAK1/JAK2 inhibitor, has been shown in different literature references to have a JAK1/JAK2/TYK2 profile (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>).<a onclick="showRef(event, 'ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref2 ref3">(2, 3)</a> In 1998, Schreiber et al. showed using JAK1<sup>–/–</sup> cells that although responsive to many cytokines, JAK1 is necessary for cells to respond effectively to multiple immune-relevant cytokines, these include all class II cytokine receptors, receptors that utilize the γ<sub>c</sub> subunit for signaling, and the family of cytokine receptors that depend on the gp130 subunit signaling.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Moreover, in 2001, Yoshimura et al. conducted in vivo collagen-induced arthritis (CIA) experiments by periarticular injection of adenovirus carrying CIS3/SOCS3/SSI3 to inhibit JAK tyrosine kinase activity.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> This study showed drastic reduction of the severity of the CIA disease, leading them to conclude that a JAK1 inhibitor may be a useful therapeutic reagent for RA (rheumatoid arthritis). The work carried out by these two groups validated the Galapagos approach to the identification of JAK1 as a possible new target in arthritis using viral siRNA libraries in functional screening. Additional recent findings suggest that JAK1 dominates IL-2 induced JAK1/JAK3/STAT5 signaling and IL-6 induced JAK1/JAK2/TYK2/STAT1 signaling. This implies that JAK1 inhibition alone can provide in vivo efficacy toward immune-inflammatory diseases.<a onclick="showRef(event, 'ref4 ref6 ref7 ref8 ref9 ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref4 ref6 ref7 ref8 ref9 ref10 ref11">(4, 6-8, 9-11)</a> Because JAK2 inhibition leads to unwanted side effects such as anemia, thrombocytopenia, and neutropenia, selective JAK1 inhibition could provide an increased therapeutic window, allowing higher dosing and efficacy while avoiding dose-limited pharmacology observed with pan JAK inhibitors (i.e., compounds inhibiting multiple JAKs).<a onclick="showRef(event, 'ref12 ref13 ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref12 ref13 ref14 ref15">(12-15)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm501262q/20141120/images/medium/jm-2014-01262q_0024.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm501262q/20141120/images/large/jm-2014-01262q_0024.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Tofacitinib, <b>1</b>; ruxolitinib, <b>2</b>. *Biochemical IC<sub>50</sub> determination: recombinant JAK1 (Invitrogen), JAK2 (Carna Biosciences). The ATP concentration was equivalent to <i>K</i><sub>m</sub> value.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm501262q/20141120/images/large/jm-2014-01262q_0024.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501262q&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Herein we describe the finding and characterization of a triazolopyridine series as JAK inhibitor along with our initial efforts at achieving the desired JAK1 selectivity profile within this chemotype.</div><div class="NLM_p">To identify chemical starting points for JAK1 inhibitors, the BioFocus kinase-focused library collection was screened against the kinase domain of JAK1 in an in vitro biochemical assay at 10 μM initially. All compounds having a percentage inhibition above 75% were further evaluated in dose response tests with measurement of IC<sub>50</sub> values. Triazolo[1,5-<i>a</i>]pyridine <b>3</b> exhibited encouraging JAK1 inhibitory activity (70 nM), and owing to its modular nature, emerged as a good platform to initiate chemistry (low molecular weight, 308; appropriate xLogP3,<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> 2.35). Furthermore, <b>3</b> appeared to be slightly more potent on JAK1 than on the other JAKs in the biochemical assays (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). A similar selectivity profile has since been reported by Siu et al. on the same triazolo-pyridine scaffold.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> The catalytically active JAK homology (JH1) kinase domain carries out the phosphorylation events responsible for the physiological function of the JAK kinases, and this selective series of molecules appeared to be ATP competitive inhibitors binding within this region. However, compound <b>3</b> was not optimal, showing a moderate potency on JAK1 kinase and low metabolic stability (6% of compound remaining after 60 min in human microsomes).</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm501262q/20141120/images/medium/jm-2014-01262q_0025.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm501262q/20141120/images/large/jm-2014-01262q_0025.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Compound <b>3</b>, hit identified during our HTS. *LiPE (lipophilic efficiency) = pIC<sub>50</sub> – xlogP3.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm501262q/20141120/images/large/jm-2014-01262q_0025.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501262q&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Exploiting the subtle sequence differences in the active sites of the JAK family kinases via a combination of structure–activity relationships (SAR) and structure-based design, we report a series of modifications to the exocyclic amine and the 5-position of compound <b>3</b>. To the best of our knowledge, at that time no JAK1 selective inhibitor was yet described and no help from known SAR could be used. Nevertheless sequential improvements in potency together with achieving a balance of drug-like features led to the discovery of compound <b>65</b> (GLPG0634, filgotinib), a potent, selective, and orally active JAK1 inhibitor with an excellent PK profile in two preclinical species (rat and dog). In addition, compound <b>65</b> showed good in vivo efficacy in a rat CIA model.</div></div><div id="sec1_1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_37368" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_37368" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Analogues of <b>3</b> were synthesized according to the procedure depicted in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>, starting from the commercially available 2-amino-6-bromo-pyridine <b>4</b>. The central scaffold was constructed by reaction of ethoxycarbonyl isothiocyanate with <b>4</b> to form the thiourea <b>5</b>, which was then reacted with hydroxylamine to yield, after heating, the desired intermediate <b>6</b>.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a></div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm501262q/20141120/images/medium/jm-2014-01262q_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm501262q/20141120/images/large/jm-2014-01262q_0004.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of the Triazolo-pyridine Scaffold<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm501262q/20141120/images/large/jm-2014-01262q_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501262q&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(i) Ethoxycarbonyl isothiocyanate, DCM, RT; (ii) hydroxylamine hydrochloride, DIPEA, EtOH/MeOH, reflux.</p></p></figure><div class="NLM_p">Next, <i>para</i>-methoxyphenyl boronic acid was first coupled via a Suzuki reaction to the bromo-amino-triazolopyridine scaffold to provide <b>7</b>. Derivatives of <b>7</b> with various groups in the 2-position were easily accessible using different functionalization of the free amine. Acylation was carried out with the acyl chlorides and the initial double acylation adducts easily hydrolyzed with an ammonia solution in methanol to provide the monoamides (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>). Palladium coupling was carried out by first transforming the free amine to iodine by a Sandmeyer reaction, followed by Buchwald or Suzuki reactions (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>). To vary the 5-position, the triazolo-pyridine scaffold <b>6</b> was acylated with cyclopropanecarboxyl chloride to give <b>9</b>, followed by a Suzuki reaction (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>).</div><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm501262q/20141120/images/medium/jm-2014-01262q_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm501262q/20141120/images/large/jm-2014-01262q_0005.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of the Triazolo-pyridine Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm501262q/20141120/images/large/jm-2014-01262q_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501262q&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(i) <i>para</i>-Methoxyphenyl boronic acid, Pd(dppf)Cl<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane/water, 100 °C; (ii) (a) acid chloride, Et<sub>3</sub>N, CH<sub>3</sub>CN, followed by NH<sub>3</sub> (7N) in MeOH, (b) 4-nitrophenyl chloroformate, DIPEA, methylamine, DCM, (c) aldehyde, Ti(O<i>i</i>Pr)<sub>4</sub>, Na(CN)BH<sub>3</sub>, EtOH;<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> (iii) HI (57% aqueous solution); NaNO<sub>2</sub>, DMSO; (iv) Pd(OAc)<sub>2</sub>, Cs<sub>2</sub>CO<sub>3</sub>, BINAP, aniline, 1,4-dioxane or toluene; (v) Pd(dppf)Cl<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, boronic acid, 1,4-dioxane; (vi) cyclopropanecarbonyl chloride, Et<sub>3</sub>N, CH<sub>3</sub>CN; (vii) <i>para</i>-methoxyphenyl boronic acid, Pd(dppf)Cl<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane/water, 100 °C.</p></p></figure><div class="NLM_p">Examples such as <b>49</b> with additional substitution on the scaffold were synthesized similarly, starting from the amino-pyridine with the desired substitution, followed by sequential coupling, acylation, and Suzuki reaction (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>).</div><figure id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm501262q/20141120/images/medium/jm-2014-01262q_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm501262q/20141120/images/large/jm-2014-01262q_0006.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of the Compound <b>49</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm501262q/20141120/images/large/jm-2014-01262q_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501262q&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(i) ethoxycarbonyl isothiocyanate, DCM, RT; (ii) hydroxylamine hydrochloride, DIPEA, EtOH/MeOH, reflux; (iii) acid chloride, Et<sub>3</sub>N, CH<sub>3</sub>CN; (iv) <i>para</i>-ethoxyphenyl boronic acid, Pd(dppf)Cl<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane/water, 100 °C.</p></p></figure><div class="NLM_p">The isomeric scaffold with substitution at the 8-position (compounds <b>50</b> and <b>52</b>) was obtained starting from the isomeric pyridine with or without substitution. Compound <b>54</b> was made by the same sequence, starting from amino-pyrazine.</div><div class="NLM_p">For the synthesis of the triazolo-pyrimidine scaffold, compound <b>51</b>, it was necessary to start the synthesis via a Suzuki coupling on 6-amino-2-chloropyrimidine, as the cyclization (step ii would not proceed in the presence of the chlorine (Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>)).</div><figure id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm501262q/20141120/images/medium/jm-2014-01262q_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm501262q/20141120/images/large/jm-2014-01262q_0007.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Compound <b>51</b>, Triazolo-pyrimidine Scaffold<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm501262q/20141120/images/large/jm-2014-01262q_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501262q&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(i) <i>para</i>-Ethoxyphenyl boronic acid, Pd(dppf)Cl<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane/water, 100 °C; (ii) ethoxycarbonyl isothiocyanate, DCM, RT; (iii) hydroxylamine hydrochloride, DIPEA, EtOH/MeOH, reflux; (iv) acid chloride, Et<sub>3</sub>N, CH<sub>3</sub>CN</p></p></figure><div class="NLM_p">An alternative approach to the synthesis of compound <b>53</b> was required as the methods above failed to give the desired product. Instead, acetophenone <b>18</b> was reacted with dimethylformamide dimethyl acetal <b>19</b> to give compound <b>20</b>, which was condensed with diaminotriazole <b>21</b> to yield <b>22</b>. Acylation of <b>22</b> gave the required product <b>53</b> (Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a>).</div><figure id="sch5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm501262q/20141120/images/medium/jm-2014-01262q_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm501262q/20141120/images/large/jm-2014-01262q_0008.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of Compound <b>53</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm501262q/20141120/images/large/jm-2014-01262q_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501262q&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(i) 150 °C, MW (<i>W</i><sub>max</sub>, 300; <i>P</i><sub>max</sub>, 150 PSI); (ii) EtOH, 100 °C; (iii) acid chloride, Et<sub>3</sub>N, CH<sub>3</sub>CN</p></p></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i8">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_64400" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_64400" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The goal of this work was to develop a potent and selective JAK1 inhibitor possessing appropriate ADME/DMPK properties to enable clinical development via oral dosing for the treatment of immune-inflammatory disorders. Moreover, it was reasoned that, in order to be a potential drug candidate, any new compounds should reach levels of potency in the low nanomolar range like the existing drug <b>1</b> or <b>2</b> with more importantly a greater JAK1 selectivity. Indeed, the accepted dose by the FDA of <b>1</b> is low (5 mg BID), but some observation of reduced hemoglobin levels at higher doses (15 mg BID) during clinical trials was attributed to possible effects on hematopoiesis through inhibition of JAK2 and consequently its lack of selectivity. This led us to hypothesize that an increased degree of selectivity for JAK1 over JAK2 may be sufficient to provide a suitable therapeutic window.</div><div class="NLM_p">Analogues of <b>3</b> were primarily screened in JAK1 and JAK2 biochemical assays. Selectivity against JAK3 and TYK2 biochemical assay was subsequently evaluated for selected compounds. Biochemical JAK2 inhibition was assessed early in the screening cascade, due to the essential role of JAK2 in hematopoiesis, including EPO receptor signaling and red blood cell homeostasis as mentioned above.<a onclick="showRef(event, 'ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref13 ref14">(13, 14)</a> Assessment against a selectivity panel of 14 kinases was also employed for compounds of interest. The series appeared to be selective toward the JAK kinases, as none of an initial target list of 14 kinases were inhibited by the compound <b>3</b> at an IC<sub>50</sub> < 2 μM (∼>30-fold of selectivity) (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Selectivity towards 14 Kinase Panel (Biochemical Assay)</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">kinase</th><th class="colsep0 rowsep0" align="center" char=".">compd <b>3</b> IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center">kinase</th><th class="colsep0 rowsep0" align="center" char=".">compd <b>3</b> IC<sub>50</sub> (nM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">FGFR3</td><td class="colsep0 rowsep0" align="char" char=".">>5741</td><td class="colsep0 rowsep0" align="left">PYK2</td><td class="colsep0 rowsep0" align="char" char=".">3184</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GSK3β</td><td class="colsep0 rowsep0" align="char" char=".">7114</td><td class="colsep0 rowsep0" align="left">RIPK2</td><td class="colsep0 rowsep0" align="char" char=".">50978</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">IKKβ</td><td class="colsep0 rowsep0" align="char" char=".">24689</td><td class="colsep0 rowsep0" align="left">ROCK1</td><td class="colsep0 rowsep0" align="char" char=".">>10000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">LCK</td><td class="colsep0 rowsep0" align="char" char=".">4440</td><td class="colsep0 rowsep0" align="left">SYK</td><td class="colsep0 rowsep0" align="char" char=".">2272</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MAPKAPK5</td><td class="colsep0 rowsep0" align="char" char=".">>10000</td><td class="colsep0 rowsep0" align="left">TAK1</td><td class="colsep0 rowsep0" align="char" char=".">>10000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">p38α</td><td class="colsep0 rowsep0" align="char" char=".">>10000</td><td class="colsep0 rowsep0" align="left">TBK1</td><td class="colsep0 rowsep0" align="char" char=".">>4000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PKA</td><td class="colsep0 rowsep0" align="char" char=".">39986</td><td class="colsep0 rowsep0" align="left">CDK2</td><td class="colsep0 rowsep0" align="char" char=".">>10000</td></tr></tbody></table></div></div><div id="sec3" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> From Hit to Potent JAK Inhibitors (SAR)</h3><div class="NLM_p">For initial SAR development toward enhancing JAK1 selectivity, both the cyclopropyl and <i>para</i>-methoxy phenyl positions were explored via carefully designed parallel synthesis efforts.</div><div class="NLM_p">We first started investigating the 2-position of the triazolo-pyridine through replacement of the cyclopropylamide of the original hit. SAR rationalization efforts were supported by modeling using a proprietary docking model based on the JAK1 cocrystal structure incorporating <b>1</b>.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> The validity of this docking model was later confirmed by the crystal structure of JAK2 with compound <b>65</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>. Synthesized compounds without a free hydrogen atom on the amine at the 2-position (<b>24</b>, <b>26</b>, and <b>31</b>) essentially lost all activity on JAK1. Modeling studies indicate that an H-bond is formed with the main chain carbonyl of Leu959 of the hinge region, as shown in Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>A.</div><figure id="fig3" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm501262q/20141120/images/medium/jm-2014-01262q_0026.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm501262q/20141120/images/large/jm-2014-01262q_0026.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (A) Model of compound <b>3</b> docked in the JAK1 JH1 kinase domain. (B) Model of compound <b>3</b> docked in the JAK1 JH1 kinase domain. Molecular surface and side chains of residues within 5 Å of compound <b>3</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm501262q/20141120/images/large/jm-2014-01262q_0026.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501262q&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">From our early investigations on the JAK1 binding mode (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>A,B), it was initially expected that the core could be substituted with various solubilizing groups at the 2-position which would drive potency and improve the ADME profile, as this portion of the molecule would be directed toward the solvent region. However, replacement of the cyclopropyl amide moiety displayed in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a> showed the importance of this position on the activity and selectivity of the compounds. Surprisingly, close amide analogues, such as isopropylamide <b>28</b> or acetamide <b>29</b>, displayed much reduced potency against JAK1. Only the crystal structure obtained later (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>) gave a possible explanation for this SAR cliff. It was hypothesized that the superior ability of the cyclopropane ring to donate an H-bond could explain the SAR observations. Indeed, the <b>65</b>/JAK2 crystal structure shows a putative H-bond between the CH carbon atom of the cyclopropylamide and the carbonyl oxygen of Leu932 and of Pro933 in JAK2 (Pro960 and Leu959 in JAK1): bond length 3.3–3.4 Å. This type of interaction has been previously described in the literature.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Cyclopropanes and other hydrocarbons containing three-membered rings have a certain sp<sup>2</sup> character and gain substantial H-bond acidity. Furthermore, compounds <b>25</b> (methyl-cyclopropyl) and <b>28</b> (isopropylamide) support this hypothesis by having little or no activity and being unable to form this nonclassical hydrogen bond. Urea <b>33</b> bearing an additional H-donor is more potent than the ethylamide analogue <b>36</b>, but it should be noted that <b>33</b> loses selective against JAK2.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Substitution on Exocyclic NH<a class="ref internalNav" href="#tbl2-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm501262q/20141120/images/medium/jm-2014-01262q_0010.gif" alt="" id="fx3" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm501262q/20141120/images/medium/jm-2014-01262q_0011.gif" alt="" id="fx4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl2-fn1"><div class="footnote" id="tbl2-fn1"><sup>Table a</sup><p class="last">N/A, compound not active against JAK2; NT, not tested against JAK2. Compounds were tested at least twice unless indicated otherwise (<i>n</i> = 1). *(JAK2 IC<sub>50</sub>)/(JAK1 IC<sub>50</sub>). Biochemical IC<sub>50</sub> determination: recombinant JAK1 (Invitrogen), JAK2 (Carna Biosciences), the ATP concentration was equivalent to <i>K</i><sub>m</sub> value.</p></div></div><div></div></div><figure id="fig4" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm501262q/20141120/images/medium/jm-2014-01262q_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm501262q/20141120/images/large/jm-2014-01262q_0001.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (A) Crystal structure of JAK2 with compound <b>65</b>. (B) Detailed view of the X-ray crystal structure of compound <b>65</b> bound to the ATP-binding site of JAK2. Presumed hydrogen bonds involving compound <b>65</b> are represented as yellow lines with interatomic distances indicated in angstroms (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4P7E">4P7E</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm501262q/20141120/images/large/jm-2014-01262q_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501262q&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Directly linking alkyl groups to the exonitrogen (e.g., <b>32</b>) was not tolerated. Thus, potency on JAK1 was lost. This is postulated to be due to the difference in p<i>K</i><sub>a</sub> of the NH, preventing a strong H-bond with the carbonyl of the hinge and/or may be due to a higher flexibility of these substituents. In addition, the carbonyl in the amide functionality is directly involved in H-bond interactions with neighboring water molecules as observed in the X-ray structure of the JAK2/<b>65</b> crystal (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>). The loss of such interactions in the alkyl analogue could be detrimental for potent binding.</div><div class="NLM_p">Larger replacement of the cyclopropyl like benzylamides or replacement of the carbonyl by sulfonamides resulted in poorly active or inactive compounds toward JAK1, possibly due to suboptimal interaction with the hinge.</div><div class="NLM_p">The only suitable replacement of the cyclopropylamide group was the aniline <b>35</b>, increasing hugely the IC<sub>50</sub> to 2.8 nM, however, the selectivity profile shifted from JAK1 to JAK2 (further details on this JAK2 selective series have been described by others).<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Some other groups reported that bulkier groups in the hinge region were better tolerated in JAK2 than in JAK1 due to a larger available space in that area for JAK2. In summary, the cyclopropyl moiety appears to be a preferred substituent for JAK1 selectivity over JAK2.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a></div><div class="NLM_p">We next turned our attention to the SAR around the phenyl group at the 5-position of the triazolo[1,5-<i>a</i>]pyridine core (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). Replacement of phenyl by more polar heterocycles (compounds <b>42</b>–<b>44</b>) resulted in a substantial (8–20-fold) reduction in potency. This is consistent with modeling studies from which it was evident that the phenyl ring sits in a hydrophobic subpocket of JAK1, forming hydrophobic contacts with Leu881 (Leu855 in JAK2), Val938 (Val863 in JAK2), Ser963 (Ser936 in JAK2), Leu1010 (Leu983 in JAK2), and Gly1020 (Gly993 in JAK2) (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>B).</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Investigation on 5-Position<a class="ref internalNav" href="#tbl3-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm501262q/20141120/images/medium/jm-2014-01262q_0012.gif" alt="" id="fx5" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm501262q/20141120/images/medium/jm-2014-01262q_0013.gif" alt="" id="fx6" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl3-fn1"><div class="footnote" id="tbl3-fn1"><sup>Table a</sup><p class="last">NT = not tested. Compounds were tested at least twice unless indicated. *(JAK2 IC<sub>50</sub>)/(JAK1 IC<sub>50</sub>), (JAK3 IC<sub>50</sub>)/(JAK1 IC<sub>50</sub>), (TYK2 IC<sub>50</sub>)/(JAK1 IC<sub>50</sub>). Biochemical IC<sub>50</sub> determination: recombinant JAK1, TYK2 (Invitrogen), JAK2, and JAK3 (Carna Biosciences).</p></div></div><div></div></div><div class="NLM_p">Relative to the unsubstituted phenyl derivative <b>37</b>, substituents in the <i>ortho</i>-position caused a 2-fold decrease in potency for small substituents. This drop in potency was even higher for larger groups (for example compound <b>47</b>). This may be explained by a steric clash observed with the triazolopyridine scaffold, forcing an unfavorable off-planar conformation of the phenyl ring.</div><div class="NLM_p">In comparison, adding a chloro-substituent at the <i>meta</i>-position of the phenyl ring (compound <b>39</b>) has no effect on the potency of JAK1 inhibition but seems to be more favorable toward JAK2 inhibition. Consequently, it was observed that the most potent and most selective compounds were those with the 5-phenyl substituted at the <i>para</i>-position. Modeling studies confirmed that substituents in this position point toward the glycine-rich loop, where it is possible to make stabilizing interactions or have a positive impact on the water network. Indeed, this loop has been reported in numerous kinase crystal structures to be involved in a network of interactions with inhibitors and displays remarkable conformational flexibility, allowing accommodation of a vast array of ligands.</div><div class="NLM_p">Substitution at the 6-position of the scaffold appears not to be tolerated for JAK1 inhibition, as shown for compound <b>49</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). The reason lies in the skewed torsion of the phenyl ring at the 5-position provoked by the adjacent methoxy group. An isomeric scaffold was made by repositioning the ring junction nitrogen. Analogues of this isomeric scaffold, 8-substituted 2-amino-[1,2,4]triazolo[1,5-<i>a</i>]pyridine, had similar or slightly reduced potency (<b>48</b> vs <b>50</b>) and similar ADME properties (data not presented). On this scaffold, additional substitution also led to loss of potency (compound <b>52</b>). Finally, modification of the scaffold by addition of an extra nitrogen atom showed no inhibition of JAK1. It appears that the electronics of the pyrazolo-pyridine scaffold are optimal for binding in the JAK ATP pocket.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Changes on Scaffold<a class="ref internalNav" href="#tbl4-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm501262q/20141120/images/medium/jm-2014-01262q_0014.gif" alt="" id="fx7" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm501262q/20141120/images/medium/jm-2014-01262q_0015.gif" alt="" id="fx8" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl4-fn1"><div class="footnote" id="tbl4-fn1"><sup>Table a</sup><p class="last">N/A= not active. *(JAK2 IC<sub>50</sub>)/(JAK1 IC<sub>50</sub>). Biochemical IC<sub>50</sub> determination: recombinant JAK1 (Invitrogen), JAK2 (Carna Biosciences).</p></div></div><div></div></div><div class="NLM_p">Encouraged by these preliminary results of the 5-phenyl substituent, we then focused the SAR exploration on the <i>para</i>-position of this substitution.</div><div class="NLM_p">An illustrative selection of the synthesized substitutions at the <i>para</i>-position is presented in Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>. Substitution seems to increase the potency when large enough to contact the glycine rich loop. Sulfonamides in the <i>para</i>-position (e.g., <b>55</b>) gave high potencies. Unfortunately, permeability was found to be compromised for this subseries with high efflux observed (Caco2 assay, permeability apparent (A2B) 3.7 cm·10<sup>–6</sup> s<sup>–1</sup>; efflux ratio, 16.5). The best potency and selectivity for JAK1 was obtained with groups consisting of a long chain terminated by an aromatic group such as compound <b>56</b> or <b>58</b> or <b>59</b>. JAK1 has a histidine in the p-loop that can have a favorable interaction with aromatic moieties. In the number of substitutions that were explored, high selectivity was achieved for compound <b>58</b>, with 11-fold selectivity for JAK1 over JAK2 inhibition (the phenyl can directly interact with the histidine and the nitrile with the glycine rich loop) and low selectivity was obtained if the aromatic was substituted by an alkoxy-like compound <b>57</b> (less favorable in the interaction with the histidine). This lipophilic motif, unfortunately, was not compatible with good ADME properties, giving low solubility, low LiPE (<6), and often high intrinsic clearance (data not presented).</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. SAR of the <i>para</i>-Position<a class="ref internalNav" href="#tbl5-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm501262q/20141120/images/medium/jm-2014-01262q_0016.gif" alt="" id="fx9" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm501262q/20141120/images/medium/jm-2014-01262q_0017.gif" alt="" id="fx10" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl5-fn1"><div class="footnote" id="tbl5-fn1"><sup>Table a</sup><p class="last">*Not measured due to precipitation. *ASOL = kinetic solubility measure with 2% DMSO. PPB = plasma protein binding. Biochemical IC<sub>50</sub> determination: recombinant JAK1, TYK2 (Invitrogen), JAK2, and JAK3 (Carna Biosciences). ** LiPE (lipophilic efficiency) = pIC<sub>50</sub>-xlogP3.</p></div></div><div></div></div><div class="NLM_p last">Moderate activity was regained with the introduction of the polar, moderately basic, morpholinomethyl group in compound <b>60</b>. Moreover, promising in vitro properties surfaced in this series: <i>T</i><sub>1/2</sub> human microsome >90 min; no efflux with high permeability and good solubility and PPB of 70% in rat.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Good Aqueous Solubility and PPB with Improved Potency</h3><div class="NLM_p">Encouraged by the good ADME properties, we sought an alternative of the morpholine moiety. <b>60</b> was used as a reference compound for probing the structure–activity relationships of a diverse subset of amines to assess if identification of a compound with high potency and improved physical properties could be attained. In this small library, all compounds conserve the JAK1 selectivity, but only a few examples show attractive potency on JAK1.</div><div class="NLM_p">The nature of the <i>para</i>-substitution on the 5-phenyl substituent, in particular lipophilic groups, was found to have a pronounced effect on potency, as shown above. To extend the understanding of this effect, compound <b>60</b> bearing a morpholino-benzyl group was used as a starting point for the optimization of the LiPE and ADME properties of the series (Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>). Extended amines with strong basicity such as piperazine <b>61</b> appeared to be completely inactive against JAK1. The less basic piperidine analogue, 4-difluoropiperidine <b>63</b>, and the nonbasic trifluoro-amide gave rise to good potency but loss of selectivity and again decreased LiPE.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. SAR of the <i>para</i>-Phenyl Substitution<a class="ref internalNav" href="#tbl6-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm501262q/20141120/images/medium/jm-2014-01262q_0018.gif" alt="" id="fx11" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm501262q/20141120/images/medium/jm-2014-01262q_0019.gif" alt="" id="fx12" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl6-fn1"><div class="footnote" id="tbl6-fn1"><sup>Table a</sup><p class="last">*RLM: rat liver microsome (% remaining after 60 min). ***Caco2, permeability (A2B) 0.3 cm·10<sup>–6</sup> s<sup>–1</sup>; efflux ratio, 69. NT = not tested (racemic mixture). Biochemical IC<sub>50</sub> determination: recombinant JAK1, TYK2 (Invitrogen), JAK2, and JAK3 (Carna Biosciences). **LiPE (lipophilic efficiency) = pIC<sub>50</sub> – xlogP3. <sup>+</sup>In-house data.</p></div></div><div></div></div><div class="NLM_p">After extensive studies, the cyclic sulfone moiety was found to offer a good balance of selectivity and with a LiPE slightly lower than compound <b>1</b>, but still higher than 6 (Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>). Thus, compounds <b>65</b> and <b>64</b> reached a JAK1 potency below 50 nM with an improved selectivity of ∼2/3-fold over JAK2 in contrast to the potent but unselective <b>1</b>. Compound <b>64</b> was not profiled further due to the very low permeability observed in Caco2 and less attractive selectivity toward the other JAK-members (the two enantiomers were not separated). Compound <b>65</b> showed the best in vitro stability in rat; however compounds <b>60</b>, <b>63</b>, and <b>65</b> were all three advanced into rat PK studies.</div><div class="NLM_p">The PK properties of the three selected compounds are summarized in Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a>. Both <b>60</b> and <b>65</b> showed good oral bioavailability, with compound <b>65</b> displaying a longer half-life with a lower total plasma clearance than compound <b>60</b> as expected from in vitro data (Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>). Therefore, compound <b>65</b> was profiled further in a dog PK, demonstrating good oral bioavailability of 67% (Table <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a>).</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Pharmacokinetics in Rats<a class="ref internalNav" href="#tbl7-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center" char="."><b>60</b></th><th class="rowsep1 colsep0" colspan="2" align="center" char="."><b>65</b></th><th class="rowsep1 colsep0" align="center" char="."><b>63</b></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">IV 1 (mg/kg)</th><th class="colsep0 rowsep0" align="center" char=".">PO 5 (mg/kg)</th><th class="colsep0 rowsep0" align="center" char=".">IV 1 (mg/kg)</th><th class="colsep0 rowsep0" align="center" char=".">PO 5 (mg/kg)</th><th class="colsep0 rowsep0" align="center" char=".">PO 5 (mg/kg)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>C</i><sub>0</sub> or <i>C</i><sub>max</sub> (ng/mL)</td><td class="colsep0 rowsep0" align="char" char=".">863</td><td class="colsep0 rowsep0" align="char" char=".">1320</td><td class="colsep0 rowsep0" align="char" char=".">1407</td><td class="colsep0 rowsep0" align="char" char=".">310</td><td class="colsep0 rowsep0" align="char" char=".">547</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>T</i><sub>max</sub> (h)</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">0.33</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">2.2</td><td class="colsep0 rowsep0" align="char" char=".">0.25</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AUC<sub>(0–<i>z</i>)</sub> (ng·h/mL)</td><td class="colsep0 rowsep0" align="char" char=".">470</td><td class="colsep0 rowsep0" align="char" char=".">1437</td><td class="colsep0 rowsep0" align="char" char=".">739</td><td class="colsep0 rowsep0" align="char" char=".">1681</td><td class="colsep0 rowsep0" align="char" char=".">690</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Cl (L/h/kg)</td><td class="colsep0 rowsep0" align="char" char=".">2.12</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">1.35</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>V</i><sub>ss</sub> (L/kg)</td><td class="colsep0 rowsep0" align="char" char=".">1.46</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">1.76</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>T</i><sub>1/2</sub> (h)</td><td class="colsep0 rowsep0" align="char" char=".">0.74</td><td class="colsep0 rowsep0" align="char" char=".">0.92</td><td class="colsep0 rowsep0" align="char" char=".">1.6</td><td class="colsep0 rowsep0" align="char" char=".">3.9</td><td class="colsep0 rowsep0" align="char" char=".">0.92</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>F</i> (%)</td><td class="colsep0 rowsep0" align="char" char=".">62</td><td class="colsep0 rowsep0" align="char" char=".">45</td><td class="colsep0 rowsep0" align="char" char=".">N/A</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl7-fn1"><div class="footnote" id="tbl7-fn1"><sup>a</sup><p class="last">Formulation was in methyl cellulose (MC) 0.5%.</p></div></div></div><div class="NLM_table-wrap" id="tbl8"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 8. Pharmacokinetics in Dog<a class="ref internalNav" href="#tbl8-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center"><b>65</b></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">IV 1 (mg/kg)</th><th class="colsep0 rowsep0" align="center">PO 5 (mg/kg)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>C</i><sub>0</sub> or <i>C</i><sub>max</sub> (ng/mL)</td><td class="colsep0 rowsep0" align="center">1143</td><td class="colsep0 rowsep0" align="center">1807</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>T</i><sub>max</sub> (h)</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">1.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AUC<sub>(0–<i>z</i>)</sub> (ng·h/mL)</td><td class="colsep0 rowsep0" align="center">4098</td><td class="colsep0 rowsep0" align="center">13908</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Cl (L/h/kg)</td><td class="colsep0 rowsep0" align="center">0.25</td><td class="colsep0 rowsep0" align="center"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>V</i><sub>ss</sub> (L/kg)</td><td class="colsep0 rowsep0" align="center">1.7</td><td class="colsep0 rowsep0" align="center"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>T</i><sub>1/2</sub> (h)</td><td class="colsep0 rowsep0" align="center">7.5</td><td class="colsep0 rowsep0" align="center">5.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>F</i> (%)</td><td class="colsep0 rowsep0" colspan="2" align="center">67</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl8-fn1"><div class="footnote" id="tbl8-fn1"><sup>a</sup><p class="last">Formulation was in methyl cellulose (MC) 0.5%.</p></div></div></div><div class="NLM_p">The biochemical potency of the described compounds was measured at the <i>K</i><sub>m</sub> of ATP, whereupon compound <b>65</b> showed only a selectivity of 2.8 fold against JAK2, lower than that for recently reported JAK1 selective inhibitors.<a onclick="showRef(event, 'ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref22 ref23">(22, 23)</a> Discrepancies between enzyme and cellular data for JAK kinases has been recognized for some time, but only recently have potential explanations supported by experimentation been published to address these inconsistencies.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> A first explanation stipulates that in the cell, the concentration of ATP is accepted to be in the 1–5 mM range. Consequently, neither a <i>K</i><sub>i</sub> nor an IC<sub>50</sub> measurement at ATP <i>K</i><sub>m</sub> in an enzymatic assay represents a good evaluation of cellular activity for ATP competitive inhibitors.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> The second explanation is due to the role of the different JAK within the cells. In recent years, the importance of the JAKs in the heterodimeric pair has been the source of intensive research.<a onclick="showRef(event, 'ref6 ref11'); return false;" href="javascript:void(0);" class="ref ref6 ref11">(6, 11)</a> Thus, different groups have demonstrated the hierarchical role of the JAKs in the cytokine pathway, in particularly the dominant role of JAK1 in the IL2, IL22, or IL6 pathways. These later observations show that different selectivity profiles of inhibitors is obtained when looking at different cytokine pathways. Finally, shifts in biochemical potency and cellular potency between JAK2 and JAK1 have since been reported on other compound series by a number of research groups.<a onclick="showRef(event, 'ref23 ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref23 ref24 ref25">(23-25)</a></div><div class="NLM_p">Consequently, to assess the profile of compound <b>65</b> in potentially more relevant cellular settings, its potency and selectivity was determined in cellular and whole blood assays. Cellular assays were developed for cytokines employing different combinations of JAK hetero- and homodimers for signaling.</div><div class="NLM_p">Cell lines were preincubated with <b>65</b> and treated with cytokines that employ different JAK heterodimeric or JAK2 homodimeric complexes for signaling (Table <a class="ref showTableEvent internalNav" data-ID="tbl9" href="#tbl9">9</a>). Compound <b>65</b> inhibited JAK1/JAK3/γ<sub>c</sub> and JAK1/TYK2 signaling pathways most potently (IC<sub>50</sub> values from 150 to 760 nM), whereas JAK1/JAK2 signaling mediated by type II and gp130 receptor complexes or JAK2 signaling were inhibited, with low micromolar potencies. Compound <b>65</b> does not inhibit JAK2 homodimer-mediated signaling induced by EPO or PRL (IC<sub>50</sub> > 10 μM). Because of the selectivity of compound <b>65</b> against JAK3 and TYK2 in the biochemical assay and precedent literature that showed JAK1 dominance,<a onclick="showRef(event, 'ref6 ref11'); return false;" href="javascript:void(0);" class="ref ref6 ref11">(6, 11)</a> it can be concluded that inhibition of JAK/STAT signaling involving JAK1, JAK3, and TYK2 is certainly due to JAK1 inhibition. Hence, compound <b>65</b> preferentially inhibits JAK/STAT signaling involving JAK1 over JAK2 kinase in a cellular context. This observation was recently confirmed elsewhere, with a selectivity of >14 reported for compound <b>65</b> in cell assays using IL-6/pSTAT1 for JAK1 pathway and EPO/pSTAT5 for JAK2.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a></div><div class="NLM_table-wrap" id="tbl9"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 9. Cell Assays Employing Different JAK Heterodimeric or Homodimeric Complex<a onclick="showRef(event, 'ref8 ref26'); return false;" href="javascript:void(0);" class="ref ref8 ref26">(8, 26)</a> Copyright 2013. The American Association of Immunologists, Inc.</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">JAK involved</th><th class="colsep0 rowsep0" align="center">cell type</th><th class="colsep0 rowsep0" align="center">trigger</th><th class="colsep0 rowsep0" align="center">read-out</th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub>, nM (pIC<sub>50</sub> ± SEM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">JAK1-JAK3</td><td class="colsep0 rowsep0" align="left">THP-1</td><td class="colsep0 rowsep0" align="left">IL-4</td><td class="colsep0 rowsep0" align="left">pSTAT6</td><td class="colsep0 rowsep0" align="center">154, 203</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">JAK1-JAK3</td><td class="colsep0 rowsep0" align="left">NK-92</td><td class="colsep0 rowsep0" align="left">IL-2</td><td class="colsep0 rowsep0" align="left">pSTAT5</td><td class="colsep0 rowsep0" align="center">148, 757, 367</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">JAK1-TYK2</td><td class="colsep0 rowsep0" align="left">U2OS</td><td class="colsep0 rowsep0" align="left">IFN-αB2</td><td class="colsep0 rowsep0" align="left">pSTAT1</td><td class="colsep0 rowsep0" align="center">494, 436</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">JAK1-JAK2</td><td class="colsep0 rowsep0" align="left">HeLa</td><td class="colsep0 rowsep0" align="left">OSM</td><td class="colsep0 rowsep0" align="left">STAT1 reporter</td><td class="colsep0 rowsep0" align="center">1045</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">JAK1-JAK2</td><td class="colsep0 rowsep0" align="left">U2OS</td><td class="colsep0 rowsep0" align="left">INFγ</td><td class="colsep0 rowsep0" align="left">pSTAT1</td><td class="colsep0 rowsep0" align="center">3364</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">JAK2</td><td class="colsep0 rowsep0" align="left">TF-1</td><td class="colsep0 rowsep0" align="left">IL-3</td><td class="colsep0 rowsep0" align="left">pSTAT5</td><td class="colsep0 rowsep0" align="center">3524</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">JAK2</td><td class="colsep0 rowsep0" align="left">BaF3</td><td class="colsep0 rowsep0" align="left">IL-3</td><td class="colsep0 rowsep0" align="left">proliferation</td><td class="colsep0 rowsep0" align="center">4546</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">JAK2</td><td class="colsep0 rowsep0" align="left">UT7-EPO</td><td class="colsep0 rowsep0" align="left">EPO</td><td class="colsep0 rowsep0" align="left">pSTAT5</td><td class="colsep0 rowsep0" align="center">>10000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">JAK2</td><td class="colsep0 rowsep0" align="left">22Rv1</td><td class="colsep0 rowsep0" align="left">PRL</td><td class="colsep0 rowsep0" align="left">pSTAT5</td><td class="colsep0 rowsep0" align="center">>10000</td></tr></tbody></table></div></div><div class="NLM_p">Human blood was preincubated with the different compounds, and IL-6 or GM-CSF was added to stimulate respectively JAK1 or JAK2 signaling pathways (Table <a class="ref showTableEvent internalNav" data-ID="tbl10" href="#tbl10">10</a>). STAT1 and STAT5 phosphorylation levels respectively were measured in CD4<sup>+</sup> lymphocytes and CD33<sup>+</sup> monocytes.</div><div class="NLM_table-wrap" id="tbl10"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 10. Human Whole Blood Potency on JAK1 and JAK2 Signaling Pathway<a class="ref internalNav" href="#tbl10-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">IL6-induced pSTAT1 IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center">GM-CSF-induced pSTAT5 IC<sub>50</sub> (nM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>65</b></td><td class="colsep0 rowsep0" align="left">629 (<i>n</i> = 7)</td><td class="colsep0 rowsep0" align="left">17453 (<i>n</i> = 7)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>60</b></td><td class="colsep0 rowsep0" align="left">5590 (<i>n</i> = 3)</td><td class="colsep0 rowsep0" align="left">>30000 (<i>n</i> = 3)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>62</b></td><td class="colsep0 rowsep0" align="left">4467 (<i>n</i> = 3)</td><td class="colsep0 rowsep0" align="left">>30000 (<i>n</i> = 3)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>64</b></td><td class="colsep0 rowsep0" align="left">6152 (<i>n</i> = 3)</td><td class="colsep0 rowsep0" align="left">>30000 (<i>n</i> = 3)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>63</b></td><td class="colsep0 rowsep0" align="left">2749 (<i>n</i> = 3)</td><td class="colsep0 rowsep0" align="left">>10000 (<i>n</i> = 2), >30000 (<i>n</i> = 1)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">74 (<i>n</i> = 16)</td><td class="colsep0 rowsep0" align="left">740 (<i>n</i> = 7)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left">1053 (<i>n</i> = 5)</td><td class="colsep0 rowsep0" align="left">4982 (<i>n</i> = 2)</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl10-fn1"><div class="footnote" id="tbl10-fn1"><sup>a</sup><p class="last">Compound <b>65</b> displayed a high selectivity for JAK1 over JAK2 in a cellular environment.</p></div></div></div><div class="NLM_p">Once again, in this setting, compound <b>65</b> showed a higher selectivity (>27-fold) for JAK1 over JAK2 (Table <a class="ref showTableEvent internalNav" data-ID="tbl10" href="#tbl10">10</a>). We also confirmed that compound <b>65</b> was the most potent compound on JAK1 signaling within the series of compounds, with improved ADME properties (<b>60</b>, <b>62</b>, <b>63</b>, and <b>64</b> IC<sub>50</sub> > 2000). In the same assay, compounds <b>1</b> and <b>2</b> do not reach the same level of selectivity as compound <b>65</b>, with <b>65</b> being 3-fold more selective than <b>1</b>. This key finding provided optimizm for the first time that JAK1 selectivity could be achieved in vivo within this series. Remarkably, compound <b>2</b> only showed a weak potency in this assay, being 2-fold less potent than compound <b>65</b>, which was not predicted from its biochemical data. This apparent discrepancy was also shown elsewhere.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a></div><div id="sec4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> Extensive ADME Profiling of <b>65</b><a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a></h4><div class="NLM_p last">The in vitro ADME and safety pharmacology properties of compound <b>65</b> were assessed. Metabolic stability in vitro is favorable with 65%, 45%, and 87% of compound left respectively in rat, dog, and human liver microsomes after 60 min incubation and a half-life of more than 200 min in hepatocytes for all species. Permeability in a Caco-2 assay was found to be 3.5 × 10<sup>–6</sup> cm/s (<i>P</i><sub>app</sub> (A2B)) with an efflux ratio of 16, indicating that <b>65</b> is a substrate of P-gp (permeability increased in the presence of verapamil, P-gp inhibitor). However, despite the high efflux, good solubility of GLPG0634 allows high absorption in animal species (Tables <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a> and <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a>). Thermodynamic solubilities of the compound in aqueous buffer solutions of pH 3 and pH 7.4 are 243 and 40 μg/mL, respectively. Plasma protein bindings are 47.5% in rat, 28.9% in dog, and 31.8% in human. An initial assessment of potential cardiovascular toxicity was performed using a hERG patch clamp assay, in which compound <b>65</b> displayed a safe profile (IC<sub>50</sub> >100 μM). Inhibition of the major cytochrome P450 (CYP) isosymes (1A2, 2C9, 2C19, 2D6, and 3A4) is notably low, with an IC<sub>50</sub> >70 μM for each CYP450 tested.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> Kinase Profiling</h4><div class="NLM_p last">Following the identification of <b>65</b> as a lead molecule, in vitro selectivity was studied extensively. The compound was tested at 1 μM against a panel of 170 kinases. Of the 170 kinases tested, only weak inhibition was observed for hFLT3, hFLT4, and hCSF1R, with IC<sub>50</sub>s of 338, 274, and 489 nM, respectively. No off-target liabilities were identified upon screening a diverse panel of 99 GPCRs, ion channels, transporters, and nonkinase enzymes (data not shown).</div></div></div><div id="sec5" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Crystallography</h3><div class="NLM_p">To explore the binding mode of our selected inhibitor to the enzyme, <b>65</b> was cocrystallized with JAK2 JH1 domain crystals, as JAK1 cocrystal was not readily available at that time and because our modeling predicted a similar binding mode. As shown in Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>, <b>65</b> binds to the ATP binding pocket of JAK2, with the amino triazolopyridine core interacting with the hinge region of the kinase. The triazolopyridine ring is positioned against the hinge and forms via the exocyclic NH and the triazolo nitrogen N3 two hydrogen bonds with the main chain atoms of Leu932. The phenyl ring sits within a hydrophobic environment. The terminal thiomorpholine dioxide group packs against the glycine rich loop, forming polar interactions with main chain atoms of this flexible loop (Gly861, Ser862), the side chain of Val863, and the catalytic Lys882 and Asp994 of the DFG segment. This same binding should occur in all JAK ATP pockets and may explain the low selectivity observed in biochemical assay. In conclusion, the crystal structure does not explain the high selectivity observed in the whole blood assay.</div><div id="sec5_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> In Vivo Efficacy Assessment<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a></h4><div class="NLM_p">The rat collagen-induced arthritis (CIA) model was used to assess the potential therapeutic utility of <b>65</b> for the treatment of autoimmune arthritis, as it was shown previously that selective JAK1 inhibitor can be efficacious.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> We measured disease progression following daily oral administration of <b>65</b> at doses of 0.1, 0.3, 1, 3, 10, and 30 mg/kg in three separate studies. Disease severity was assessed periodically, scoring clinical signs of disease and comparing to a vehicle and an etanercept-treated group as positive control (Enbrel 10 mg/kg, 3 times/week). Data obtained from the three studies were normalized to the vehicle data for each experiment, allowing a meta-analysis of the three studies (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>). A dose-dependent effect was observed in all readouts. A statistically significant reduction of the clinical score was measured, surprisingly even at doses as low as 0.1 and 0.3 mg/kg.</div><figure id="fig5" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm501262q/20141120/images/medium/jm-2014-01262q_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm501262q/20141120/images/large/jm-2014-01262q_0002.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. CIA rat model.<a onclick="showRef(event, 'ref8 ref27'); return false;" href="javascript:void(0);" class="ref ref8 ref27">(8, 27)</a> Difference between the clinical score at day 0 and day 15 (meta-analysis of combined data obtained for the three studies after 15 d of treatment). E, etanercept; V, vehicle. 65 doses are indicated on the <i>x</i>-axis. The numbers of animals used to obtain a meta-analysis score for V, E, 0.1, 0.3, 1, 3, 10, and 30 mg/kg were 29, 10, 20, 20, 29, 20, 10, and 29, respectively. *<i>p</i>, 0.05; **<i>p</i>, 0.01; ***<i>p</i>, 0.001 versus vehicle, Student <i>t</i> test). Copyright 2013. The American Association of Immunologists, Inc.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm501262q/20141120/images/large/jm-2014-01262q_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501262q&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Only at 10 mg/kg, the concentration of <b>65</b> in blood covered whole blood IC<sub>50</sub> for almost 8 h (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>). At doses up to 3 mg/kg, the in vivo exposure of the compound barely reaches the IC<sub>50</sub> in the whole blood assay (IL-6/pSTAT1). Note that the potency of in the rat biochemical assay is in the same range as human (29 nM ± 8.9). In particular, showing efficacy for <b>65</b> in the rat CIA model at doses as low as 0.1 and 0.3 mg/kg, the latter confirmed in two separate experiments, was surprising. It is difficult to understand the strong efficacy of the compound at these low doses. As discussed by Van Rompaey et al., we cannot provide a definitive explanation for the exceptional efficacy of compound <b>65</b>.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> One can surmise that the very low protein binding of <b>65</b> allows for a rapid and extensive penetration into tissues, including the inflamed joints. FLT3 and FLT4 are the closest off-target kinases and their inhibition could contribute to the anti-inflammatory effects, but the >25-fold selectivity for JAK1 inhibition does not support this hypothesis.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> The compound is also known to form an active metabolite (compound <b>66</b>, Scheme <a class="ref internalNav" href="#sch6" aria-label="6">6</a>).<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> This metabolite is formed by simple hydrolysis of the electron deficient aniline in position 2 of the triazolo-pyridine and was found to be less potent than compound <b>65</b> while retaining a good JAK1 selectivity. The PK profile of <b>66</b> in humans show a high and sustained exposure, well exceeding the exposure of parent <b>65</b>, and this metabolite is understood to contribute to the overall clinical efficacy.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> However, at doses below 3 mg/kg in rats, plasma levels would still remain well below its IC<sub>50</sub> for JAK1 inhibition. Thus, none of the current hypotheses are truly satisfactory, and future work will need to identify more likely explanations.</div><figure id="fig6" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm501262q/20141120/images/medium/jm-2014-01262q_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm501262q/20141120/images/large/jm-2014-01262q_0003.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Steady state PK (day 9) of 65 in rat CIA. WBA IC<sub>50</sub> pSAT1/IL6 and GM_CSF/pSTAT5 are indicated.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm501262q/20141120/images/large/jm-2014-01262q_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501262q&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="sch6" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm501262q/20141120/images/medium/jm-2014-01262q_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm501262q/20141120/images/large/jm-2014-01262q_0009.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Structure of Compound <b>66</b>, Metabolite of Compound <b>65</b><a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm501262q/20141120/images/large/jm-2014-01262q_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501262q&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div></div><div id="sec6" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i26">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_74570" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_74570" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">A potent and novel series of JAK1 inhibitors was discovered from an initial screening hit to lead SAR study. Importantly, this has led to the identification of GLPG0634, the first reported selective JAK1 inhibitor in clinical trials. GLPG0634 exhibits: good potency in enzyme and cellular systems, selectivity against JAK2 in whole blood assays, good in vitro ADME properties, oral bioavailability in animal species, and dose-dependent efficacy in CIA with oral dosing. Results from two phase 2A studies in RA have shown an encouraging efficacy and safety profile, and compound <b>65</b> is being currently tested in phase 2B clinical trials in rheumatoid arthritis and phase 2A in inflammatory bowel disease.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a></div></div><div id="sec7" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i27">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_72181" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_72181" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec7_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> Biochemical Assays</h3><div class="NLM_p last">All details were reported in ref <a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">8</a>.</div></div><div id="sec7_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> Chemistry Procedures</h3><div class="NLM_p">All reagents were of commercial grade and were used as received without further purification unless otherwise stated. Commercially available anhydrous solvents were used for reactions conducted under inert atmosphere. Reagent grade solvents were used in all other cases unless otherwise specified. Column chromatography was performed on silica gel 60 (35–70 μm). Thin layer chromatography was carried out using precoated silica gel F-254 plates (thickness 0.25 mm). <sup>1</sup>H NMR spectra were recorded on a Bruker DPX 400 NMR spectrometer (400 MHz). Chemical shifts (δ) for <sup>1</sup>H NMR spectra are reported in parts per million (ppm) relative to tetramethylsilane (δ 0.00) or the appropriate residual solvent peak, i.e., CHCl<sub>3</sub> (δ 7.27), as internal reference. Multiplicities are given as singlet (s), doublet (d), triplet (t), quartet (q), multiplet (m), and broad (br). Coupling constants (<i>J</i>) are given in Hz. Electrospray MS spectra were obtained on a Micromass platform LC/MS spectrometer. Columns Used for LCMS analysis: Hichrom, Kromasil Eternity, 2.5 μm C18, 150 mm × 4.6 mm, Waters Xbridge 5 μm C18 (2), 250 mm × 4.6 mm (ref 86003117), Waters Xterra MS 5 μm C18, 100 mm × 4.6 mm (plus guard cartridge) (ref 186000486), Gemini-NX 3 μm C18, 100 mm × 3.0 mm (ref 00D-4453-Y0), Phenomenex Luna 5 μm C18 (2), 100 mm × 4.6 mm (plus guard cartridge) (ref 00D-4252-E0), Kinetix fused core 2.7 μm C18, 100 mm × 4.6 mm (ref 00D-4462-E0), Supelco, Ascentis Express C18 (ref 53829-U), or Hichrom Halo C18, 2.7 μm C18, 150 mm × 4.6 mm (ref 92814-702). LC-MS were recorded on a Waters Micromass ZQ coupled to a HPLC Waters 2795, equipped with a UV detector Waters 2996. LC were also run on a HPLC Agilent 1100 coupled to a UV detector Agilent G1315A. Preparative HPLC: Waters XBridge Prep C18 5 μm, ODB 19 mm ID × 100 mm L (part no. 186002978). All the methods are using MeCN/H<sub>2</sub>O gradients. H<sub>2</sub>O contains either 0.1% TFA or 0.1% NH<sub>3</sub>.</div><div id="sec7_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> General Procedure for Monoacylation</h4><div class="NLM_p last">To a solution of the triazolo[1,5-<i>a</i>]pyridin-2-ylamine intermediate (1 equiv) in dry CH<sub>3</sub>CN at 5 °C was added Et<sub>3</sub>N (2.5 equiv) followed by the acyl chloride (2.5 equiv). The reaction mixture was then allowed to warm to rt and stirred until all starting material was consumed. If required, further Et<sub>3</sub>N (1 equiv) and acyl chloride (1 equiv) were added to ensure complete reaction. Following solvent evaporation in vacuum, the resultant residue was treated with 7 N methanolic ammonia solution and stirred at rt (for 1–16 h) to hydrolyze any bis-acylated product. Product isolation was made by removal of volatiles in vacuum followed by trituration with Et<sub>2</sub>O. The solids were collected by filtration, washed with H<sub>2</sub>O, acetone, and Et<sub>2</sub>O, and then dried in vacuum to give the required desired compound.</div></div><div id="sec7_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> General Procedure for Suzuki Coupling</h4><div class="NLM_p last">The appropriate boronic acid or boronic pinacol ester (2 equiv) was added to a solution of the halide intermediate in 1,4-dioxane/water (5:1). K<sub>2</sub>CO<sub>3</sub> (2 equiv) and PdCl<sub>2</sub>dppf (0.05 equiv) were added to the solution. The resulting mixture was then heated in a microwave at 140 °C for 30 min (this reaction can also be carried out by traditional heating in an oil bath at 90 °C for 16h under N<sub>2</sub>). Water was added, and the solution was extracted with EtOAc. The organic layers were dried over anhydrous MgSO<sub>4</sub> and evaporated in vacuum. The compound was obtained after purification by flash chromatography or preparative HPLC. HPLC: Waters XBridge Prep C18 5 μm, ODB 19 mm ID × 100 mm L (part no. 186002978). All the methods used MeCN/H<sub>2</sub>O gradients. H<sub>2</sub>O contains either 0.1% TFA or 0.1% NH<sub>3</sub>.</div></div><div id="sec7_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> Preparation of 1-(6-Bromo-pyridin-2-yl)-3-carboethoxy-thiourea (<b>5</b>)</h4><div class="NLM_p last">To a solution of 2-amino-6-bromopyridine (<b>4</b>) (253.8 g, 1.467 mol) in DCM (2.5 L) cooled to 5 °C was added ethoxycarbonyl isothiocyanate (173.0 mL, 1.467 mol) dropwise over 15 min. The reaction mixture was then allowed to warm to room temp (20 °C) and stirred for 16 h. Evaporation in vacuum gave a solid, which was collected by filtration, thoroughly washed with petrol (3 × 600 mL), and air-dried to afford (<b>5</b>) (100% of conversion observed by UPLC). The thiourea was used as such for the next step without any purification (purity, 99% by UPLC). <sup>1</sup>H (400 MHz, CDCl<sub>3</sub>) δ 12.03 (1H, br s, NH), 8.81 (1H, d, <i>J</i> = 7.8 Hz, H-3), 8.15 (1H, br s, NH), 7.60 (1H, t, <i>J</i> = 8.0 Hz, ArH), 7.32 (1H, dd, <i>J</i> = 7.7 and 0.6 Hz, ArH), 4.31 (2H, q, <i>J</i> = 7.1 Hz, CH<sub>2</sub>), 1.35 (3H, t, <i>J</i> = 7.1 Hz, CH<sub>3</sub>).</div></div><div id="sec7_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> Preparation of 5-Bromo-[1,2,4]triazolo[1,5-<i>a</i>]pyridin-2-ylamine (<b>6</b>)</h4><div class="NLM_p last">To a suspension of hydroxylamine hydrochloride (101.8 g, 1.465 mol) in EtOH/MeOH (1:1, 900 mL) was added <i>N</i>,<i>N</i>-diisopropylethylamine (145.3 mL, 0.879 mol), and the mixture was stirred at rt (20 °C) for 1 h. 1-(6-Bromo-pyridin-2-yl)-3-carboethoxy-thiourea (<b>5</b>) (89.0 g, 0.293 mol) was then added and the mixture slowly heated to reflux (note: bleach scrubber is required to quench H<sub>2</sub>S evolved). After 3 h at reflux, the mixture was allowed to cool and filtered to collect the precipitated solid. Further product were collected by evaporation under vacuum of the filtrate, addition of H<sub>2</sub>O (250 mL), and filtration. The combined solids were washed successively with H<sub>2</sub>O (250 mL), EtOH/MeOH (1:1, 250 mL), and Et<sub>2</sub>O (250 mL) and then dried under vacuum to afford the triazolopyridine derivative (<b>6</b>) as a solid (100% conversion observed by UPLC. The compound was used as such for the next step without any purification (99% purity by UPLC). <sup>1</sup>H (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.43–7.34 (2H, m, ArH), 7.24 (1H, dd, <i>J</i> = 6.8 and 1.8 Hz, ArH), 6.30 (2H, br, NH<sub>2</sub>). LCMS <i>m</i>/<i>z</i> 213/215 (1:1, M + H<sup>+</sup>, 100%).</div></div><div id="sec7_2_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> Preparation of Cyclopropanecarboxylic Acid (5-Bromo-[1,2,4]triazolo[1,5-<i>a</i>]pyridin-2-yl)-amide <b>9</b></h4><div class="NLM_p last">Starting from 5-bromo-[1,2,4]triazolo[1,5-<i>a</i>]pyridin-2-ylamine, <b>6</b> (0.15 mg, 0.7 mmol), cyclopropanecarbonylacid chloride (0.159 mL, 1.76 mmol), and triethylamine (0.25 mL, 1.76 mmol), compound <b>9</b> was prepared in 79% yield (99% purity by UPLC), using the general procedure for monoacylation. <sup>1</sup>H (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.18 (1H, br s, NH), 7.71 (1H, dd, <i>J</i> = 8.5 and 1.3 Hz, ArH), 7.56 (1H, t, <i>J</i> = 7.6 Hz, ArH), 7.48 (1H, dd, <i>J</i> = 7.6 and 1.3 Hz, ArH), 2.05 (1H, br, CH), 0.84–0.83 (4H, m, 2 × CH<sub>2</sub>). LCMS <i>m</i>/<i>z</i> 281.0/283.0 (1:1, M + H<sup>+</sup>).</div></div><div id="sec7_2_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> Preparation of Cyclopropanecarboxylic Acid [5-(4-Methoxy-phenyl)-[1,2,4]triazolo[1,5-<i>a</i>]pyridin-2-yl]-amide, <b>3</b></h4><div class="NLM_p last">Starting from 4-methoxyphenyl boronic acid (0.132 mg, 0.85 mmol) and cyclopropanecarboxylic acid (5-bromo-[1,2,4]triazolo[1,5-<i>a</i>]pyridin-2-yl)-amide <b>9</b> (0.120 mg, 0.42 mmol), compound <b>3</b> was prepared using the general procedure for the Suzuki coupling reaction. Purification by silica chromatography (EtOAc/petrol ether; 50:50) afforded the desired compound in 15% yield (99% purity by UPLC). LCMS <i>m</i>/<i>z</i> 309.8 (M + H<sup>+</sup>). <sup>1</sup>H (400 MHz, CDCl<sub>3</sub>) 9.12 (1H, br s, NH), 7.97 (2H, d, <i>J</i> = 8.5 Hz, ArH), 7.60 (21H, m, ArH), 7.08 (3H, m, ArH), 7.09 (2H, d, <i>J</i> = 8.8 Hz, ArH), 3.90 (3H, s, OCH<sub>3</sub>), 1.60 (1H, under water peak, CH), 1.00–0.81 (4H, m, 2 × CH<sub>2</sub>).</div></div><div id="sec7_2_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> Preparation of 5-(4-Methoxy-phenyl)-[1,2,4]triazolo[1,5-<i>a</i>]pyridin-2-ylamine <b>7</b></h4><div class="NLM_p last">Starting from 4-methoxyphenyl boronic acid (0.282 mmol, 42.80 mg) and 5-bromo-[1,2,4]triazolo[1,5-<i>a</i>]pyridin-2-ylamine <b>6</b> (0.141 mmol, 30 mg), compound <b>7</b> was prepared using the general procedure for the Suzuki coupling reaction. Recrystallization with MeOH/EtOAc afforded the desired compound in 82% yield (28 mg, 99% purity by UPLC). LCMS <i>m</i>/<i>z</i> 241.1 (M + H<sup>+</sup>).</div></div><div id="sec7_2_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> Preparation of 2-Iodo-5-(4-methoxy-phenyl)-[1,2,4] triazolo[1,5-<i>a</i>]pyridine <b>8</b></h4><div class="NLM_p last">A solution of 57% aqueous HI (8.4 mL) in DMSO (20 mL) was added dropwise to a solution of 5-(4-methoxy-phenyl)-[1,2,4]triazolo[1,5-<i>a</i>]pyridin-2-ylamine <b>7</b> (5.4 g, 23 mmol) in a mixture of NaNO<sub>2</sub> in DMSO (6.3 g in 30 mL of DMSO) at 35 °C with stirring. The mixture was stirred at 35 °C for 10 min (monitored by LCMS), and then it was transferred to a solution containing K<sub>2</sub>CO<sub>3</sub> (10 g) in 80 mL of water. The reaction mixture was taken up in EtOAc, and the extract was washed with water, dried (MgSO<sub>4</sub>), filtered, and concentrated under vacuum. The crude product was obtained in 72% yield and was used without further purification (99% purity by UPLC). LCMS <i>m</i>/<i>z</i> 351.8 (M + H<sup>+</sup>).</div></div><div id="sec7_2_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> Preparation of Cyclopropanecarboxylic Acid [5-(4-Methoxy-phenyl)-[1,2,4]triazolo[1,5-<i>a</i>]pyridin-2-yl]-methyl-amide <b>26</b> and 5-(4-Methoxy-phenyl)-[1,2,4]triazolo[1,5-<i>a</i>]pyridin-2-yl]-dimethyl-amine <b>24</b></h4><div class="NLM_p">To compound <b>3</b> (25 mg, 0.080 mmol) in dry THF (0.5 mL) at 0 °C was added NaH (60% dispersion, 0.20 mmol, 6 mg) followed by MeI (6 μL, 0.097 mmol), and the mixture was stirred at rt for 2 h. The solution was quenched with water, extracted with ethyl acetate, dried (MgSO<sub>4</sub>), filtered, and concentrated under vacuum. The crude material contained both title compounds <b>26</b> and <b>24</b> that were purified by preparative HPLC (<b>26</b>, 7 mg, 28% yield; <b>24</b>, 4 mg, 13% yield)</div><div class="NLM_p">Compound <b>24</b>: (99% purity by UPLC). LCMS <i>m</i>/<i>z</i> 269.1 (M + H<sup>+</sup>). <sup>1</sup>H (400 MHz, CDCl<sub>3</sub>) 8.04 (2H, d, <i>J</i> = 8.9 Hz, ArH), 7.37–7.40 (2H, m, ArH), 7.05 (2H, d, <i>J</i> = 9.0 Hz, ArH), 6.87 (1H, m, ArH), 3.9 (3H, s, OCH<sub>3</sub>), 3.16 (6H, s, 2 × CH<sub>3</sub>).</div><div class="NLM_p last">Compound <b>26</b>: (99% purity by LCMS): LCMS <i>m</i>/<i>z</i> 323.1 (M + H<sup>+</sup>). <sup>1</sup>H (400 MHz, CDCl<sub>3</sub>) 7.97 (2H, d, <i>J</i> = 8.8 Hz ArH), 7.62 (2H, m, ArH), 7.12 (1H, dd, <i>J</i> = 2.8, 5.8 Hz ArH), 7.06 (2H, d, <i>J</i> = 8.8 Hz, ArH), 3.92 (3H, s, OCH<sub>3</sub>), 3.53 (3H, s, CH<sub>3</sub>), 2.65–2.57 (1H, m, CH), 1.17–1.12 (2H, m, CH<sub>2</sub>), 0.85–0.81 (2H, m, CH<sub>2</sub>).</div></div><div id="sec7_2_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> Preparation of 1-Methyl-cyclopropanecarboxylic Acid [5-(4-Methoxy-phenyl)-[1,2,4]triazolo[1,5-<i>a</i>]pyridin-2-yl]-amide <b>25</b></h4><div class="NLM_p">Step i: Preparation of 1-methyl-cyclopropanecarbonyl chloride.</div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm501262q/20141120/images/medium/jm-2014-01262q_0021.gif" alt="" id="fx1" /></img><div class="NLM_p">1-Methyl-cyclopropanecarboxylic acid (84 mg, 0.83 mmol) was dissolved in DCM with a catalytic amount of DMF (1 drop) under nitrogen. The mixture was cooled to 5 °C, and SOCl<sub>2</sub> (84 μL, 1.16 mmol) was added dropwise. The excess of solvent and reagent was evaporated under vacuum, and the obtained acid chloride was used without further purification.</div><div class="NLM_p last">Step ii: Preparation of 1-methyl-cyclopropanecarboxylic acid [5-(4-methoxy-phenyl)-[1,2,4]triazolo[1,5-<i>a</i>]pyridin-2-yl]-amide <b>25</b>. Using the previously made acid chloride and the amine <b>7</b>, compound <b>25</b> was obtained in 48% yield using the general procedure for monoacylation (99% purity by UPLC). <sup>1</sup>H (400 MHz, CDCl<sub>3</sub>) 9.19 (1H, br s, NH), 7.99 (2H, d, <i>J</i> = 8.8 Hz, ArH), 7.66 (1H, dd, <i>J</i> = 8.8, 7.6 Hz, ArH), 7.60 (1H, d, <i>J</i> = 8.4 Hz, ArH), 7.18 (1H, dd, <i>J</i> = 7.2, 1.2 Hz, ArH), 7.09 (2H, d, <i>J</i> = 8.8 Hz, ArH), 3.88 (3H, s, OCH<sub>3</sub>), 1.50 (3H, s, CH<sub>3</sub>), 1.41 (2H, dd, <i>J</i> = 7.2, 4.4 Hz, CH<sub>2</sub>), 0.75 (2H, dd, <i>J</i> = 6.8, 4.4 Hz, CH<sub>2</sub>). LCMS <i>m</i>/<i>z</i> 323.0 (M + H<sup>+</sup>).</div></div><div id="sec7_2_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> Preparation of Cyclopropanesulfonic Acid [5-(4-Methoxy-phenyl)-[1,2,4]triazolo[1,5-<i>a</i>]pyridin-2-yl]-amide <b>27</b></h4><div class="NLM_p last">A mixture of compound <b>8</b> (100 mg, 0.28 mmol), cyclopropanesulfonamide (42 mg, 0.34 mmol), Pd(OAc)<sub>2</sub> (28 mg, 0.12 mmol), Xantphos (72 mg, 0.12 mmol), and Cs<sub>2</sub>CO<sub>3</sub> (446 mg, 1.36 mmol) in dry 1,4-dioxane (1.8 mL) was degassed under nitrogen and then stirred at 120 °C until completion. The resulting mixture was diluted with EtOAc and washed with water. The organic layer was dried (MgSO<sub>4</sub>), filtered, and concentrated in vacuum. Purification by preparative HPLC gave the desired product (3 mg, 3% yield) (86% purity by UPLC). <sup>1</sup>H (400 MHz, CDCl<sub>3</sub>) δ 7.96 (2H, d, <i>J</i> = 8.8 Hz, ArH), 7.72 (1H, dd, <i>J</i> = 8.8, 1.2 Hz, ArH), 7.57 (1H, dd, <i>J</i> = 8.8, 7.2 Hz, ArH), 7.08–7.04 (3H, m, ArH), 3.90 (3H, s, OCH<sub>3</sub>), 3.08–3.02 (1H, m, CH), 1.47–1.43 (2H, m, CH<sub>2</sub>), 1.08–1.03 (2H, m, CH<sub>2</sub>). LCMS <i>m</i>/<i>z</i> 344.9 (M + H<sup>+</sup>).</div></div><div id="sec7_2_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> Preparation of <i>N</i>-[5-(4-Methoxy-phenyl)-[1,2,4]triazolo[1,5-<i>a</i>]pyridin-2-yl]-isobutyramide <b>28</b></h4><div class="NLM_p last">Starting from compound <b>7</b> (20 mg, 0.083 mmol) and isobutyryl chloride (0.022 mL, 0.208 mmol), compound <b>28</b> was obtained in 85% yield using the general procedure for monoacylation (22 mg, 99% purity by HPLC). <sup>1</sup>H (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.71 (1H, s, NH), 8.03 (2H, d, <i>J</i> = 8.8 Hz, ArH), 7.70 (1H, dd, 8.8, 7.2 Hz, ArH), 7.64 (1H, dd, <i>J</i> = 8.8, 1.6 Hz, ArH), 7.27 (1H, dd, <i>J</i> = 7.2, 1.2 Hz, ArH), 7.13 (2H, d, <i>J</i> = 8.8 Hz, ArH), 3.86 (3H, s, OCH<sub>3</sub>), 2.77 (1H, br, CH), 1.11–1.08 (6H, m, 2 × CH<sub>3</sub>). LCMS <i>m</i>/<i>z</i> 311.0 (M + H<sup>+</sup>).</div></div><div id="sec7_2_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> Preparation of <i>N</i>-[5-(4-Methoxy-phenyl)-[1,2,4]triazolo[1,5-<i>a</i>]pyridin-2-yl]-acetamide <b>29</b></h4><div class="NLM_p">Step i: Preparation of <i>N</i>-(5-bromo-[1,2,4]triazolo[1,5-<i>a</i>]pyridin-2-yl)-acetamide.</div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm501262q/20141120/images/medium/jm-2014-01262q_0022.gif" alt="" id="fx2" /></img><div class="NLM_p">Starting from compound <b>6</b> (50 mg, 0.235 mmol) and acetyl chloride (0.042 mL, 0.587 mmol), the title compound was obtained in 73% yield using the general procedure for monoacylation (44 mg). LCMS <i>m</i>/<i>z</i> 255.1/257.1 (1:1; M + H<sup>+</sup>). The compound was used in the next step without further purification.</div><div class="NLM_p last">Step ii: Starting from <i>N</i>-(5-bromo-[1,2,4]triazolo[1,5-<i>a</i>]pyridin-2-yl)-acetamide (44 mg, 0.172 mmol) and 4-methoxyphenyl boronic acid (52.4 mg, 0.345 mmol), compound <b>29</b> was obtained in 25% yield using the general procedure for Suzuki coupling (13 mg) (99% purity by UPLC). <sup>1</sup>H (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.69 (1H, br s, NH), 8.01 (2H, d, <i>J</i> = 8.8 Hz, ArH), 7.69 (1H, dd, <i>J</i> = 8.8, 6.8 Hz, ArH), 7.64 (1H, dd, <i>J</i> = 8.8, 1.2 Hz, ArH), 7.26 (1H, dd, <i>J</i> = 7.2, 1.2 Hz, ArH), 7.12 (2H, d, <i>J</i> = 8.8 Hz, ArH), 3.86 (3H, s, OCH<sub>3</sub>), 2.14 (3H, br s, CH<sub>3</sub>). LCMS <i>m</i>/<i>z</i> 283.1 (M + H<sup>+</sup>).</div></div><div id="sec7_2_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> Preparation of <i>N</i>-[5-(4-Methoxy-phenyl)-[1,2,4]triazolo[1,5-<i>a</i>]pyridin-2-yl]-benzamide <b>30</b></h4><div class="NLM_p last">Starting from compound <b>7</b> (20 mg, 0.083 mmol) and benzoyl chloride (0.024 mL, 0.208 mmol), compound <b>30</b> was prepared in 21% yield using the general procedure for monoacylation (7 mg) (99% purity established by UPLC). <sup>1</sup>H (400 MHz, CDCl<sub>3</sub>) δ 10.9 (1H, br s, NH), 8.01–7.99 (4H, m, ArH), 7.67–7.50 (5H, m, ArH), 7.15 (1H, d, <i>J</i> = 6.4 Hz, ArH), 7.07 (2H, d, <i>J</i> = 8.8 Hz, ArH), 3.88 (3H, s, OCH<sub>3</sub>). LCMS <i>m</i>/<i>z</i> 345.1 (M + H<sup>+</sup>).</div></div><div id="sec7_2_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> Preparation of 5-(4-Methoxy-phenyl)-2-piperidin-1-yl-[1,2,4]triazolo[1,5-<i>a</i>]pyridine <b>31</b></h4><div class="NLM_p last">A mixture of 2-chloro-5-(4-methoxy-phenyl)-[1,2,4]triazolo[1,5-<i>a</i>]pyridine (30 mg, 0.116 mmol), piperidine (14 μL, 0.114 mmol), and DIPEA (0.22 mmol) in <i>t</i>-BuOH (0.5 mL) was heated at 120 °C for 14 days. The resulting mixture was diluted with EtOAc and washed with water (3 times). The organics were dried (MgSO<sub>4</sub>), filtered, and concentrated to give the desired compound in 31% yield (99% purity by UPLC). <sup>1</sup>H (400 MHz, CD<sub>3</sub>OD) δ 8.00 (2H, d, <i>J</i> = 9.2 Hz, ArH), 7.85 (1H, dd, <i>J</i> = 8.8, 7.6 Hz, ArH), 7.52 (1H, dd, <i>J</i> = 8.8, 1.2 Hz, ArH), 7.37 (1H, dd, <i>J</i> = 7.6, 1.6 Hz, ArH), 7.12 (2H, d, <i>J</i> = 8.8 Hz, ArH), 3.91 (3H, s, OCH<sub>3</sub>), 3.59 (1H, br, 2 × CH<sub>2</sub>), 1.73 (6H, br, 3 × CH<sub>2</sub>). LCMS <i>m</i>/<i>z</i> 309.0 (M + H<sup>+</sup>).</div></div><div id="sec7_2_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> Preparation of Cyclopropylmethyl-[5-(4-methoxy-phenyl)-[1,2,4]triazolo[1,5-<i>a</i>]pyridin-2-yl]-amine <b>32</b></h4><div class="NLM_p last">A mixture of cyclopropanecarboxaldehyde (15 μL, 0.166 mmol), compound <b>7</b> (20 mg, 0.083 mmol) and Ti(O<i>i</i>Pr)<sub>4</sub> (64 μL, 0.194 mmol) was stirred at rt. After 1 h, the mixture was diluted with EtOH (0.1 mL), Na(CN)BH<sub>3</sub> (6 mg, 0.083 mmol) was added, and the solution was stirred for 20 h. Water (2 mL) was added with stirring, and the resulting precipitate was filtered and washed with EtOH. The filtrate was concentrated, dissolved in EtOAc, filtered to remove the remaining inorganic solids, and concentrated under vacuum. Purification by preparative HPLC afforded the desired compound in 28% yield (99% purity by UPLC). <sup>1</sup>H (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.98 (2H, d, <i>J</i> = 9.2 Hz, ArH), 7.55 (1H, dd, <i>J</i> = 8.8, 7.6 Hz, ArH), 7.37 (1H, dd, <i>J</i> = 8.8, 1.2 Hz, ArH), 7.11–7.06 (3H, m, ArH), 3.85 (3H, s, OCH<sub>3</sub>), 3.12 (1H, d, <i>J</i> = 6.8 Hz, CH<sub>2</sub>), 1.11–1.04 (1H, m, CH), 0.44–0.39 (2H, m, CH<sub>2</sub>), 0.24–0.21 (2H, m, CH<sub>2</sub>). LCMS <i>m</i>/<i>z</i> 295.1 (M + H<sup>+</sup>).</div></div><div id="sec7_2_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> Preparation of 1-[5-(4-Methoxy-phenyl)-[1,2,4]triazolo[1,5-<i>a</i>]pyridin-2-yl]-3-methyl-urea <b>33</b></h4><div class="NLM_p last">To a mixture of compound <b>7</b> (30 mg, 0.125 mmol) in DCM (0.3 mL) was added DIPEA (50 μL, 0.289 mmol) followed by 4-nitrophenyl chloroformate (31 mg, 0.150 mmol), and the mixture was stirred for 20. Then methylamine (27 mg, 0.875 mmol) and DIPEA (0.15 mL, 0.875 mmol) were added. After completion, the resulting mixture was diluted with EtOAc and washed with aq satd NaHCO<sub>3</sub> (3×). The organic was dried (MgSO<sub>4</sub>), filtered, and concentrated under vacuum. Purification by preparative HPLC afforded the desired compound in 16% yield (99% purity by UPLC). <sup>1</sup>H (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.88 (1H, s, NH), 8.14 (1H, app d, <i>J</i> = 5.2 Hz, NH), 7.96 (2H, d, <i>J</i> = 8.8 Hz, ArH), 7.71 (1H, dd, <i>J</i> = 8.8, 7.2 Hz, ArH), 7.62 (1H, dd, <i>J</i> = 8.8, 1.6 Hz, ArH), 7.24 (1H, dd, <i>J</i> = 7.2, 1.2 Hz, ArH), 7.13 (2H, d, <i>J</i> = 8.8 Hz, ArH), 3.86 (3H, s, OCH<sub>3</sub>), 2.78 (3H, d, <i>J</i> = 4.4 Hz, CH<sub>3</sub>). LCMS <i>m</i>/<i>z</i> 298.0 (M + H<sup>+</sup>).</div></div><div id="sec7_2_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> Preparation of 5-(4-Methoxy-phenyl)-2-pyridin-3-yl-[1,2,4]triazolo[1,5-<i>a</i>]pyridine <b>34</b></h4><div class="NLM_p last">A mixture of the 2-pyridine boronic acid (29 mg, 0.23 mmol), 2-chloro-5-(4-methoxy-phenyl)-[1,2,4]triazolo[1,5-<i>a</i>]pyridine (30 mg, 0.23 mmol), K<sub>2</sub>CO<sub>3</sub> (80 mg, 0.58 mmol), and PdCl<sub>2</sub>dppf (13 mg, 0.012 mmol) in DME/water/EtOH (7:3:2 (v:v:v), 0.5 mL) was heated for 30 min at 140 °C in a microwave reactor. The resulting mixture was diluted with EtOAc and washed with water (3 times). The organic was dried (MgSO<sub>4</sub>), filtered, and evaporated under vacuum. Purification by preparative HPLC afforded the desired compound in 43% yield (99% purity by UPLC). <sup>1</sup>H (400 MHz, CDCl<sub>3</sub>) δ 9.61 (1H, s, ArH), 8.98 (1H, d, <i>J</i> = 7.6 Hz, ArH), 8.79 (1H, d, <i>J</i> = 4.8 Hz, ArH), 7.71 (2H, d, <i>J</i> = 8.4 Hz, ArH), 7.80–7.54 (2H, m, ArH), 7.67 (1H, dd, <i>J</i> = 8.4, 7.6 Hz, ArH), 7.18 (1H, dd, <i>J</i> = 7.2, 1.2 Hz, ArH), 7.11 (2H, d, <i>J</i> = 8.4 Hz, ArH), 3.94 (3H, s, OCH<sub>3</sub>). LCMS <i>m</i>/<i>z</i> 303.0 (M + H<sup>+</sup>).</div></div><div id="sec7_2_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> Preparation of [5-(4-Methoxy-phenyl)-[1,2,4]triazolo[1,5-<i>a</i>]pyridin-2-yl]-phenyl-amine <b>35</b></h4><div class="NLM_p last">A mixture of 2-chloro-5-(4-methoxy-phenyl)-[1,2,4]triazolo[1,5-<i>a</i>]pyridine (30 mg, 0.086 mmol), <i>N</i>-(4-amino-phenyl)-acetamide (14.2 mg, 0.095 mmol), Pd(OAc)<sub>2</sub> (2 mg, 0.0086 mmol), BINAP (5.4 mg, 0.0086 mmol), and Cs<sub>2</sub>CO<sub>3</sub> (140 mg, 0.43 mmol) in toluene (0.5 mL) was degassed under nitrogen and then stirred at 100 °C for 15 h. The resulting mixture was diluted with EtOAc and washed with water (3 times). The organic layer was dried (MgSO<sub>4</sub>), filtered, and concentrated under vacuum. Purification by preparative HPLC to give the desired product in 31% yield (10 mg, 99% purity by UPLC). <sup>1</sup>H (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.76 (1H, s, NH); 9.51 (1H, s, NH), 8.04 (2H, d, <i>J</i> = 8.8 Hz, ArH), 7.60 (3H, m, <i>J</i> = 9.0, 8.8, 7.4 Hz, ArH), 7.51 (1H, dd, <i>J</i> = 8.8, 1.2 Hz, ArH), 7.44 (2H, d, <i>J</i> = 9.2 Hz, ArH), 7.14 (2H, d, <i>J</i> = 8.9 Hz, ArH), 7.13 (1H, dd, <i>J</i> = 7.32, 1.3 Hz, ArH), 3.87 (3H, s, OCH<sub>3</sub>);, 2.01 (3H, s, CH<sub>3</sub>)..</div></div><div id="sec7_2_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> Preparation of <i>N</i>-[5-(4-Methoxy-phenyl)-[1,2,4]triazolo[1,5-<i>a</i>]pyridin-2-yl]-propionamide <b>36</b></h4><div class="NLM_p last">Starting from compound <b>7</b> (20 mg, 0.083 mmol) and propionyl chloride (0.029 mL, 0.332 mmol), compound <b>33</b> was prepared in 44% yield using the general procedure for monoacylation (12 mg) (99% purity by UPLC). <sup>1</sup>H (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.68 (1H, br s, NH), 8.01 (2H, d, <i>J</i> = 9.1 Hz, ArH), 7.69 (1H, dd, <i>J</i> = 7.3, 8.8 Hz, ArH), 7.62 (1H, dd, <i>J</i> = 1.3, 8.8 Hz, ArH), 7.26 (1H, dd, <i>J</i> = 1.5, 7.1 Hz, ArH), 7.12 (2H, d, <i>J</i> = 8.8 Hz, ArH), 3.86 (3H, s, OCH<sub>3</sub>), 3.5 (peak of CH<sub>2</sub> under peak of water), 1.06 (3H, t, <i>J</i> = 7.5 Hz, CH<sub>3</sub>). LCMS <i>m</i>/<i>z</i> 297.1 (M + H<sup>+</sup>).</div></div><div id="sec7_2_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> Preparation of Cyclopropanecarboxylic Acid (5-Phenyl-[1,2,4]triazolo[1,5-<i>a</i>]pyridin-2-yl)-amide <b>37</b></h4><div class="NLM_p last">Starting from compound <b>9</b> (120 mg, 0.427 mmol)) and phenylboronic acid (104 mg, 0.854 mmol), compound <b>37</b> was prepared using the general procedure for the Suzuki coupling reaction. Purification by silica chromatography (EtOAc/petrol ether; 1:1) followed by trituration with petrol ether afforded the desired compound (33.7 mg, 28% yield, 99% purity by UPLC). <sup>1</sup>H (400 MHz, CDCl<sub>3</sub>) δ 9.30 (1H, brs, NH), 7.98 (2H, m, ArH), 7.54 (5H, m, ArH), 7.01 (1H, m, ArH), 1.90 (1H, under water peak), 1.20 (2H, m, CH<sub>2</sub>), 0.93 (2H, m, CH<sub>2</sub>). LCMS <i>m</i>/<i>z</i> 279.1 (M + H<sup>+</sup>).</div></div><div id="sec7_2_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> Preparation of Cyclopropanecarboxylic Acid [5-(2-Methoxy-phenyl)-[1,2,4]triazolo[1,5-<i>a</i>]pyridin-2-yl]-amide <b>38</b></h4><div class="NLM_p last">Starting from compound <b>9</b> (40 mg, 0.142 mmol) and 2-methoxyphenylboronic acid (64.87 mg, 0.285 mmol), compound <b>35</b> was prepared using the general procedure for the Suzuki coupling reaction. Purification by preparative HPLC afforded the desired compound (43 mg, 99% yield) (99% pure by UPLC). <sup>1</sup>H (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.10 (1H, br s, NH), 7.70 (2H, d, <i>J</i> = 3.6 Hz, ArH), 7.53 (1H, t, <i>J</i> = 7.6 Hz, ArH), 7.44 (1H, d, <i>J</i> = 7.2 Hz, ArH), 7.21 (1H, d, <i>J</i> = 8.4 Hz, ArH), 7.11–7.08 (2H, m, ArH), 3.72 (3H, s, OCH<sub>3</sub>), 1.99 (1H, br, CH), 0.79 (4H, app d, <i>J</i> = 5.6 Hz, 2 × CH<sub>2</sub>). LCMS <i>m</i>/<i>z</i> 309.1 (M + H<sup>+</sup>).</div></div><div id="sec7_2_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> Preparation of Cyclopropanecarboxylic Acid [5-(3-Chloro-phenyl)-[1,2,4]triazolo[1,5-<i>a</i>]pyridin-2-yl]-amide <b>39</b></h4><div class="NLM_p last">Starting from compound <b>9</b> (100 mg, 0.35 mmol) and 3-chlorophenylboronic acid (82 mg, 0.53 mmol), compound <b>36</b> was prepared using the general procedure for the Suzuki coupling reaction. Purification by silica chromatography (EtOAc/petrol ether; 70:30) afforded the desired compound (84.6 mg, 77% yield) (99% purity by UPLC). <sup>1</sup>H (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.04 (1H, br s, NH), 8.13–8.12 (1H, m, ArH), 7.97–7.95 (1H, m, ArH), 7.74–7.72 (2H, m, ArH), 7.62–7.60 (2H, m, ArH), 7.36 (1H, dd, <i>J</i> = = 4.8, 4.0 Hz, ArH), 2.05 (1H, br, CH), 0.83–0.81 (4H, m, 2 × CH<sub>2</sub>). LCMS <i>m</i>/<i>z</i> 313.1 (M + H<sup>+</sup>).</div></div><div id="sec7_2_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> Preparation of Cyclopropanecarboxylic Acid [5-(4-Chloro-phenyl)-[1,2,4]triazolo[1,5-<i>a</i>]pyridin-2-yl]-amide <b>40</b></h4><div class="NLM_p last">Starting from compound <b>9</b> (30 mg, 0.10 mmol) and 4-chlorophenylboronic acid (24 mg, 0.15 mmol), compound <b>37</b> was prepared using the general procedure for the Suzuki coupling reaction. Purification by preparative HPLC afforded the desired compound (23 mg, 73% yield) (purity 99% by UPLC). LCMS <i>m</i>/<i>z</i> 313.1 (M + H<sup>+</sup>). <sup>1</sup>H (400 MHz, CDCl<sub>3</sub>) δ 9.0 (1H, br s, NH), 7.95 (2H, d, <i>J</i> = 8.5 Hz, ArH), 7.63 (2H, m, ArH), 7.53 (2H, d, <i>J</i> = 8.8 Hz, ArH), 7.11 (1H, d, <i>J</i> = 8.6 Hz, ArH), 2.22 (1H, under water peak, CH), 1.21 (2H, m, CH<sub>2</sub>), 0.96 (2H, m, CH<sub>2</sub>). LCMS <i>m</i>/<i>z</i> 309.1 (M + H<sup>+</sup>).</div></div><div id="sec7_2_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> Preparation of Cyclopropanecarboxylic Acid (5-Quinolin-5-yl-[1,2,4]triazolo[1,5-<i>a</i>]pyridin-2-yl)-amide <b>41</b></h4><div class="NLM_p last">Starting from compound <b>9</b> (30 mg, 0.10 mmol) and quinoline-5-boronic acid (26 mg, 0.15 mmol), <b>41</b> was prepared using the general procedure for the Suzuki coupling reaction. Purification by preparative HPLC afforded the desired compound (34 mg, 99% yield, 99% puirity by UPLC). LCMS <i>m</i>/<i>z</i> 329.4 (M + H<sup>+</sup>). <sup>1</sup>H (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.00 (1H, b, NH), 9.03 (1H, b, ArH), 8.27 (1H, d, <i>J</i> = 8.3 Hz, ArH), 7.99 (1H, m, ArH), 7.89 (4H, m, ArH), 7.57 (1H, m, ArH), 7.32 (1H, d, <i>J</i> = 6.40 Hz, ArH), 1.91 (1H, b, CH), 0.75 (4H, m, 2 × CH<sub>2</sub>).</div></div><div id="sec7_2_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> Preparation of Cyclopropanecarboxylic Acid [5-(6-Methoxy-pyridin-3-yl)-[1,2,4]triazolo[1,5-<i>a</i>]pyridin-2-yl]-amide <b>42</b></h4><div class="NLM_p last">Starting from compound <b>9</b> (40.0 mg, 0.142 mmol) and 6-methoxypyridin-3-ylboronic acid (43.3 mg, 0.285 mmol), compound <b>42</b> was prepared using the general procedure for the Suzuki coupling reaction. Purification by preparative HPLC afforded the desired compound (43.9 mg, 46% yield, 99% purity by UPLC). <sup>1</sup>H (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.11 (1H, s, NH), 8.87 (1H, s, ArH), 8.39 (1H, d, <i>J</i> = 8.8 Hz, ArH), 7.75–7.67 (2H, m, ArH), 7.37 (1H, d, <i>J</i> = 6.8 Hz, ArH), 7.02 (1H, d, <i>J</i> = 8.8 Hz, ArH), 3.95 (3H, s, OCH<sub>3</sub>), 2.02 (1H, br, CH), 0.82 (4H, app d, 2 × CH<sub>2</sub>). LCMS <i>m</i>/<i>z</i> 310.1 (M + H<sup>+</sup>).</div></div><div id="sec7_2_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> Preparation of Cyclopropanecarboxylic Acid [5-(2-Methoxy-pyrimidin-5-yl)-[1,2,4]triazolo[1,5-<i>a</i>]pyridin-2-yl]-amide <b>43</b></h4><div class="NLM_p last">Starting from compound <b>9</b> (30.0 mg, 0.10 mmol) and 2-methoxypyrimidin-5-ylboronic acid (23.0, 15 mmol), compound <b>43</b> was prepared using the general procedure for the Suzuki coupling reaction. Purification by preparative HPLC afforded the desired compound <b>43</b> (11.6 mg, 37% yield, 99% purity by UPLC). <sup>1</sup>H (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.20 (2H, s, ArH), 7.91 (1H, br s, NH), 7.71 (1H, dd, <i>J</i> = 9.2, 1.6 Hz, ArH), 7.63 (1H, dd, <i>J</i> = 8.8, 7.2 Hz, ArH), 7.12 (1H, dd, <i>J</i> = 7.2, 1.2 Hz, ArH), 4.14 (3H, s, OCH<sub>3</sub>), 1.67 (1H, br, CH), 1.24–1.20 (2H, m, CH<sub>2</sub>), 1.00–0.96 (2H, m, CH<sub>2</sub>). LCMS <i>m</i>/<i>z</i> 311.1 (M + H<sup>+</sup>).</div></div><div id="sec7_2_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> Preparation of Cyclopropanecarboxylic Acid [5-(1<i>H</i>-Pyrazol-4-yl)-[1,2,4]triazolo[1,5-<i>a</i>]pyridin-2-yl]-amide <b>44</b></h4><div class="NLM_p last">Starting from compound <b>9</b> (30.0 mg, 0.10 mmol) and 4-pyrazoleboronic acid pinacol ester (30.0 mg, 0.15 mmol), compound <b>44</b> was prepared using the general procedure for the Suzuki coupling reaction. Purification by preparative HPLC afforded the desired compound (14.2 mg, 53% yield, 99% purity by UPLC). LCMS <i>m</i>/<i>z</i> 269.1 (M + H<sup>+</sup>). <sup>1</sup>H (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.17 (1H, b, NH), 8.7 (2H, brs, ArH), 7.67 (1H, m, ArH), 7.61 (1H, d, <i>J</i> = 7.0 Hz, ArH), 7.52 (1H, d, <i>J</i> = 8.6 Hz, ArH), 2.08 (1H, b, CH), 0.87 (4H, m, 2 × CH<sub>2</sub>).</div></div><div id="sec7_2_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> Preparation of Cyclopropanecarboxylic Acid [5-(3-Methoxymethyl-phenyl)-[1,2,4]triazolo[1,5-<i>a</i>]pyridin-2-yl]-amide <b>45</b></h4><div class="NLM_p last">Starting from compound <b>9</b> (30.0 mg, 0.10 mmol) and 3-(methoxymethyl)phenylboronic acid (24.8 mg, 0.15 mmol), compound <b>45</b> was prepared using the general procedure for the Suzuki coupling reaction. Purification by preparative HPLC afforded the desired compound (19.8 mg, 62% yield, 99% purity by UPLC). <sup>1</sup>H (400 MHz, CDCl<sub>3</sub>) δ 7.96 (1H, d, <i>J</i> = 7.6 Hz, ArH), 7.90 (1H, s, ArH), 7.75 (1H, app t, <i>J</i> = 8.8 Hz, ArH), 7.67 (1H, d, <i>J</i> = 8.8 Hz, ArH), 7.54 (1H, t, <i>J</i> = 7.6 Hz, ArH), 7.49 (1H, d, 7.6 Hz, ArH), 7.27 (1H, d, <i>J</i> = 8.0 Hz, ArH), 4.55 (2H, s, OCH<sub>2</sub>), 3.43 (3H, s, OCH<sub>3</sub>), 2.01 (1H, br, CH), 1.18–1.15 (2H, m, CH<sub>2</sub>), 0.96–0.91 (2H, m, CH<sub>2</sub>). LCMS <i>m</i>/<i>z</i> 323.1 (M + H<sup>+</sup>).</div></div><div id="sec7_2_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> Preparation of Cyclopropanecarboxylic Acid [5-(3-Benzyloxy-phenyl)-[1,2,4]triazolo[1,5-<i>a</i>]pyridin-2-yl]-amide <b>46</b></h4><div class="NLM_p last">Starting from compound <b>9</b> (30.0 mg, 0.10 mmol) and 3-benzyloxyphenylboronic acid (34.0 mg, 0.15 mmol), compound <b>46</b> was prepared using the general procedure for the Suzuki coupling reaction. Purification by preparative HPLC afforded the desired compound (14.9 mg, 39% yield) (purity 94% by UPLC). LCMS <i>m</i>/<i>z</i> 385.2 (M + H<sup>+</sup>). <sup>1</sup>H (400 MHz, CDCl<sub>3</sub>) δ 9.59 (1H, b, NH), 7.70–7.28 (10H, m, ArH), 7.21 (2H, m, ArH), 5.17 (2H, s, CH<sub>2</sub>), 2.06 (1H, b, CH), 1.20 (2H, m, CH<sub>2</sub>), 0.93 (2H, m, CH<sub>2</sub>).</div></div><div id="sec7_2_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> Preparation of Cyclopropanecarboxylic Acid [5-(2-<i>tert</i>-Butoxymethyl-phenyl)-[1,2,4]triazolo[1,5-<i>a</i>]pyridin-2-yl]-amide <b>47</b></h4><div class="NLM_p last">Starting from compound <b>9</b> (30.0 mg, 0.10 mmol) and 2-(<i>tert</i>-butoxymethyl)phenylboronic acid (31.2 mg, 0.15 mmol), compound <b>47</b> was prepared using the general procedure for the Suzuki coupling reaction. Purification by silica chromatography (EtOAc/petrol ether; 1:1) afforded the desired compound (24.3 mg, 66% yield, 99% purity by UPLC). LCMS <i>m</i>/<i>z</i> 365.2 (M + H<sup>+</sup>).</div></div><div id="sec7_2_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> Preparation of <i>N</i>-(5-(4-Ethoxyphenyl)-[1,2,4]triazolo[1,5-<i>a</i>]pyridin-2-yl)cyclopropane carboxamide Compound <b>48</b></h4><div class="NLM_p last">Starting from compound <b>9</b> (30.0 mg, 0.10 mmol) and 4-ethoxyphenylboronic acid (25.0 mg, 0.15 mmol), compound <b>48</b> was prepared using the general procedure for the Suzuki coupling reaction. Purification by silica chromatography (EtOAc/petrol ether; 7:3) afforded the desired compound (24.5 mg, 76% yield) (99% purity by UPLC). LCMS <i>m</i>/<i>z</i> 323.1 (M + H<sup>+</sup>). <sup>1</sup>H (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.99 (1H, b, NH), 8.01 (2H, d, <i>J</i> = 8.8 Hz, ArH), 7.68 (1H, dd, <i>J</i> = 8.9, 7.4 Hz, ArH), 7.63 (1H, dd, <i>J</i> = 8.9, 1.2 Hz, ArH), 7.25 (1H, dd, <i>J</i> = 1.2, 7.6 Hz, ArH), 7.10 (2H, d, <i>J</i> = 9.1 Hz, ArH), 4.14 (2H, q, <i>J</i> = 7.0 Hz, CH<sub>2</sub>), 1.98 (1H, b, CH), 1.38 (3H, t, <i>J</i> = 7.0 Hz, CH<sub>3</sub>), 0.82 (4H, m, 2 × CH<sub>2</sub>).</div></div><div id="sec7_2_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> Preparation of 1-(6-Methoxy-pyridin-2-yl)-3-carboethoxy-thiourea <b>11</b></h4><div class="NLM_p last">To a solution of 6-chloro-5-methoxy-pyridin-2-ylamine (100 mg, 0.63 mmol) in 1,4-dioxane (3 mL) at 0 °C was added ethoxycarbonyl isothiocyanate (73 μL, 0.63 mmol) dropwise, and the reaction mixture was allowed to warm to rt and stirred for 16 h. Evaporation in vacuum gives a solid, which was thoroughly washed with petrol and dried to afford the desired compound in 89% yield (99% pure by UPLC). LCMS <i>m</i>/<i>z</i> 290.0 (M + H<sup>+</sup>). It was used in the next step without further purification.</div></div><div id="sec7_2_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> Preparation of 5-Chloro-6-methoxy-[1,2,4]triazolo[1,5-<i>a</i>]pyridin-2-ylamine <b>12</b></h4><div class="NLM_p last">To a suspension of hydroxylamine hydrochloride (194 mg, 2.80 mmol) in EtOH/MeOH (1:1, 3 mL) was added <i>N</i>,<i>N</i>-diisopropylethylamine (0.28 mL, 1.68 mmol), and the mixture was stirred at rt for 1 h. 1-(6-Methoxy-pyridin-2-yl)-3-carboethoxy-thiourea <b>11</b> (162 mg, 0.56 mmol) was then added, and the mixture was heated at reflux for 3 h. The mixture was allowed to cool to rt and filtered to collect the precipitated solid. Further product was collected by evaporation under vacuum of the filtrate, addition of H<sub>2</sub>O (2 mL), and filtration. The combined solids were washed successively with H<sub>2</sub>O (2 mL), EtOH/MeOH (1:1 (v:v), 2 mL), and Et<sub>2</sub>O (2 mL) and then dried under vacuum to afford the triazolopyridine derivative <b>12</b> as a white solid in 62% yield (69 mg, 99% pure by UPLC). LCMS <i>m</i>/<i>z</i> 199.0 (M + H<sup>+</sup>). It was used in the next step without further purification.</div></div><div id="sec7_2_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> Preparation of Cyclopropanecarboxylic Acid (5-Chloro-6-methoxy-[1,2,4]triazolo[1,5-<i>a</i>]pyridin-2-yl)-amide <b>13</b></h4><div class="NLM_p last">Starting from 5-chloro-6-methoxy-[1,2,4]triazolo[1,5-<i>a</i>]pyridin-2-ylamine <b>12</b> (69 mg, 0.347 mmol) and cyclopropanecarbonyl chloride (80 μL, 0.868 mmol), compound <b>13</b> was prepared in 65% yield using the general procedure for monoacylation (60 mg, 99% purity by UPLC). LCMS <i>m</i>/<i>z</i> 267.0 (M + H<sup>+</sup>).</div></div><div id="sec7_2_36" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> Preparation of Cyclopropanecarboxylic Acid [5-(4-Ethoxy-phenyl)-6-methoxy-[1,2,4]triazolo[1,5-<i>a</i>]pyridin-2-yl]-amide <b>49</b></h4><div class="NLM_p last">Starting from cyclopropanecarboxylic acid (5-chloro-6-methoxy-[1,2,4]triazolo[1,5-<i>a</i>]pyridin-2-yl)-amide <b>13</b> (30.0 mg, 0.11 mmol) and 4-ethoxyphenylboronic acid (28.0 mg, 0.17 mmol), compound <b>49</b> was prepared using the general procedure for the Suzuki coupling reaction. Purification by preparative HPLC afforded the desired compound in 60% yield (23.0 mg, 99% purity by UPLC). <sup>1</sup>H (400 MHz, CDCl<sub>3</sub>) δ 8.52 (1H, br s, NH), 7.70 (2H, d, <i>J</i> = 8.0 Hz, ArH), 7.59 (1H, br d, ArH), 7.50 (1H, br d, ArH), 7.05 (2H, d, <i>J</i> = 8.4 Hz, ArH), 4.14 (2H, q, <i>J</i> = 7.1 Hz, OCH<sub>2</sub>), 3.82 (3H, s, CH<sub>3</sub>), 1.90 (1H, br, CH), 1.48 (3H, t, <i>J</i> = 6.8 Hz, CH<sub>3</sub>), 1.17 (2H, br s, CH<sub>2</sub>), 0.91 (2H, br s, CH<sub>2</sub>). LCMS <i>m</i>/<i>z</i> 354.0 (M + H<sup>+</sup>).</div></div><div id="sec7_2_37" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> Preparation of Cyclopropanecarboxylic Acid [8-(4-Ethoxy-phenyl)-[1,2,4]triazolo[1,5-<i>a</i>]pyridin-2-yl]-amide <b>50</b></h4><div class="NLM_p">Step i: Preparation of cyclopropanecarboxylic acid (8-bromo-[1,2,4]triazolo[1,5-<i>a</i>]pyridin-2-yl)-amide. Starting from 8-bromo-[1,2,4]triazolo[1,5-<i>a</i>]pyridin-2-ylamine (1g, 4.69 mmol) and cyclopropanecarbonyl chloride (1.07 mL, 11.73 mmol), compound was prepared in 57% yield using the general procedure for monoacylation (0.76 g). LCMS <i>m</i>/<i>z</i> 283.0 (M + H<sup>+</sup>). It was used in the next step without further purification.</div><div class="NLM_p last">Step ii: Starting from cyclopropanecarboxylic acid (8-bromo-[1,2,4]triazolo[1,5-<i>a</i>]pyridin-2-yl)-amide (30.0 mg, 0.10 mmol) and 4-ethoxyphenylboronic acid (26.0 mg, 0.15 mmol), compound <b>49</b> was prepared using the general procedure for the Suzuki coupling reaction. Purification by preparative HPLC afforded the desired compound in 46% yield (15.0 mg, 99% purity by UPLC). <sup>1</sup>H (400 MHz, CDCl<sub>3</sub>) δ 9.26 (1H, br s, NH), 8.56 (1H, s, ArH), 7.88 (2H, d, <i>J</i> = 8.6 Hz, ArH), 7.61 (1H, d, <i>J</i> = 7.3 Hz, ArH), 7.10–7.02 (3H, m, ArH), 4.11 (2H, q, <i>J</i> = 6.8 Hz, OCH<sub>2</sub>), 1.90 (1H, br, CH), 1.47 (3H, t, <i>J</i> = 6.8 Hz, CH<sub>3</sub>), 1.14 (2H, br, CH<sub>2</sub>), 0.85 (2H, br, CH<sub>2</sub>). LCMS <i>m</i>/<i>z</i> 323.1 (M + H<sup>+</sup>).</div></div><div id="sec7_2_38" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> Preparation of Cyclopropanecarboxylic Acid [5-(4-Ethoxy-phenyl)-[1,2,4]triazolo[1,5-<i>c</i>]pyrimidin-2-yl]-amide <b>51</b></h4><div class="NLM_p">Step i: Preparation of 2-(4-ethoxy-phenyl)-pyrimidin-4-ylamine. Starting from 2-chloro-pyrimidin-4-ylamine (50.0 mg, 0.38 mmlol) and 4-ethoxyphenylboronic acid (64.0 mg, 0.38 mmol), title compound was prepared using the general procedure for the Suzuki coupling reaction. Purification by silica chromatography (EtOAc/petrol ether; 20:80 to 40:60) afforded the compound in 50% yield (52 mg, 90% purity). LCMS <i>m</i>/<i>z</i> 216.1 (M + H<sup>+</sup>).</div><div class="NLM_p">Step ii: Preparation of [2-(4-ethoxy-phenyl)-pyrimidin-4-yl]-3-carboethoxy-thiourea. To a solution of 2-(4-ethoxy-phenyl)-pyrimidin-4-ylamine (39 mg, 0.18 mmol) in 1,4-dioxane (0.9 mL) at 0 °C was added ethoxycarbonyl isothiocyanate (30 μL, 0.27 mmol) dropwise, and the reaction mixture was then allowed to warm to rt and stirred for 16 h. Evaporation in vacuum gives the crude compound that was used as such in the next step (50% purity by UPLC). LCMS <i>m</i>/<i>z</i> 347.1 (M + H<sup>+</sup>).</div><div class="NLM_p">Step iii: Preparation of 5-(4-ethoxy-phenyl)-[1,2,4]triazolo[1,5-<i>c</i>]pyrimidin-2-ylamine. To a suspension of hydroxylamine hydrochloride (60 mg, 0.87 mmol) in EtOH/MeOH (1:1 (v:v), 1 mL) was added <i>N</i>,<i>N</i>-diisopropylethylamine (85 μL, 0.62 mmol), and the mixture was stirred at rt for 1 h. [2-(4-Ethoxy-phenyl)-pyrimidin-4-yl]-3-carboethoxy-thiourea (crude, 0.18 mmol) was then added, and the mixture heated to reflux for 1 h. The mixture was allowed to cool and filtered to collect the precipitated solid. Further product was collected by evaporation in vacuum of the filtrate, addition of H<sub>2</sub>O (2 mL), and filtration. The combined solids were washed successively with H<sub>2</sub>O (2 mL), EtOH/MeOH (1:1 (v:v), 2 mL), and Et<sub>2</sub>O (2 mL) and then dried in vacuum to afford the triazolopyridine derivative as a white solid in 28% yield. LCMS <i>m</i>/<i>z</i> 256.1 (M + H<sup>+</sup>).</div><div class="NLM_p last">Step iv: Starting from 5-(4-ethoxy-phenyl)-[1,2,4]triazolo[1,5-<i>c</i>]pyrimidin-2-ylamine (13.0 mg, 0.051 mmol) and cyclopropanecarbonyl chloride (11.6 μL, 0.127 mmol), compound <b>51</b> was prepared using the general procedure for monoacylation. Purification by preparative HPLC afforded the desired compound in 18% yield (3 mg, 99% purity by UPLC). <sup>1</sup>H (400 MHz, CDCl<sub>3</sub>) δ 8.61 (2H, d, <i>J</i> = 9.2 Hz, ArH), 8.48 (1H, br s, NH), 7.25 (1H, d, <i>J</i> = 6.4 Hz, ArH), 7.36 (1H, d, <i>J</i> = 6.4 Hz, ArH), 6.99 (2H, d, <i>J</i> = 9.2 Hz, ArH), 4.07 (2H, q, <i>J</i> = 6.8 Hz, OCH<sub>2</sub>), 1.40 (3H, t, <i>J</i> = 6.8 Hz, CH<sub>3</sub>), 1.18–1.16 (3H, m, CH and CH<sub>2</sub>), 0.93–0.91 (2H, m, CH<sub>2</sub>). LCMS <i>m</i>/<i>z</i> 324.1 (M + H<sup>+</sup>).</div></div><div id="sec7_2_39" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> Preparation of Cyclopropanecarboxylic Acid [8-(4-Methoxy-phenyl)-6-trifluoromethyl-[1,2,4]triazolo[1,5-<i>a</i>]pyridin-2-yl]-amide <b>52</b></h4><div class="NLM_p">Step i: Preparation of cyclopropanecarboxylic acid (8-chloro-6-trifluoromethyl-[1,2,4]triazolo[1,5-<i>a</i>]pyridin-2-yl)-amide. Starting from 8-chloro-6-trifluoromethyl-[1,2,4]triazolo[1,5-<i>a</i>]pyridin-2-ylamine (100 mg, 0.42 mmol) and cyclopropanecarbonyl chloride (97 μL, 1.06 mmol), the title compound was prepared in quantitative yield using the general procedure for monoacylation (83% purity). It was used in the next step without further purification.</div><div class="NLM_p last">Step ii: Starting from cyclopropanecarboxylic acid (8-chloro-6-trifluoromethyl-[1,2,4]triazolo[1,5-<i>a</i>]pyridin-2-yl)-amide (140.0 mg, 0.46 mmol) and 4-methoxyphenylboronic acid (84.0 mg, 0.55 mmol), <b>52</b> was prepared using the general procedure for the Suzuki coupling reaction. Purification by preparative HPLC afforded the desired compound in 4% yield (7 mg, 99% purity by UPLC). <sup>1</sup>H (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.36 (1H, br s, NH), 9.46 (1H, s, ArH), 8.18 (2H, d, <i>J</i> = 8.8 Hz, ArH), 8.03 (1H, s, ArH), 7.10 (2H, d, <i>J</i> = 8.8 Hz, ArH), 3.85 (3H, s, OCH<sub>3</sub>), 2.02 (1H, br, CH), 0.85 (4H, app d, CH<sub>2</sub>). LCMS <i>m</i>/<i>z</i> 376.9 (M + H<sup>+</sup>).</div></div><div id="sec7_2_40" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69"> Preparation of <i>N</i>-(7-Phenyl-[1,2,4]triazolo[1,5-<i>a</i>]pyrimidin-2-yl)cyclopropanecarboxamide <b>53</b></h4><div class="NLM_p">Step i: Acetophenone (200 mg, 1.66 mmol) and <i>N</i>,<i>N</i>-dimethylformamide diethyl acetal (198 mg, 1.66 mmol) was heated in a sealed tube in microwave (300 W) 6 min. After cooling to rt, the product was isolated by recrystallization in diethyl ether (185 mg, 64% yield). The compound was used in the next step without further purification.</div><div class="NLM_p">Step ii: Dimethyl-((<i>E</i>)-3-phenyl-propenyl)-amine (100 mg, 0.57 mmol) and 1<i>H</i>-[1,2,4]triazole-3,5-diamine (57 mg, 0.57 mmol) were dissolved in ethanol (2 mL), and the reaction was subjected to reflux until completion. The solvent was removed under vacuum to yield the expected product (120 mg, 100% yield). It was used in the next step without further purification.</div><div class="NLM_p last">Step iii: Starting from 7-phenyl-[1,2,4]triazolo[1,5-<i>a</i>]pyrimidin-2-ylamine (50 mg, 0.24 mmol) and cyclopropanecarbonyl chloride (65 μL, 0.72 mmol), the title compound was prepared in 33% yield using the general procedure for monoacylation (22 mg, 99% purity). <sup>1</sup>H (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.20 (1H, b, NH), 8.77 (1H, d, <i>J</i> = 4.8 Hz, ArH), 8.19 (2H, m, ArH), 7.60 (3H, m, ArH), 7.49 (1H, d, <i>J</i> = 4.8 Hz, Ar), 2.01 (1H, b, CH), 0.81 (4H, m, 2 × CH<sub>2</sub>)</div></div><div id="sec7_2_41" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70"> Preparation of Cyclopropanecarboxylic Acid [5-(4-Ethoxy-phenyl)-[1,2,4]triazolo[1,5-<i>a</i>]pyrazin-2-yl]-amide <b>54</b></h4><div class="NLM_p">Step i: Preparation of (6-chloro-pyrazin-2-yl)-3-carboethoxy-thiourea. To a solution of 6-chloro-pyrazin-2-ylamine (1.0 g, 8.23 mmol) in 1,4-dioxane (10 mL) at 0 °C was added ethoxycarbonyl isothiocyanate (0.74 mL, 6.56 mmol) dropwise, and the reaction mixture was allowed to warm to rt and then heated at reflux for 2 h. Evaporation in vacuum gives a solid which was thoroughly washed with petrol and dried to afford the desired compound in 51% yield; used in the next step without further purification.</div><div class="NLM_p">Step ii: Preparation of 5-chloro-[1,2,4]triazolo[1,5-<i>a</i>]pyrazin-2-ylamine. To a suspension of hydroxylamine hydrochloride (1.5 g, 21.6 mmol) in EtOH/MeOH (1:1 (v:v), 20 mL) was added <i>N</i>,<i>N</i>-diisopropylethylamine (1.8 mL, 10.9 mmol), and the mixture was stirred at rt for 1 h. (6-Chloro-pyrazin-2-yl)-3-carboethoxy-thiourea (0.88 g, 3.38 mmol) was then added, and the mixture was heated to reflux for 16 h. The mixture was allowed to cool and filtered to collect the precipitated solid. Further product was collected by evaporation in vacuum of the filtrate, addition of H<sub>2</sub>O (2 mL), and filtration. The combined solids were washed successively with H<sub>2</sub>O (2 mL), EtOH/MeOH (1:1, 2 mL), and Et<sub>2</sub>O (2 mL) and then dried in vacuum to afford the title compound as a white solid in 64% yield (99% pure by UPLC). It was used in the next step without further purification</div><div class="NLM_p">Step iii: Preparation of cyclopropanecarboxylic acid (5-chloro-[1,2,4]triazolo[1,5-<i>a</i>]pyrazin-2-yl)-amide. Starting from 5-chloro-[1,2,4]triazolo[1,5-<i>a</i>]pyrazin-2-ylamine (0.37 g, 2.19 mmol) and cyclopropanecarbonyl chloride (395 μL, 4.38 mmol), the title compound was prepared using the general procedure for monoacylation. Purification by silica chromatography (EtOAc/petrol ether; 1:4) afforded the compound in 15% yield (80 mg). It was used in the next step without further purification.</div><div class="NLM_p last">Step iv: Starting from cyclopropanecarboxylic acid (5-chloro-[1,2,4]triazolo[1,5-<i>a</i>]pyrazin-2-yl)-amide (40 mg, 0.169 mmol) and 4-ethoxyphenylboronic acid (56 mg, 0.338 mmol), compound <b>53</b> was prepared using the general procedure for the Suzuki coupling reaction. Purification by preparative HPLC afforded the desired compound in 14% yield (7 mg, 99% purity by UPLC). LCMS <i>m</i>/<i>z</i> 324.1 (M + H<sup>+</sup>). <sup>1</sup>H (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.35 (1H, b, NH), 9.13 (1H, s, ArH), 8.41 (1H, s, ArH), 8.11 (2H, d, <i>J</i> = 8.9 Hz, ArH), 7.14 (2H, d, <i>J</i> = 8.8, ArH), 4.15 (2H, q, <i>J</i> = 7.0 Hz, CH<sub>2</sub>), 2.05 (1H, b, CH), 1.38 (3H, t, <i>J</i> = 7.0 Hz, CH<sub>3</sub>), 0.85 (4H, m, 2 × CH<sub>2</sub>)</div></div><div id="sec7_2_42" class="NLM_sec NLM_sec_level_3"><div id="ac_i71" class="anchor-spacer"></div><h4 class="article-section__title" id="_i71"> Preparation of Cyclopropanecarboxylic Acid [5-(4-Cyclopropanesulfonylamino-phenyl)-[1,2,4]triazolo[1,5-<i>a</i>]pyridin-2-yl]-amide <b>55</b></h4><div class="NLM_p">Step i: Preparation of {4-[2-(cyclopropanecarbonyl-amino)-[1,2,4]triazolo[1,5-<i>a</i>]pyridin-5-yl]-phenyl}-carbamic acid <i>tert</i>-butyl ester. Starting from compound <b>9</b> and 4-(N-Boc-amino)phenylboronic acid pinacol ester, the title compound was prepared using the general procedure for the Suzuki coupling reaction. Purification by silica chromatography (EtOAc/petrol ether; 70:30) afforded the compound in 53% yield. LCMS <i>m</i>/<i>z</i> 338.0 (M + H<sup>+</sup>).</div><div class="NLM_p">Step ii: Preparation of cyclopropanecarboxylic acid [5-(4-amino-phenyl)-[1,2,4]triazolo[1,5-<i>a</i>]pyridin-2-yl]-amide. To a solution of the {4-[2-(cyclopropanecarbonyl-amino)-[1,2,4]triazolo[1,5-<i>a</i>]pyridin-5-yl]-phenyl}-carbamic acid <i>tert</i>-butyl ester (200 mg, 0.51 mmol) in MeOH (2 mL) was added conc HCl (0.5 mL), and the mixture was stirred at 50 °C for 4 h. After concentration in vacuum, the title compound was obtained in quantitative yield. LCMS <i>m</i>/<i>z</i> 293.9 (M + H).</div><div class="NLM_p last">Step iii: To cyclopropanecarboxylic acid [5-(4-amino-phenyl)-[1,2,4]triazolo[1,5-<i>a</i>]pyridin-2-yl]-amide (25 mg, 0.085 mmol) in DCM (1 mL) at 0 °C was added triethylamine (42 μL, 0.306 mmol) followed by cyclopropylsulfonyl chloride (32 μL, 0.153 mmol). The resulting mixture was stirred at rt for 72 h and then concentrated in vacuum. Purification by preparative HPLC afforded <b>52</b> in 12% yield (99% purity by UPLC). <sup>1</sup>H (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.08 (1H, br s, NH), 10.13 (1H, br s, NH), 8.03 (2H, d, <i>J</i> = 8.8 Hz, ArH), 7.71–7.67 (3H, m, ArH), 7.39 (2H, d, <i>J</i> = 8.8 Hz, ArH), 7.29 (1H, dd, <i>J</i> = 7.2, 1.6 Hz, ArH), 2.88 (1H, br, CH), 2.01 (1H, br, CH), 1.02–1.00 (4H, m, 2 × CH<sub>2</sub>), 0.83–0.82 (4H, m, CH<sub>2</sub>). LCMS <i>m</i>/<i>z</i> 398.0 (M + H<sup>+</sup>).</div></div><div id="sec7_2_43" class="NLM_sec NLM_sec_level_3"><div id="ac_i72" class="anchor-spacer"></div><h4 class="article-section__title" id="_i72"> Preparation of 4-(2-(Cyclopropanecarboxamido)-[1,2,4]triazolo[1,5-<i>a</i>]pyridin-5-yl)-<i>N</i>-(2-(1-phenyl-1<i>H</i>-pyrazol-4-yl)ethyl)benzamide <b>56</b></h4><div class="NLM_p">Step i: preparation of 4-[2-(cyclopropanecarbonyl-amino)-[1,2,4]triazolo[1,5-<i>a</i>]pyridin-5-yl]-benzoic acid. Starting from compound <b>9</b> (400 mg, 1.49 mmol) and 4-(ethoxycarobonyl) phenylboronic acid (283 mg, 1.70 mmol), the title compound was prepared using the general procedure for the Suzuki coupling reaction. Purification by silica chromatography (EtOAc/petrol ether; 50:50) afforded the compound in 93% yield (764 mg, 95% purity by UPLC). The obtained compound was dissolved in THF/H20/MeOH (2 mL/1 mL/1 mL), NaOH solution (2N), 3.5 mL was added to the solution. After 1 h 30 min of stirring at room temperature, the reaction was completed. Solvents were removed. Then 12 mL of HCl solution (1N) was added to precipitate the expected product. Filtration gave the pure title compound (100% yield, 90% purity by UPLC).</div><div class="NLM_p">Step ii: Preparation of 4-[2-(cyclopropanecarbonyl-amino)-[1,2,4]triazolo[1,5-<i>a</i>]pyridin-5-yl]-benzoyl chloride. 4-[2-(Cyclopropanecarbonyl-amino)-[1,2,4]triazolo[1,5-<i>a</i>]pyridin-5-yl]-benzoic acid (150 mg, 0.46 mmol) was dissolved in DCM (1.5 mL) at room temperature, and a drop of DMF was added under nitrogen atmosphere. Oxalyl chloride (50 μL, 0.56 mmol) was added dropwise to the solution. The reaction mixture was stirred for 2 h at room temperature. The solvent was removed under vacuum, and the residue was used directly in the next step without further isolation.</div><div class="NLM_p last">Step iii: 4-[2-(Cyclopropanecarbonyl-amino)-[1,2,4]triazolo[1,5-<i>a</i>]pyridin-5-yl]-benzoyl chloride (30 mg, 0.09 mmol) was dissolved in DCM (1 mL). Et<sub>3</sub>N (20 μL, 0.14 mmol) was added, followed by 2-(1-phenyl-1<i>H</i>-pyrazol-4-yl)-ethylamine (26 mg, 0.14 mmol). The reaction was stirred at room temperature for 2 h. Water was added, and the organic layer was separated and dried over MgSO<sub>4</sub>. The crude was purified by preparative HPLC (15 mg, 33%). LCMS <i>m</i>/<i>z</i> 514.1 (M + 23). <sup>1</sup>H (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.05 (1H, b, NH), 8.79 (1H, bt, <i>J</i> = 5.5 Hz, NH), 8.39 (1H, s, ArH), 8.12 (2H, d, <i>J</i> = 8.5 Hz, ArH), 8.01 (2H, d, <i>J</i> = 8.5 Hz, ArH), 7.80 (2H, m, ArH) 7.74 (1H, d, <i>J</i> = 2.0 Hz, ArH), 7.73 (1H, s, ArH), 7.65 (1H, s, ArH), 7.48 (2H, m, ArH), 7.36 (1H, dd, <i>J</i> = 3.3, 5.3 Hz, ArH), 7.27 (1H, m, ArH), 3.54 (2H, q apparent, CH<sub>2</sub>), 2.81 (2H, t, <i>J</i> = 7.3 Hz, CH<sub>2</sub>), 1.99 (1H, b, CH), 0.82 (4H, d, <i>J</i> = 6.04 Hz, 2 ×  CH<sub>2</sub>)</div></div><div id="sec7_2_44" class="NLM_sec NLM_sec_level_3"><div id="ac_i73" class="anchor-spacer"></div><h4 class="article-section__title" id="_i73"> Preparation of <b>57</b>: Cyclopropanecarboxylic Acid {5-[4-(4-hydroxy-3-hydroxymethyl-benzyl)-phenyl]-[1,2,4]triazolo[1,5-<i>a</i>]pyridin-2-yl}-amide</h4><div class="NLM_p">Step i: 2-Hydroxymethyl-4-[4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-benzyl]-phenol. To 2-hydroxymethyl-phenol (167 mg, 1.35 mmol) in dry DCM/MeOH (5/1 mL) at RT was added NaH (60% dispersion, 2.02 mmol, 29 mg), followed by 2-(4-bromomethyl-phenyl)-4,4,5,5-tetramethyl-[1,3,2]dioxaborolane (200 mg, 0.67 mmol), and the mixture was stirred at rt for 16 h. The solution was quenched with water, extracted with ethyl acetate, dried (MgSO<sub>4</sub>), filtered, and concentrated under vacuum. The crude material was used in the next step without further purification.</div><div class="NLM_p last">Step 2: Starting from compound <b>made in step i</b> (0.673 mmol) and compound <b>9</b> (172 mg, 0.61 mmol), the title compound was prepared using the general procedure for the Suzuki coupling reaction. Purification by preparative HPLC afforded the compound in 57% yield (144 mg, 100% purity by UPLC). <sup>1</sup>H (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.9 (2H, d, <i>J</i> = 8.6 Hz, ArH), 7.67 (1H, dd, <i>J</i> = 8.9, 7.3, ArH), 7.57 (1H, m, ArH), 7.33 (2H, d, <i>J</i> = 8.5 Hz, ArH), 7.20 (1H, m, ArH), 7.13 (1H, m, ArH), 6.95 (1H, dd, <i>J</i> = 8.3, 2.3, AeH), 6.69 (1H, d, <i>J</i> = 8.2, ArH), 4.6 (2H, s, CH2), 4.5 (1H, b, OH), 3.94 (2H, s, CH2), 1.9 (1H, b, CH), 0.99 (2H, m, CH2), 0.88 (2H, m, CH<sub>2</sub>).</div></div><div id="sec7_2_45" class="NLM_sec NLM_sec_level_3"><div id="ac_i74" class="anchor-spacer"></div><h4 class="article-section__title" id="_i74"> Preparation of <i>N</i>-(5-(4-((2-(Cyanomethyl)phenylamino)methyl)phenyl)-[1,2,4]triazolo[1,5-<i>a</i>]pyridin-2-yl)cyclopropanecarboxamide <b>58</b></h4><div class="NLM_p">Step i: To a mixture of (2-amino-phenyl)-acetonitrile (178 mg, 1.347 mmol) and <i>N</i>,<i>N</i>-diisopropylethylamine (0.235 mL, 1.347 mmol) in DCM (5 mL) and MeOH (1 mL) was added 2-(4-bromomethyl-phenyl)-4,4,5,5-tetramethyl-[1,3,2]dioxaborolane (200 mg, 0.673 mmol) slowly, and the reaction was stirred at rt for 18 h. The resulting mixture was concentrated in vacuum, rediluted with EtOAc, washed with water, dried (MgSO<sub>4</sub>), filtered, and concentrated in vacuum to give quantitatively the desired compound that was used as such in the next step.</div><div class="NLM_p last">Step ii: Starting from compound <b>9</b> (172 mg, 0.612 mmol) and compound from step i (234 mg, 0.673 mmol), compound <b>58</b> was prepared using the general procedure for the Suzuki coupling reaction. Purification by silica chromatography followed by trituration with Et<sub>2</sub>O afforded the desired compound in 29% yield (75 mg, 99% purity by UPLC). LCMS <i>m</i>/<i>z</i> 423.1 (M + H<sup>+</sup>). <sup>1</sup>H (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.98 (1H, b, NH) 7.96 (2H, d, <i>J</i> = 8.0 Hz, ArH) 7.68 (2H, m, ArH) 7.56 (2H, d, <i>J</i> = 8.15 Hz, ArH) 7.27 (1H, m, ArH) 7.19 (1H, m, ArH) 7.07 (1H, m, ArH) 6.60 (1H, m, ArH) 6.52 (1H, d, <i>J</i> = 8.3 Hz, ArH) 6.11 (1H, m, NH) 4.48 (2H, d, <i>J</i> = 5.8 Hz CH<sub>2</sub>) 3.93 (2H, s, CH<sub>2</sub>) 2.02 (1H, b, CH) 0.80 (4H, m, 2 × CH<sub>2</sub>).</div></div><div id="sec7_2_46" class="NLM_sec NLM_sec_level_3"><div id="ac_i75" class="anchor-spacer"></div><h4 class="article-section__title" id="_i75"> Preparation of <i>N</i>-(5-(4-((3-((4-Cyanophenoxy)methyl)azetidin-1-yl)methyl)phenyl)-[1,2,4]triazolo[1,5-<i>a</i>]pyridin-2-yl)cyclopropanecarboxamide <b>59</b></h4><div class="NLM_p">Step i: Preparation of 4-{1-[4-(4,4,5,5-Tetramethyl-[1,3,2 ]dioxaborolan-2-yl)-benzyl]-azetidin-3-ylmethoxy}-benzonitrile. 4-(Azetidin-3-ylmethoxy)-benzonitrile(50 mg, 0.27 mmol)) was dissolved in DCM (6 mL); diisopropylethylamine (235 μL, 1.34 mmol) was added to the solution followed by 2-(4-bromomethyl-phenyl)-4,4,5,5-tetramethyl-[1,3,2]dioxaborolane (39 mgn 0.13 mmol). The reaction mixture was stirred for 16 h at room temperature. Solvent was removed under vacuum. After addition of water, the organics were extracted with EtOAc. Solvent was evaporated under vacuum, and the crude was used without further purification. LCMS <i>m</i>/<i>z</i> 405.0 (M + H<sup>+</sup>).</div><div class="NLM_p last">Step 2: Preparation of <i>N</i>-(5-(4-((3-((4-cyanophenoxy)methyl)azetidin-1-yl)methyl)phenyl)-[1,2,4]triazolo[1,5-<i>a</i>]pyridin-2-yl)cyclopropanecarboxamide. Starting from 4-{1-[4-(4,4,5,5-Tetramethyl-[1,3,2 ]dioxaborolan-2-yl)-benzyl]-azetidin-3-ylmethoxy}-benzonitrile. Starting from compound <b>9</b> (33.9 mg, 0.12 mmol) and 4-(4-morpholinomethyl)-phenylboronic acid pinacol ester hydrochloride (53.7 mg, 0.13 mmol), compound <b>59</b> was prepared using the general procedure for the Suzuki coupling reaction. Purification by preparative HPLC afforded the desired compound in 10% yield (6 mg, 99% purity by UPLC). LCMS <i>m</i>/<i>z</i> 479 (M + H<sup>+</sup>). <sup>1</sup>H (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.04 (1H, bs, NH), 8.22 (1Hn s, ArH), 7.94 (2H, d, <i>J</i> = 8.6 Hz, ArH), 7.76 (2H, m, ArH) 7.69 (2H, m, ArH), 7.44 (2H, d, <i>J</i> = 8.3, ArH), 7.27 (1H, dd, <i>J</i> = 1.8, 6.5 Hz, ArH), 7.13 (2H, m, ArH), 4.24 (2H, d, <i>J</i> = 7.1 Hz, CH2), 3.67 (2H, s, CH2), ∼3.4 (2H, under DMSO peak), 3.07 (2H, m, CH2), 2.8 (1H, m, CH), 2.0 (1H, m, CH), 0.8 (4H, m, 2 × CH<sub>2</sub>).</div></div><div id="sec7_2_47" class="NLM_sec NLM_sec_level_3"><div id="ac_i76" class="anchor-spacer"></div><h4 class="article-section__title" id="_i76"> Preparation of <i>N</i>-(5-(4-(Morpholinomethyl)phenyl)-[1,2,4]triazolo[1,5-<i>a</i>]pyridin-2-yl)cyclopropanecarboxamide <b>60</b></h4><div class="NLM_p last">Starting from compound <b>9</b> (30 mg, 0.10 mmol) and 4-(4-morpholinomethyl)-phenylboronic acid pinacol ester hydrochloride (51 mg, 0.15 mmol), compound <b>60</b> was prepared using the general procedure for the Suzuki coupling reaction. Purification by preparative HPLC afforded the desired compound in 100% yield (38 mg, 99% purity by UPLC). <sup>1</sup>H (400 MHz, CDCl<sub>3</sub>) δ 10.22 (1H, br s, NH), 8.06 (2H, d, <i>J</i> = 8.4 Hz ArH), 7.78 (2H, m, ArH), 7.62 (2H, d, <i>J</i> = 8.3 Hz, ArH) 7.22 (1H, d, <i>J</i> = 6.8 Hz, ArH), 4.28 (2H, s, CH<sub>2</sub>), 3.99 (4H, s, 2 × CH<sub>2</sub>), 3.50 (2H, br s, CH<sub>2</sub>), 2.97 (2H, br s, CH<sub>2</sub>), 1.97 (1H, br, CH), 1.18–1.16 (2H, m, CH<sub>2</sub>), 0.96–0.94 (2H, m, CH<sub>2</sub>). LCMS <i>m</i>/<i>z</i> 378.2 (M + H<sup>+</sup>).</div></div><div id="sec7_2_48" class="NLM_sec NLM_sec_level_3"><div id="ac_i77" class="anchor-spacer"></div><h4 class="article-section__title" id="_i77"> Preparation of <i>N</i>-(5-(4-((4-Methylpiperazin-1-yl)methyl)phenyl)-[1,2,4]triazolo[1,5-<i>a</i>]pyridin-2-yl)cyclopropanecarboxamide <b>61</b></h4><div class="NLM_p">Step i: Preparation of cyclopropanecarboxylic acid [5-(4-formyl-phenyl)-[1,2,4]triazolo[1,5-<i>a</i>]pyridin-2-yl]-amide. Starting from compound <b>9</b> (1 g, 3.56 mmol) and 4-formylphenylboronic acid (0.639 g, 4.63 mmol), the title compound was obtained in 74% yield using the general procedure for the Suzuki coupling reaction used in the next step without further purification (85% pure by UPLC).</div><div class="NLM_p last">Step ii: Cyclopropanecarboxylic acid [5-(4-formyl-phenyl)-[1,2,4]triazolo[1,5-<i>a</i>]pyridin-2-yl]-amide (30 mg, 0.098 mmol) was stirred with <i>N</i>-methylpiperazine (9.82 mg, 0.098 mmol) in titanium(IV) isopoxide (40 μL). After 1 h of stirring at room temperature, ethanol (0.1 mL) was added, followed by Na(CN)BH<sub>3</sub> (6 mg, 0.098 mmol). After completion of the reaction, 2 mL of water was added and the suspension was filtered. The white solid was washed with ethanol and ethyl acetate. The solvent was removed under vacuum to afford the expected product (15 mg, 40% yield) (99% purity by LCMS). LCMS <i>m</i>/<i>z</i> 391.1 (M + H<sup>+</sup>). <sup>1</sup>H (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.07 (1H, broad s, NH), 8.02 (2H, d, <i>J</i> = 8.3 Hz, ArH), 7.70 (2H, m, ArH), 7.51 (2H, d, <i>J</i> = 8.2 Hz, ArH), 7.28 (1H, dd, <i>J</i> = 2.0, 6.1 Hz, ArH), 3.73 (4H, broad, 2 × CH<sub>2</sub>), 3.03 (4H, broad, 2 × CH<sub>2</sub>), 2.79 (3H, s, CH<sub>3</sub>), 1.99 (1H, b, CH), 0.81 (4H, m, 2 × CH<sub>2</sub>)</div></div><div id="sec7_2_49" class="NLM_sec NLM_sec_level_3"><div id="ac_i78" class="anchor-spacer"></div><h4 class="article-section__title" id="_i78"> Preparation of <i>N</i>-(5-(4-((2,2,2-Trifluoroacetamido)methyl)phenyl)-[1,2,4]triazolo[1,5-<i>a</i>]pyridin-2-yl)cyclopropanecarboxamide <b>62</b></h4><div class="NLM_p">Step i: Cyclopropanecarboxylic acid [5-(4-aminomethyl-phenyl)-[1,2,4]triazolo[1,5-<i>a</i>]pyridin-2-yl]-amide. Starting from compound <b>9</b> (0.10 mmol, 30 mg)) and 4-(aminomethyl)phenylboronic acid hydrochloride (28 mg, 0.15 mmol), the title compound was obtained in 6% yield using the general procedure for the Suzuki coupling reaction used in the next step without further purification (2 mg).</div><div class="NLM_p last">Step ii: <i>N</i>-(5-(4-((2,2,2-Trifluoroacetamido)methyl)phenyl)-[1,2,4]triazolo[1,5-<i>a</i>]pyridin-2-yl)cyclopropanecarboxamide. The benzylamine derivative (30 mg, 0.097 mmol) obtained above and Et<sub>3</sub>N (0.489 mmol, 68 μL) were dissolved in DCM under N<sub>2</sub> and cooled at 0 °C. Trifluoroacteic anhydride (0.146 mmol, 30 mg) dissolved in DCM was added dropwise to this solution. The reaction was stirred at room temperature for 16 h. After this time, the reaction was complete. The compound was extracted with EtOAc and water, washed with brine, and dried over MgSO<sub>4</sub>. Organic layers were filtered and evaporated. The final compound was isolated by preparative HPLC, 33% yield (99% purity by UPLC). LCMS <i>m</i>/<i>z</i> 404.1 (M + H<sup>+</sup>). <sup>1</sup>H (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.00 (1H, br, NH), 10.13 (1H, brt, NH), 7.98 (2H, d, <i>J</i> = 8.4 Hz, ArH), 7.70 (2H, m, ArH), 7.45 (2H, d, <i>J</i> = 8.0 Hz, ArH), 7.28 (1H, m, ArH), 4.49 (2H, d, <i>J</i> = 6.4 Hz, CH<sub>2</sub>), 2.0 (1H, b, CH), 0.80 (4H, m, 2 ×  CH<sub>2</sub>)</div></div><div id="sec7_2_50" class="NLM_sec NLM_sec_level_3"><div id="ac_i79" class="anchor-spacer"></div><h4 class="article-section__title" id="_i79"> Preparation of Cyclopropanecarboxylic Acid {5-[4-(4,4-Difluoro-piperidin-1-ylmethyl)-phenyl]-[1,2,4]triazolo[1,5-<i>a</i>]pyridin-2-yl}-amide <b>63</b></h4><div class="NLM_p">Step i: Preparation of (2-fluoro-phenyl)-[4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-benzyl]-amine. To a mixture of 2-fluoro-phenylamine (129 μL, 1.347 mmol) and <i>N</i>,<i>N</i>-diisopropylethylamine (235 μL, 1.347 mmol) in DCM (5 mL) and MeOH (1 mL) was added 2-(4-bromomethyl-phenyl)-4,4,5,5-tetramethyl-[1,3,2]dioxaborolane (200 mg, 0.673 mmol) slowly, and the reaction was stirred at rt for 18 h. The resulting mixture was concentrated under vacuum, rediluted with EtOAc, washed with water, dried (MgSO<sub>4</sub>), filtered, and concentrated under vacuum to give the desired compound in quantitative yield.</div><div class="NLM_p">Step ii: Preparation of 4,4-difluoro-1-[4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-benzyl]-piperidine. To a mixture of 4,4-difluoro-piperidine (212 mg, 1.347 mmol) and <i>N</i>,<i>N</i>-diisopropylethylamine (235 μL, 1.347 mmol) in DCM (5 mL) and MeOH (1 mL) was added 2-(4-bromomethyl-phenyl)-4,4,5,5-tetramethyl-[1,3,2]dioxaborolane (200 mg, 0.673 mmol) slowly, and the reaction was stirred at rt for 18 h. The resulting mixture was concentrated under vacuum, rediluted with EtOAc, washed with water, dried (MgSO<sub>4</sub>), filtered, and concentrated under vacuum to give the desired compound that was used as such in the next step.</div><div class="NLM_p last">Step iii: Starting from compound <b>9</b> and 4,4-difluoro-1-[4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-benzyl]-piperidine, compound <b>63</b> was prepared using the general procedure for the Suzuki coupling reaction. Purification by preparative HPLC afforded the compound in 35% yield (99% purity by UPLC). <sup>1</sup>H (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.00 (1H, br s, NH), 7.98 (2H, d, <i>J</i> = 8.4 Hz, ArH), 7.73–7.66 (2H, m, ArH), 7.50 (2H, d, <i>J</i> = 8.4 Hz, ArH), 7.29 (1H, dd, <i>J</i> = 6.8, 1.6 Hz, ArH), 3.65 (2H, s, CH<sub>2</sub>), 2.56–2.52 (4H, m, 2 × CH<sub>2</sub>), 2.04–1.94 (5H, m, 2 × CH<sub>2</sub> and CH), 0.82–0.81 (4H, m, 2 × CH<sub>2</sub>). LCMS <i>m</i>/<i>z</i> 412.1 (M + H<sup>+</sup>).</div></div><div id="sec7_2_51" class="NLM_sec NLM_sec_level_3"><div id="ac_i80" class="anchor-spacer"></div><h4 class="article-section__title" id="_i80"> Preparation of Cyclopropanecarboxylic Acid (5-{4-[(1,1-Dioxo-tetrahydrothiophen-3-ylamino)-methyl]-phenyl}-[1,2,4]triazolo[1,5-<i>a</i>]pyridine-2-yl)-amide <b>64</b></h4><div class="NLM_p">Step i: 2-(4-Bromomethyl-phenyl)-4,4,5,5-tetramethyl-[1,3,2]dioxaborolane (0.674 mmol, 200 mg) and DIPEA (1.347 mmol, 234 μL)) were dissolved in DCM/MeOH (4:1 v:v) under N<sub>2</sub>, and 1,1-dioxo-tetrahydrothiophen-3-ylamine (1.347 mmol, 200 mg)) was added dropwise. The resulting solution was stirred at room temperature for 16 h. After this time, the reaction was complete. The solvent was evaporated. The compound was extracted with EtOAc and water, washed with brine, and dried over MgSO<sub>4</sub>. Organic layers were filtered and evaporated. The final compound was isolated by flash chromatography. (231 mg, 97% yield). Used in the next step without further purification.</div><div class="NLM_p last">Step ii: Starting from compound <b>9</b> (172 mg, 0.612 mmol) and compound described above (225 mg, 0.673 mmol), the title compound was obtained in 51% yield using the general procedure for the Suzuki coupling reaction (99% purity by LCMS). LCMS <i>m</i>/<i>z</i> 416 (M + H<sup>+</sup>). <sup>1</sup>H (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.99 (1H, b, NH), 7.97 (2H, d, <i>J</i> = 8.6 Hz, ArH), 7.69 (2H, m, 2 × ArH), 7.53 (2H, d, <i>J</i> = 8.6 Hz, ArH), 7.28 (1H, dd, <i>J</i> = 1.8, 6.8 Hz ArH), 3.90 (1H, b, NH), 3.83 (2H, m, CH<sub>2</sub>), 3.48 (1H, m, CH), 3.34 (1H, m, CH), 3.26 (1H, m, CH), 3.05 (1H, m, CH), 2.94 (1H, m, CH), 2.28 (1H, m, CH), 2.03 (2H, m, 2 ×  CH), 0.81 (4H, m, 2 × CH<sub>2</sub>)</div></div><div id="sec7_2_52" class="NLM_sec NLM_sec_level_3"><div id="ac_i81" class="anchor-spacer"></div><h4 class="article-section__title" id="_i81"> Preparation of Cyclopropanecarboxylic Acid {5-[4-(1,1-Dioxo-1λ*6*-thiomorpholin-4-ylmethyl)-phenyl]-[1,2,4]triazolo[1,5-<i>a</i>]pyridin-2-yl}-amide <b>65</b></h4><div class="NLM_p">Step1: Preparation of 4-[4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-benzyl]-thiomorpholine 1,1-dioxide. To a mixture of thiomorpholine 1,1-dioxide (455 mg, 3.367 mmol) and <i>N</i>,<i>N</i>-diisopropylethylamine (0.58 mL, 3.367 mmol) in DCM (15 mL) and MeOH (3 mL) was added 2-(4-bromomethyl-phenyl)-4,4,5,5-tetramethyl-[1,3,2]dioxaborolane (500 mg, 1.683 mmol) slowly, and the reaction was stirred at rt for 18 h. The resulting mixture was concentrated in vacuo, rediluted with EtOAc, washed with water, dried (MgSO<sub>4</sub>), filtered, and concentrated in vacuo to give the desired compound that was used as such in the next step.</div><div class="NLM_p last">Step ii: Starting from compound <b>9</b> and 4-[4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-benzyl]-thiomorpholine 1,1-dioxide, compound <b>65</b> was prepared using the general procedure for the Suzuki coupling reaction. Purification by silica chromatography followed by trituration with Et<sub>2</sub>O afforded the desired compound in 59% yield (99% purity by UPLC). <sup>1</sup>H (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.15 (1H, br s, NH), 8.11 (2H, m, ArH), 7.78 (2H, m, ArH), 7.76 (1H, dd, <i>J</i> = 8.8, 6.5 Hz, ArH), 7.73 (1H, dd, <i>J</i> = 8.8, 2.1 Hz, ArH), 7.36 (1H, dd, <i>J</i> = 6.5, 2.1 Hz, ArH), 4.44 (2H, s, CH<sub>2</sub>), 3.53 (8H, m, 4 × CH<sub>2</sub>), 2.03 2.03 (1H, br, CH), 0.82–0.81 (4H, m, 2 × CH<sub>2</sub>). LCMS <i>m</i>/<i>z</i> 426.0 (M + H<sup>+</sup>). <sup>13</sup>C (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 171.5, 157.5, 149.9, 138.8, 132.7, 132.1, 131.1, 130.6, 129.3, 114.1, 113.7, 57.7, 49.7, 47.8, 13.8, 7.7. LCMS <i>m</i>/<i>z</i> 426 (M + H<sup>+</sup>). CHN analysis C%, 48.64; H%, 5.81; N%, 13.41; Cl%, 6.88; S%, 6.37 (theoretical: C%, 48.88; H%, 8.86; N%, 13.57; Cl%, 6.87; S%, 6.21).</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="NOTES-d2158e5598-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i82"><a href="/doi/suppl/10.1021/jm501262q">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_01275" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_01275" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Protein crystallography, crystallographic data, and molecular modeling. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm501262q/suppl_file/jm501262q_si_001.pdf">jm501262q_si_001.pdf (119.66 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm501262q" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_34257" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_34257" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christel J. Menet</span> - <span class="hlFld-Affiliation affiliation">Galapagos
NV, Generaal de Wittelaan
L11A3, 2800 Mechelen, Belgium</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#e5868d978c96918089cb88808b8091a582899582cb868a88"><span class="__cf_email__" data-cfemail="96f5fee4ffe5e2f3fab8fbf3f8f3e2d6f1fae6f1b8f5f9fb">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stephen R Fletcher</span> - <span class="hlFld-Affiliation affiliation">BioFocus, Chesterford Research Park, Saffron Walden, Essex CB10 1XL, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Guy Van Lommen</span> - <span class="hlFld-Affiliation affiliation">Galapagos
NV, Generaal de Wittelaan
L11A3, 2800 Mechelen, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Raphael Geney</span> - <span class="hlFld-Affiliation affiliation">Galapagos
SASU, 102 Avenue Gaston
Roussel, 93230 Romainville, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Javier Blanc</span> - <span class="hlFld-Affiliation affiliation">Galapagos
NV, Generaal de Wittelaan
L11A3, 2800 Mechelen, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Koen Smits</span> - <span class="hlFld-Affiliation affiliation">Galapagos
NV, Generaal de Wittelaan
L11A3, 2800 Mechelen, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nolwenn Jouannigot</span> - <span class="hlFld-Affiliation affiliation">Galapagos
NV, Generaal de Wittelaan
L11A3, 2800 Mechelen, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Pierre Deprez</span> - <span class="hlFld-Affiliation affiliation">Galapagos
SASU, 102 Avenue Gaston
Roussel, 93230 Romainville, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ellen M. van der Aar</span> - <span class="hlFld-Affiliation affiliation">Galapagos
NV, Generaal de Wittelaan
L11A3, 2800 Mechelen, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Philippe Clement-Lacroix</span> - <span class="hlFld-Affiliation affiliation">Galapagos
SASU, 102 Avenue Gaston
Roussel, 93230 Romainville, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Liên Lepescheux</span> - <span class="hlFld-Affiliation affiliation">Galapagos
SASU, 102 Avenue Gaston
Roussel, 93230 Romainville, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">René Galien</span> - <span class="hlFld-Affiliation affiliation">Galapagos
SASU, 102 Avenue Gaston
Roussel, 93230 Romainville, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Béatrice Vayssiere</span> - <span class="hlFld-Affiliation affiliation">Galapagos
SASU, 102 Avenue Gaston
Roussel, 93230 Romainville, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Luc Nelles</span> - <span class="hlFld-Affiliation affiliation">Galapagos
NV, Generaal de Wittelaan
L11A3, 2800 Mechelen, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Thierry Christophe</span> - <span class="hlFld-Affiliation affiliation">Galapagos
NV, Generaal de Wittelaan
L11A3, 2800 Mechelen, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Reginald Brys</span> - <span class="hlFld-Affiliation affiliation">Galapagos
NV, Generaal de Wittelaan
L11A3, 2800 Mechelen, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Muriel Uhring</span> - <span class="hlFld-Affiliation affiliation">NovAliX, Boulevardd Sébastien Brant,
BP 30170, F-67405 Illkirch CEDEX, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Fabrice Ciesielski</span> - <span class="hlFld-Affiliation affiliation">NovAliX, Boulevardd Sébastien Brant,
BP 30170, F-67405 Illkirch CEDEX, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Luc Van Rompaey</span> - <span class="hlFld-Affiliation affiliation">Galapagos
NV, Generaal de Wittelaan
L11A3, 2800 Mechelen, Belgium</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare the following competing financial interest(s): C.J.M., G.V.L., J.B., K.S., N.J., E.M.V.D.A., L.N., T.C., R.B., L.V.R, P.D., P.C.L., L.L., R.G., and B.V.C. are employees of Galapagos NV.<br /></br></div></li></ul></div><div class="ack" id="ACK-d2158e5607-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i83">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_48304" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_48304" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We acknowledge the expert technical or editorial assistance of Cécile Belleville, Marie Christine Cecotti, Christelle David, Francois Gendrot, Didier Merciris, Alain Monjardet, Isabelle Orlans, Isabelle Parent, Laetitia Perret, and Emanuelle Wakselmann (affiliated with Galapagos SASU) and of Katja Conrath, Annick Hagers, Annelies Iwens, Daisy Liekens, Maarten Van Balen, and Kris Van Beeck (affiliated with Galapagos NV). We thank GSK for their financial support and especially Mike Skynner and Phil Jeffrey for the scientific discussions. AbbVie has provided funding to Galapagos for development of compound <b>65</b>.</p></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i84">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_13101" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_13101" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 29 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">O’Shea, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plenge, R.</span><span> </span><span class="NLM_article-title">JAK and STAT Signaling Molecules in Immunoregulation and Immune-Mediated Disease</span> <span class="citation_source-journal">Immunity</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">542</span><span class="NLM_x">–</span> <span class="NLM_lpage">550</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2012&pages=542-550&author=J.+J.+O%E2%80%99Sheaauthor=R.+Plenge&title=JAK+and+STAT+Signaling+Molecules+in+Immunoregulation+and+Immune-Mediated+Disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DJ.%2BJ.%26aulast%3DPlenge%26aufirst%3DR.%26atitle%3DJAK%2520and%2520STAT%2520Signaling%2520Molecules%2520in%2520Immunoregulation%2520and%2520Immune-Mediated%2520Disease%26jtitle%3DImmunity%26date%3D2012%26volume%3D36%26spage%3D542%26epage%3D550" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">West, K.</span><span> </span><span class="NLM_article-title">CP-690550, a JAK3 Inhibitor as an Immunosuppressant for the Treatment of Rheumatoid Arthritis, Transplant Rejection, Psoriasis and Other Immune-Mediated Disorders</span> <span class="citation_source-journal">Curr. Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">491</span><span class="NLM_x">–</span> <span class="NLM_lpage">504</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2009&pages=491-504&author=K.+West&title=CP-690550%2C+a+JAK3+Inhibitor+as+an+Immunosuppressant+for+the+Treatment+of+Rheumatoid+Arthritis%2C+Transplant+Rejection%2C+Psoriasis+and+Other+Immune-Mediated+Disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWest%26aufirst%3DK.%26atitle%3DCP-690550%252C%2520a%2520JAK3%2520Inhibitor%2520as%2520an%2520Immunosuppressant%2520for%2520the%2520Treatment%2520of%2520Rheumatoid%2520Arthritis%252C%2520Transplant%2520Rejection%252C%2520Psoriasis%2520and%2520Other%2520Immune-Mediated%2520Disorders%26jtitle%3DCurr.%2520Opin.%2520Invest.%2520Drugs%26date%3D2009%26volume%3D10%26spage%3D491%26epage%3D504" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Clark, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flanagan, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Telliez, J.-B.</span><span> </span><span class="NLM_article-title">Discovery and Development of Janus Kinase (JAK) Inhibitors for Inflammatory Diseases</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">5023</span><span class="NLM_x">–</span> <span class="NLM_lpage">5038</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm401490p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm501262q&amp;key=1%3ACAS%3A528%3ADC%252BC2cXotVCjsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=5023-5038&author=J.+D.+Clarkauthor=M.+E.+Flanaganauthor=J.-B.+Telliez&title=Discovery+and+Development+of+Janus+Kinase+%28JAK%29+Inhibitors+for+Inflammatory+Diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Development of Janus Kinase (JAK) Inhibitors for Inflammatory Diseases</span></div><div class="casAuthors">Clark, James D.; Flanagan, Mark E.; Telliez, Jean-Baptiste</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5023-5038</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The Janus kinases (JAKs) are a family of intracellular tyrosine kinases that play an essential role in the signaling of numerous cytokines that have been implicated in the pathogenesis of inflammatory diseases.  As a consequence, the JAKs have received significant attention in recent years from the pharmaceutical and biotechnol. industries as therapeutic targets.  Here, we provide a review of the JAK pathways, the structure, function, and activation of the JAK enzymes followed by a detailed look at the JAK inhibitors currently in the clinic or approved for these indications.  Finally, a perspective is provided on what the past decade of research with JAK inhibitors for inflammatory indications has taught along with thoughts on what the future may hold in terms of addressing the opportunities and challenges that remain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3f7W5g8N6brVg90H21EOLACvtfcHk0lhylN0twHt9sw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXotVCjsA%253D%253D&md5=6763ae2d46f52ddcda23e235a60634ae</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1021%2Fjm401490p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401490p%26sid%3Dliteratum%253Aachs%26aulast%3DClark%26aufirst%3DJ.%2BD.%26aulast%3DFlanagan%26aufirst%3DM.%2BE.%26aulast%3DTelliez%26aufirst%3DJ.-B.%26atitle%3DDiscovery%2520and%2520Development%2520of%2520Janus%2520Kinase%2520%2528JAK%2529%2520Inhibitors%2520for%2520Inflammatory%2520Diseases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D5023%26epage%3D5038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Rodig, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meraz, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lampe, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riley, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arthur, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheehan, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pennica, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, E. M.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreiber, R. D.</span><span> </span><span class="NLM_article-title">Disruption of the Jak1 Gene Demonstrates Obligatory and Nonredundant Roles of the Jaks in Cytokine-Induced Biologic Responses</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">93</span><span class="NLM_x">, </span> <span class="NLM_fpage">373</span><span class="NLM_x">–</span> <span class="NLM_lpage">383</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=1998&pages=373-383&author=S.+J.+Rodigauthor=M.+A.+Merazauthor=J.+M.+Whiteauthor=P.+A.+Lampeauthor=J.+K.+Rileyauthor=C.+D.+Arthurauthor=K.+L.+Kingauthor=K.+C.+Sheehanauthor=L.+Yinauthor=D.+Pennicaauthor=E.+M.+Johnsonauthor=R.+D.+Schreiber&title=Disruption+of+the+Jak1+Gene+Demonstrates+Obligatory+and+Nonredundant+Roles+of+the+Jaks+in+Cytokine-Induced+Biologic+Responses"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRodig%26aufirst%3DS.%2BJ.%26aulast%3DMeraz%26aufirst%3DM.%2BA.%26aulast%3DWhite%26aufirst%3DJ.%2BM.%26aulast%3DLampe%26aufirst%3DP.%2BA.%26aulast%3DRiley%26aufirst%3DJ.%2BK.%26aulast%3DArthur%26aufirst%3DC.%2BD.%26aulast%3DKing%26aufirst%3DK.%2BL.%26aulast%3DSheehan%26aufirst%3DK.%2BC.%26aulast%3DYin%26aufirst%3DL.%26aulast%3DPennica%26aufirst%3DD.%26aulast%3DJohnson%26aufirst%3DE.%2BM.%26aulast%3DSchreiber%26aufirst%3DR.%2BD.%26atitle%3DDisruption%2520of%2520the%2520Jak1%2520Gene%2520Demonstrates%2520Obligatory%2520and%2520Nonredundant%2520Roles%2520of%2520the%2520Jaks%2520in%2520Cytokine-Induced%2520Biologic%2520Responses%26jtitle%3DCell%26date%3D1998%26volume%3D93%26spage%3D373%26epage%3D383" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Shouda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanada, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wakioka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oishi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyoshi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Komiya, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kosai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanakawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashimoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagata, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshimura, A.</span><span> </span><span class="NLM_article-title">Induction of the Cytokine Signal Regulator SOCS3/CIS3 as a Therapeutic Strategy for Treating Inflammatory Arthritis</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">108</span><span class="NLM_x">, </span> <span class="NLM_fpage">1781</span><span class="NLM_x">–</span> <span class="NLM_lpage">1788</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2001&pages=1781-1788&author=T.+Shoudaauthor=T.+Yoshidaauthor=T.+Hanadaauthor=T.+Wakiokaauthor=M.+Oishiauthor=K.+Miyoshiauthor=S.+Komiyaauthor=K.+Kosaiauthor=Y.+Hanakawaauthor=K.+Hashimotoauthor=K.+Nagataauthor=A.+Yoshimura&title=Induction+of+the+Cytokine+Signal+Regulator+SOCS3%2FCIS3+as+a+Therapeutic+Strategy+for+Treating+Inflammatory+Arthritis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShouda%26aufirst%3DT.%26aulast%3DYoshida%26aufirst%3DT.%26aulast%3DHanada%26aufirst%3DT.%26aulast%3DWakioka%26aufirst%3DT.%26aulast%3DOishi%26aufirst%3DM.%26aulast%3DMiyoshi%26aufirst%3DK.%26aulast%3DKomiya%26aufirst%3DS.%26aulast%3DKosai%26aufirst%3DK.%26aulast%3DHanakawa%26aufirst%3DY.%26aulast%3DHashimoto%26aufirst%3DK.%26aulast%3DNagata%26aufirst%3DK.%26aulast%3DYoshimura%26aufirst%3DA.%26atitle%3DInduction%2520of%2520the%2520Cytokine%2520Signal%2520Regulator%2520SOCS3%252FCIS3%2520as%2520a%2520Therapeutic%2520Strategy%2520for%2520Treating%2520Inflammatory%2520Arthritis%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2001%26volume%3D108%26spage%3D1781%26epage%3D1788" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Haan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rolvering, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raulf, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapp, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drückes, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thoma, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behrmann, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zerwes, H.-G.</span><span> </span><span class="NLM_article-title">Jak1 Has a Dominant Role over Jak3 in Signal Transduction through Γc-Containing Cytokine Receptors</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">314</span><span class="NLM_x">–</span> <span class="NLM_lpage">323</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm501262q&amp;key=10.1016%2Fj.chembiol.2011.01.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm501262q&amp;key=21439476" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm501262q&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjvFSrtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=314-323&author=C.+Haanauthor=C.+Rolveringauthor=F.+Raulfauthor=M.+Kappauthor=P.+Dr%C3%BCckesauthor=G.+Thomaauthor=I.+Behrmannauthor=H.-G.+Zerwes&title=Jak1+Has+a+Dominant+Role+over+Jak3+in+Signal+Transduction+through+%CE%93c-Containing+Cytokine+Receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Jak1 Has a Dominant Role over Jak3 in Signal Transduction through γc-Containing Cytokine Receptors</span></div><div class="casAuthors">Haan, Claude; Rolvering, Catherine; Raulf, Friedrich; Kapp, Manuela; Drueckes, Peter; Thoma, Gebhard; Behrmann, Iris; Zerwes, Hans-Guenter</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">314-323</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: Genetic deficiency of Jak3 leads to abrogation of signal transduction through the common gamma chain (γc) and thus to immunodeficiency suggesting that specific inhibition of Jak3 kinase may result in immunosuppression.  Jak1 cooperates with Jak3 in signaling through γc-contg. receptors.  Unexpectedly, a Jak3-selective inhibitor was less efficient in abolishing STAT5 phosphorylation than pan-Jak inhibitors.  We therefore explored the roles of Jak1 and Jak3 kinase functionality in signaling using a reconstituted system.  The presence of kinase-inactive Jak1 but not kinase-inactive Jak3 resulted in complete abolishment of STAT5 phosphorylation.  Specific inhibition of the "analog-sensitive" mutant AS-Jak1 but not AS-Jak3 by the ATP-competitive analog 1NM-PP1 abrogated IL-2 signaling, corroborating the data with the selective Jak3 inhibitor.  Jak1 thus plays a dominant role over Jak3 and these data challenge the notion that selective ATP-competitive Jak3 kinase inhibitors will be effective.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUv04vX29Zk7Vg90H21EOLACvtfcHk0ljT_7N-fzVjhg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjvFSrtrw%253D&md5=0109f316cfe0bee40f80a79f244e6ba5</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2011.01.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2011.01.012%26sid%3Dliteratum%253Aachs%26aulast%3DHaan%26aufirst%3DC.%26aulast%3DRolvering%26aufirst%3DC.%26aulast%3DRaulf%26aufirst%3DF.%26aulast%3DKapp%26aufirst%3DM.%26aulast%3DDr%25C3%25BCckes%26aufirst%3DP.%26aulast%3DThoma%26aufirst%3DG.%26aulast%3DBehrmann%26aufirst%3DI.%26aulast%3DZerwes%26aufirst%3DH.-G.%26atitle%3DJak1%2520Has%2520a%2520Dominant%2520Role%2520over%2520Jak3%2520in%2520Signal%2520Transduction%2520through%2520%25CE%2593c-Containing%2520Cytokine%2520Receptors%26jtitle%3DChem.%2520Biol.%26date%3D2011%26volume%3D18%26spage%3D314%26epage%3D323" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Ghoreschi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jesson, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghosh, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alsup, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warner, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steward-Tharp, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gadina, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minnerly, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Storer, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaBranche, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radi, Z. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dowty, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Head, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kishore, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Shea, J. J.</span><span> </span><span class="NLM_article-title">Modulation of Innate and Adaptive Immune Responses by Tofacitinib (CP-690,550)</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">186</span><span class="NLM_x">, </span> <span class="NLM_fpage">4234</span><span class="NLM_x">–</span> <span class="NLM_lpage">4243</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=186&publication_year=2011&pages=4234-4243&author=K.+Ghoreschiauthor=M.+I.+Jessonauthor=X.+Liauthor=J.+L.+Leeauthor=S.+Ghoshauthor=J.+W.+Alsupauthor=J.+D.+Warnerauthor=M.+Tanakaauthor=S.+M.+Steward-Tharpauthor=M.+Gadinaauthor=C.+J.+Thomasauthor=J.+C.+Minnerlyauthor=C.+E.+Storerauthor=T.+P.+LaBrancheauthor=Z.+A.+Radiauthor=M.+E.+Dowtyauthor=R.+D.+Headauthor=D.+M.+Meyerauthor=N.+Kishoreauthor=J.+J.+O%E2%80%99Shea&title=Modulation+of+Innate+and+Adaptive+Immune+Responses+by+Tofacitinib+%28CP-690%2C550%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGhoreschi%26aufirst%3DK.%26aulast%3DJesson%26aufirst%3DM.%2BI.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DLee%26aufirst%3DJ.%2BL.%26aulast%3DGhosh%26aufirst%3DS.%26aulast%3DAlsup%26aufirst%3DJ.%2BW.%26aulast%3DWarner%26aufirst%3DJ.%2BD.%26aulast%3DTanaka%26aufirst%3DM.%26aulast%3DSteward-Tharp%26aufirst%3DS.%2BM.%26aulast%3DGadina%26aufirst%3DM.%26aulast%3DThomas%26aufirst%3DC.%2BJ.%26aulast%3DMinnerly%26aufirst%3DJ.%2BC.%26aulast%3DStorer%26aufirst%3DC.%2BE.%26aulast%3DLaBranche%26aufirst%3DT.%2BP.%26aulast%3DRadi%26aufirst%3DZ.%2BA.%26aulast%3DDowty%26aufirst%3DM.%2BE.%26aulast%3DHead%26aufirst%3DR.%2BD.%26aulast%3DMeyer%26aufirst%3DD.%2BM.%26aulast%3DKishore%26aufirst%3DN.%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DJ.%2BJ.%26atitle%3DModulation%2520of%2520Innate%2520and%2520Adaptive%2520Immune%2520Responses%2520by%2520Tofacitinib%2520%2528CP-690%252C550%2529%26jtitle%3DJ.%2520Immunol.%26date%3D2011%26volume%3D186%26spage%3D4234%26epage%3D4243" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Van Rompaey, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galien, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Aar, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clement-Lacroix, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelles, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smets, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lepescheux, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christophe, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conrath, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vandeghinste, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vayssiere, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Vos, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fletcher, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brys, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van ’t Klooster, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feyen, J. H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menet, C.</span><span> </span><span class="NLM_article-title">Preclinical Characterization of GLPG0634, a Selective Inhibitor of JAK1, for the Treatment of Inflammatory Diseases</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">191</span><span class="NLM_x">, </span> <span class="NLM_fpage">3568</span><span class="NLM_x">–</span> <span class="NLM_lpage">3577</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=191&publication_year=2013&pages=3568-3577&author=L.+Van+Rompaeyauthor=R.+Galienauthor=E.+M.+van+der+Aarauthor=P.+Clement-Lacroixauthor=L.+Nellesauthor=B.+Smetsauthor=L.+Lepescheuxauthor=T.+Christopheauthor=K.+Conrathauthor=N.+Vandeghinsteauthor=B.+Vayssiereauthor=S.+De+Vosauthor=S.+Fletcherauthor=R.+Brysauthor=G.+van+%E2%80%99t+Kloosterauthor=J.+H.+M.+Feyenauthor=C.+Menet&title=Preclinical+Characterization+of+GLPG0634%2C+a+Selective+Inhibitor+of+JAK1%2C+for+the+Treatment+of+Inflammatory+Diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BRompaey%26aufirst%3DL.%26aulast%3DGalien%26aufirst%3DR.%26aulast%3Dvan%2Bder%2BAar%26aufirst%3DE.%2BM.%26aulast%3DClement-Lacroix%26aufirst%3DP.%26aulast%3DNelles%26aufirst%3DL.%26aulast%3DSmets%26aufirst%3DB.%26aulast%3DLepescheux%26aufirst%3DL.%26aulast%3DChristophe%26aufirst%3DT.%26aulast%3DConrath%26aufirst%3DK.%26aulast%3DVandeghinste%26aufirst%3DN.%26aulast%3DVayssiere%26aufirst%3DB.%26aulast%3DDe%2BVos%26aufirst%3DS.%26aulast%3DFletcher%26aufirst%3DS.%26aulast%3DBrys%26aufirst%3DR.%26aulast%3Dvan%2B%25E2%2580%2599t%2BKlooster%26aufirst%3DG.%26aulast%3DFeyen%26aufirst%3DJ.%2BH.%2BM.%26aulast%3DMenet%26aufirst%3DC.%26atitle%3DPreclinical%2520Characterization%2520of%2520GLPG0634%252C%2520a%2520Selective%2520Inhibitor%2520of%2520JAK1%252C%2520for%2520the%2520Treatment%2520of%2520Inflammatory%2520Diseases%26jtitle%3DJ.%2520Immunol.%26date%3D2013%26volume%3D191%26spage%3D3568%26epage%3D3577" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Shimoda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aoki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyamoto, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shibamori, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamashita, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Numata, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takase, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shibata, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asano, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gondo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sekiguchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakayama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakayama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niho, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakayama, K.</span><span> </span><span class="NLM_article-title">Tyk2 Plays a Restricted Role in IFN Alpha Signaling, Although It Is Required for IL-12-Mediated T Cell Function</span> <span class="citation_source-journal">Immunity</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">561</span><span class="NLM_x">–</span> <span class="NLM_lpage">571</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2000&pages=561-571&author=K.+Shimodaauthor=K.+Katoauthor=K.+Aokiauthor=T.+Matsudaauthor=A.+Miyamotoauthor=M.+Shibamoriauthor=M.+Yamashitaauthor=A.+Numataauthor=K.+Takaseauthor=S.+Kobayashiauthor=S.+Shibataauthor=Y.+Asanoauthor=H.+Gondoauthor=K.+Sekiguchiauthor=K.+Nakayamaauthor=T.+Nakayamaauthor=T.+Okamuraauthor=S.+Okamuraauthor=Y.+Nihoauthor=K.+Nakayama&title=Tyk2+Plays+a+Restricted+Role+in+IFN+Alpha+Signaling%2C+Although+It+Is+Required+for+IL-12-Mediated+T+Cell+Function"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShimoda%26aufirst%3DK.%26aulast%3DKato%26aufirst%3DK.%26aulast%3DAoki%26aufirst%3DK.%26aulast%3DMatsuda%26aufirst%3DT.%26aulast%3DMiyamoto%26aufirst%3DA.%26aulast%3DShibamori%26aufirst%3DM.%26aulast%3DYamashita%26aufirst%3DM.%26aulast%3DNumata%26aufirst%3DA.%26aulast%3DTakase%26aufirst%3DK.%26aulast%3DKobayashi%26aufirst%3DS.%26aulast%3DShibata%26aufirst%3DS.%26aulast%3DAsano%26aufirst%3DY.%26aulast%3DGondo%26aufirst%3DH.%26aulast%3DSekiguchi%26aufirst%3DK.%26aulast%3DNakayama%26aufirst%3DK.%26aulast%3DNakayama%26aufirst%3DT.%26aulast%3DOkamura%26aufirst%3DT.%26aulast%3DOkamura%26aufirst%3DS.%26aulast%3DNiho%26aufirst%3DY.%26aulast%3DNakayama%26aufirst%3DK.%26atitle%3DTyk2%2520Plays%2520a%2520Restricted%2520Role%2520in%2520IFN%2520Alpha%2520Signaling%252C%2520Although%2520It%2520Is%2520Required%2520for%2520IL-12-Mediated%2520T%2520Cell%2520Function%26jtitle%3DImmunity%26date%3D2000%26volume%3D13%26spage%3D561%26epage%3D571" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Parganas, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stravopodis, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Topham, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marine, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teglund, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanin, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bodner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colamonici, O. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Deursen, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grosveld, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ihle, J. N.</span><span> </span><span class="NLM_article-title">Jak2 Is Essential for Signaling through a Variety of Cytokine Receptors</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">93</span><span class="NLM_x">, </span> <span class="NLM_fpage">385</span><span class="NLM_x">–</span> <span class="NLM_lpage">395</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=1998&pages=385-395&author=E.+Parganasauthor=D.+Wangauthor=D.+Stravopodisauthor=D.+J.+Tophamauthor=J.+C.+Marineauthor=S.+Teglundauthor=E.+F.+Vaninauthor=S.+Bodnerauthor=O.+R.+Colamoniciauthor=J.+M.+van+Deursenauthor=G.+Grosveldauthor=J.+N.+Ihle&title=Jak2+Is+Essential+for+Signaling+through+a+Variety+of+Cytokine+Receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DParganas%26aufirst%3DE.%26aulast%3DWang%26aufirst%3DD.%26aulast%3DStravopodis%26aufirst%3DD.%26aulast%3DTopham%26aufirst%3DD.%2BJ.%26aulast%3DMarine%26aufirst%3DJ.%2BC.%26aulast%3DTeglund%26aufirst%3DS.%26aulast%3DVanin%26aufirst%3DE.%2BF.%26aulast%3DBodner%26aufirst%3DS.%26aulast%3DColamonici%26aufirst%3DO.%2BR.%26aulast%3Dvan%2BDeursen%26aufirst%3DJ.%2BM.%26aulast%3DGrosveld%26aufirst%3DG.%26aulast%3DIhle%26aufirst%3DJ.%2BN.%26atitle%3DJak2%2520Is%2520Essential%2520for%2520Signaling%2520through%2520a%2520Variety%2520of%2520Cytokine%2520Receptors%26jtitle%3DCell%26date%3D1998%26volume%3D93%26spage%3D385%26epage%3D395" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Sohn, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrett, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Abbema, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohli, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanda, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macleod, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurley, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kulagowski, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewin-Koh, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dengler, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghilardi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blair, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magnuson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, L. C.</span><span> </span><span class="NLM_article-title">A Restricted Role for TYK2 Catalytic Activity in Human Cytokine Responses Revealed by Novel TYK2-Selective Inhibitors</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">191</span><span class="NLM_x">, </span> <span class="NLM_fpage">2205</span><span class="NLM_x">–</span> <span class="NLM_lpage">2216</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=191&publication_year=2013&pages=2205-2216&author=S.+J.+Sohnauthor=K.+Barrettauthor=A.+Van+Abbemaauthor=C.+Changauthor=P.+B.+Kohliauthor=H.+Kandaauthor=J.+Smithauthor=Y.+Laiauthor=A.+Zhouauthor=B.+Zhangauthor=W.+Yangauthor=K.+Williamsauthor=C.+Macleodauthor=C.+A.+Hurleyauthor=J.+J.+Kulagowskiauthor=N.+Lewin-Kohauthor=H.+S.+Denglerauthor=A.+R.+Johnsonauthor=N.+Ghilardiauthor=M.+Zakauthor=J.+Liangauthor=W.+S.+Blairauthor=S.+Magnusonauthor=L.+C.+Wu&title=A+Restricted+Role+for+TYK2+Catalytic+Activity+in+Human+Cytokine+Responses+Revealed+by+Novel+TYK2-Selective+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSohn%26aufirst%3DS.%2BJ.%26aulast%3DBarrett%26aufirst%3DK.%26aulast%3DVan%2BAbbema%26aufirst%3DA.%26aulast%3DChang%26aufirst%3DC.%26aulast%3DKohli%26aufirst%3DP.%2BB.%26aulast%3DKanda%26aufirst%3DH.%26aulast%3DSmith%26aufirst%3DJ.%26aulast%3DLai%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DB.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DWilliams%26aufirst%3DK.%26aulast%3DMacleod%26aufirst%3DC.%26aulast%3DHurley%26aufirst%3DC.%2BA.%26aulast%3DKulagowski%26aufirst%3DJ.%2BJ.%26aulast%3DLewin-Koh%26aufirst%3DN.%26aulast%3DDengler%26aufirst%3DH.%2BS.%26aulast%3DJohnson%26aufirst%3DA.%2BR.%26aulast%3DGhilardi%26aufirst%3DN.%26aulast%3DZak%26aufirst%3DM.%26aulast%3DLiang%26aufirst%3DJ.%26aulast%3DBlair%26aufirst%3DW.%2BS.%26aulast%3DMagnuson%26aufirst%3DS.%26aulast%3DWu%26aufirst%3DL.%2BC.%26atitle%3DA%2520Restricted%2520Role%2520for%2520TYK2%2520Catalytic%2520Activity%2520in%2520Human%2520Cytokine%2520Responses%2520Revealed%2520by%2520Novel%2520TYK2-Selective%2520Inhibitors%26jtitle%3DJ.%2520Immunol.%26date%3D2013%26volume%3D191%26spage%3D2205%26epage%3D2216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Kremer, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bloom, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breedveld, F. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coombs, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fletcher, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gruben, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krishnaswami, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgos-Vargas, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilkinson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zerbini, C. A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zwillich, S. H.</span><span> </span><span class="NLM_article-title">The Safety and Efficacy of a JAK Inhibitor in Patients with Active Rheumatoid Arthritis: Results of a Double-Blind, Placebo-Controlled Phase IIa Trial of Three Dosage Levels of CP-690,550 versus Placebo</span> <span class="citation_source-journal">Arthritis Rheum.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">1895</span><span class="NLM_x">–</span> <span class="NLM_lpage">1905</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm501262q&amp;key=10.1002%2Fart.24567" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm501262q&amp;key=19565475" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm501262q&amp;key=1%3ACAS%3A528%3ADC%252BD1MXptlKktLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2009&pages=1895-1905&author=J.+M.+Kremerauthor=B.+J.+Bloomauthor=F.+C.+Breedveldauthor=J.+H.+Coombsauthor=M.+P.+Fletcherauthor=D.+Grubenauthor=S.+Krishnaswamiauthor=R.+Burgos-Vargasauthor=B.+Wilkinsonauthor=C.+A.+F.+Zerbiniauthor=S.+H.+Zwillich&title=The+Safety+and+Efficacy+of+a+JAK+Inhibitor+in+Patients+with+Active+Rheumatoid+Arthritis%3A+Results+of+a+Double-Blind%2C+Placebo-Controlled+Phase+IIa+Trial+of+Three+Dosage+Levels+of+CP-690%2C550+versus+Placebo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">The safety and efficacy of a JAK inhibitor in patients with active rheumatoid arthritis: results of a double-blind, placebo-controlled phase IIa trial of three dosage levels of CP-690,550 versus placebo</span></div><div class="casAuthors">Kremer, Joel M.; Bloom, Bradley J.; Breedveld, Ferdinand C.; Coombs, John H.; Fletcher, Mark P.; Gruben, David; Krishnaswami, Sriram; Burgos-Vargas, Ruben; Wilkinson, Bethanie; Zerbini, Cristiano A. F.; Zwillich, Samuel H.</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis & Rheumatism</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1895-1905</span>CODEN:
                <span class="NLM_cas:coden">ARHEAW</span>;
        ISSN:<span class="NLM_cas:issn">0004-3591</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">To det. the efficacy, safety, and tolerability of 3 different dosages of CP-690,550, a potent, orally active JAK inhibitor, in patients with active rheumatoid arthritis (RA) in whom methotrexate, etanercept, infliximab, or adalimumab caused an inadequate or toxic response.  Patients (n = 264) were randomized equally to receive placebo, 5 mg of CP-690,550,15 mg of CP-690,550, or 30 mg of CP-690,550 twice daily for 6 wk, and were followed up for an addnl. 6 wk after treatment.  The primary efficacy end point was the American College of Rheumatol. 20% improvement criteria (ACR20) response rate at 6 wk.  By week 6, the ACR20 response rates were 70.5%, 81.2%, and 76.8% in the 5 mg, 15 mg, and 30 mg twice daily groups, resp., compared with 29.2% in the placebo group (P < 0.001).  Improvements in disease activity in CP-690,550-treated patients compared with placebo were seen in all treatment groups as early as week 1.  ACR50 and ACR70 response rates significantly improved in all treatment groups by week 4.  The most common adverse events reported were headache and nausea.  The infection rate in both the 15 mg twice daily group and the 30 mg twice daily group was 30.4% (vs. 26.2% in the placebo group).  No opportunistic infections or deaths occurred.  Increases in mean low-d. lipoprotein cholesterol and high-d. lipoprotein cholesterol levels, and increases in mean serum creatinine level (0.04-0.06 mg/dL) were seen in all CP-690,550 treatment arms.  Our findings indicate that CP-690,550 is efficacious in the treatment of RA, resulting in rapid, statistically significant, and clin. meaningful redns. in the signs and symptoms of RA.  Further studies of CP-690,550 in RA are warranted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBhxBhh_mG7rVg90H21EOLACvtfcHk0liJUmC-RoKNHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXptlKktLg%253D&md5=ab5fb34e43d8643871560c67bbbca07d</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1002%2Fart.24567&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.24567%26sid%3Dliteratum%253Aachs%26aulast%3DKremer%26aufirst%3DJ.%2BM.%26aulast%3DBloom%26aufirst%3DB.%2BJ.%26aulast%3DBreedveld%26aufirst%3DF.%2BC.%26aulast%3DCoombs%26aufirst%3DJ.%2BH.%26aulast%3DFletcher%26aufirst%3DM.%2BP.%26aulast%3DGruben%26aufirst%3DD.%26aulast%3DKrishnaswami%26aufirst%3DS.%26aulast%3DBurgos-Vargas%26aufirst%3DR.%26aulast%3DWilkinson%26aufirst%3DB.%26aulast%3DZerbini%26aufirst%3DC.%2BA.%2BF.%26aulast%3DZwillich%26aufirst%3DS.%2BH.%26atitle%3DThe%2520Safety%2520and%2520Efficacy%2520of%2520a%2520JAK%2520Inhibitor%2520in%2520Patients%2520with%2520Active%2520Rheumatoid%2520Arthritis%253A%2520Results%2520of%2520a%2520Double-Blind%252C%2520Placebo-Controlled%2520Phase%2520IIa%2520Trial%2520of%2520Three%2520Dosage%2520Levels%2520of%2520CP-690%252C550%2520versus%2520Placebo%26jtitle%3DArthritis%2520Rheum.%26date%3D2009%26volume%3D60%26spage%3D1895%26epage%3D1905" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Tefferi, A.</span><span> </span><span class="NLM_article-title">JAK Inhibitors for Myeloproliferative Neoplasms: Clarifying Facts from Myths</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">119</span><span class="NLM_x">, </span> <span class="NLM_fpage">2721</span><span class="NLM_x">–</span> <span class="NLM_lpage">2730</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2012&pages=2721-2730&author=A.+Tefferi&title=JAK+Inhibitors+for+Myeloproliferative+Neoplasms%3A+Clarifying+Facts+from+Myths"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTefferi%26aufirst%3DA.%26atitle%3DJAK%2520Inhibitors%2520for%2520Myeloproliferative%2520Neoplasms%253A%2520Clarifying%2520Facts%2520from%2520Myths%26jtitle%3DBlood%26date%3D2012%26volume%3D119%26spage%3D2721%26epage%3D2730" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Park, S. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wamsley, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bae, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choe, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slayton, W. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oh, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, K.-U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sayeski, P. P.</span><span> </span><span class="NLM_article-title">Conditional Deletion of Jak2 Reveals an Essential Role in Hematopoiesis throughout Mouse Ontogeny: Implications for Jak2 Inhibition in Humans</span> <span class="citation_source-journal">PloS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">e59675</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e59675&author=S.+O.+Parkauthor=H.+L.+Wamsleyauthor=K.+Baeauthor=Z.+Huauthor=X.+Liauthor=S.+Choeauthor=W.+B.+Slaytonauthor=S.+P.+Ohauthor=K.-U.+Wagnerauthor=P.+P.+Sayeski&title=Conditional+Deletion+of+Jak2+Reveals+an+Essential+Role+in+Hematopoiesis+throughout+Mouse+Ontogeny%3A+Implications+for+Jak2+Inhibition+in+Humans"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DS.%2BO.%26aulast%3DWamsley%26aufirst%3DH.%2BL.%26aulast%3DBae%26aufirst%3DK.%26aulast%3DHu%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DChoe%26aufirst%3DS.%26aulast%3DSlayton%26aufirst%3DW.%2BB.%26aulast%3DOh%26aufirst%3DS.%2BP.%26aulast%3DWagner%26aufirst%3DK.-U.%26aulast%3DSayeski%26aufirst%3DP.%2BP.%26atitle%3DConditional%2520Deletion%2520of%2520Jak2%2520Reveals%2520an%2520Essential%2520Role%2520in%2520Hematopoiesis%2520throughout%2520Mouse%2520Ontogeny%253A%2520Implications%2520for%2520Jak2%2520Inhibition%2520in%2520Humans%26jtitle%3DPloS%2520One%26date%3D2013%26volume%3D8%26spage%3De59675" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">O’Shea, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holland, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staudt, L. M.</span><span> </span><span class="NLM_article-title">JAKs and STATs in Immunity, Immunodeficiency, and Cancer</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">368</span><span class="NLM_x">, </span> <span class="NLM_fpage">161</span><span class="NLM_x">–</span> <span class="NLM_lpage">170</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm501262q&amp;key=10.1056%2FNEJMra1202117" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm501262q&amp;key=23301733" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm501262q&amp;key=1%3ACAS%3A528%3ADC%252BC3sXovVyhuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=368&publication_year=2013&pages=161-170&author=J.+J.+O%E2%80%99Sheaauthor=S.+M.+Hollandauthor=L.+M.+Staudt&title=JAKs+and+STATs+in+Immunity%2C+Immunodeficiency%2C+and+Cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">JAKs and STATs in immunity, immunodeficiency, and cancer</span></div><div class="casAuthors">O'Shea, John J.; Holland, Steven M.; Staudt, Louis M.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">368</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">161-170</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">A review highlights interferon-mediated gene regulation has resulted in a new framework for the study of cell signaling and JAKs STATs in immunity, immunodeficiency, and cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqk1n-UgWrlWrVg90H21EOLACvtfcHk0liJUmC-RoKNHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXovVyhuw%253D%253D&md5=5d87b67f72b721eb0ca9413adf92a7b9</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1056%2FNEJMra1202117&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMra1202117%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DJ.%2BJ.%26aulast%3DHolland%26aufirst%3DS.%2BM.%26aulast%3DStaudt%26aufirst%3DL.%2BM.%26atitle%3DJAKs%2520and%2520STATs%2520in%2520Immunity%252C%2520Immunodeficiency%252C%2520and%2520Cancer%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2013%26volume%3D368%26spage%3D161%26epage%3D170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Cheng, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, L.</span><span> </span><span class="NLM_article-title">Computation of Octanol–Water Partition Coefficients by Guiding an Additive Model with Knowledge</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">2140</span><span class="NLM_x">–</span> <span class="NLM_lpage">2148</span></span><div class="citationLinks">[<a href="/doi/10.1021/ci700257y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm501262q&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1KisbvF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2007&pages=2140-2148&author=T.+Chengauthor=Y.+Zhaoauthor=X.+Liauthor=F.+Linauthor=Y.+Xuauthor=X.+Zhangauthor=Y.+Liauthor=R.+Wangauthor=L.+Lai&title=Computation+of+Octanol%E2%80%93Water+Partition+Coefficients+by+Guiding+an+Additive+Model+with+Knowledge"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Computation of Octanol-Water Partition Coefficients by Guiding an Additive Model with Knowledge</span></div><div class="casAuthors">Cheng, Tiejun; Zhao, Yuan; Li, Xun; Lin, Fu; Xu, Yong; Zhang, Xinglong; Li, Yan; Wang, Renxiao; Lai, Luhua</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2140-2148</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We have developed a new method, i.e., XLOGP3, for logP computation.  XLOGP3 predicts the logP value of a query compd. by using the known logP value of a ref. compd. as a starting point.  The difference in the logP values of the query compd. and the ref. compd. is then estd. by an additive model.  The additive model implemented in XLOGP3 uses a total of 87 atom/group types and two correction factors as descriptors.  It is calibrated on a training set of 8199 org. compds. with reliable logP data through a multivariate linear regression anal.  For a given query compd., the compd. showing the highest structural similarity in the training set will be selected as the ref. compd.  Structural similarity is quantified based on topol. torsion descriptors.  XLOGP3 has been tested along with its predecessor, i.e., XLOGP2, as well as several popular logP methods on two independent test sets: one contains 406 small-mol. drugs approved by the FDA and the other contains 219 oligopeptides.  On both test sets, XLOGP3 produces more accurate predictions than most of the other methods with av. unsigned errors of 0.24-0.51 units.  Compared to conventional additive methods, XLOGP3 does not rely on an extensive classification of fragments and correction factors in order to improve accuracy.  It is also able to utilize the ever-increasing exptl. measured logP data more effectively.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUq0p6A6frurVg90H21EOLACvtfcHk0liv3Ggq8cBRNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1KisbvF&md5=492b857ffa462283dace225c7dcb9ad5</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fci700257y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci700257y%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DT.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DLin%26aufirst%3DF.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DR.%26aulast%3DLai%26aufirst%3DL.%26atitle%3DComputation%2520of%2520Octanol%25E2%2580%2593Water%2520Partition%2520Coefficients%2520by%2520Guiding%2520an%2520Additive%2520Model%2520with%2520Knowledge%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2007%26volume%3D47%26spage%3D2140%26epage%3D2148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Siu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pastor, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrett, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berry, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blair, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eigenbrot, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghilardi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbons, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurley, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenny, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cyrus Khojasteh, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyssikatos, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magnuson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pulk, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsui, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ultsch, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sampath, D.</span><span> </span><span class="NLM_article-title">2-Amino-[1,2,4]triazolo[1,5-<i>a</i>]pyridines as JAK2 Inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">5014</span><span class="NLM_x">–</span> <span class="NLM_lpage">5021</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=5014-5021&author=M.+Siuauthor=R.+Pastorauthor=W.+Liuauthor=K.+Barrettauthor=M.+Berryauthor=W.+S.+Blairauthor=C.+Changauthor=J.+Z.+Chenauthor=C.+Eigenbrotauthor=N.+Ghilardiauthor=P.+Gibbonsauthor=H.+Heauthor=C.+A.+Hurleyauthor=J.+R.+Kennyauthor=S.+Cyrus+Khojastehauthor=H.+Leauthor=L.+Leeauthor=J.+P.+Lyssikatosauthor=S.+Magnusonauthor=R.+Pulkauthor=V.+Tsuiauthor=M.+Ultschauthor=Y.+Xiaoauthor=B.+Zhuauthor=D.+Sampath&title=2-Amino-%5B1%2C2%2C4%5Dtriazolo%5B1%2C5-a%5Dpyridines+as+JAK2+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSiu%26aufirst%3DM.%26aulast%3DPastor%26aufirst%3DR.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DBarrett%26aufirst%3DK.%26aulast%3DBerry%26aufirst%3DM.%26aulast%3DBlair%26aufirst%3DW.%2BS.%26aulast%3DChang%26aufirst%3DC.%26aulast%3DChen%26aufirst%3DJ.%2BZ.%26aulast%3DEigenbrot%26aufirst%3DC.%26aulast%3DGhilardi%26aufirst%3DN.%26aulast%3DGibbons%26aufirst%3DP.%26aulast%3DHe%26aufirst%3DH.%26aulast%3DHurley%26aufirst%3DC.%2BA.%26aulast%3DKenny%26aufirst%3DJ.%2BR.%26aulast%3DCyrus%2BKhojasteh%26aufirst%3DS.%26aulast%3DLe%26aufirst%3DH.%26aulast%3DLee%26aufirst%3DL.%26aulast%3DLyssikatos%26aufirst%3DJ.%2BP.%26aulast%3DMagnuson%26aufirst%3DS.%26aulast%3DPulk%26aufirst%3DR.%26aulast%3DTsui%26aufirst%3DV.%26aulast%3DUltsch%26aufirst%3DM.%26aulast%3DXiao%26aufirst%3DY.%26aulast%3DZhu%26aufirst%3DB.%26aulast%3DSampath%26aufirst%3DD.%26atitle%3D2-Amino-%255B1%252C2%252C4%255Dtriazolo%255B1%252C5-a%255Dpyridines%2520as%2520JAK2%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D5014%26epage%3D5021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Nettekoven, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Püllmann, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmitt, S.</span><span> </span><span class="NLM_article-title">Synthetic Access to 2-Amido-5-aryl-8-methoxy-triazolopyridine and 2-Amido-5-morpholino-8-methoxy-triazolopyridine Derivatives as Potential Inhibitors of the Adenosine Receptor Subtypes</span> <span class="citation_source-journal">Synthesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">2003</span><span class="NLM_x">, </span> <span class="NLM_fpage">1649</span><span class="NLM_x">–</span> <span class="NLM_lpage">1652</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm501262q&amp;key=10.1055%2Fs-2003-40874" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2003&publication_year=2003&pages=1649-1652&author=M.+Nettekovenauthor=B.+P%C3%BCllmannauthor=S.+Schmitt&title=Synthetic+Access+to+2-Amido-5-aryl-8-methoxy-triazolopyridine+and+2-Amido-5-morpholino-8-methoxy-triazolopyridine+Derivatives+as+Potential+Inhibitors+of+the+Adenosine+Receptor+Subtypes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1055%2Fs-2003-40874&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-2003-40874%26sid%3Dliteratum%253Aachs%26aulast%3DNettekoven%26aufirst%3DM.%26aulast%3DP%25C3%25BCllmann%26aufirst%3DB.%26aulast%3DSchmitt%26aufirst%3DS.%26atitle%3DSynthetic%2520Access%2520to%25202-Amido-5-aryl-8-methoxy-triazolopyridine%2520and%25202-Amido-5-morpholino-8-methoxy-triazolopyridine%2520Derivatives%2520as%2520Potential%2520Inhibitors%2520of%2520the%2520Adenosine%2520Receptor%2520Subtypes%26jtitle%3DSynthesis%26date%3D2003%26volume%3D2003%26spage%3D1649%26epage%3D1652" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Mattson, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pham, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leuck, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowen, K. A.</span><span> </span><span class="NLM_article-title">An improved method for reductive alkylation of amines using titanium(IV) isopropoxide and sodium cyanoborohydride</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">2552</span><span class="NLM_x">–</span> <span class="NLM_lpage">2554</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo00295a060" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=1990&pages=2552-2554&author=R.+J.+Mattsonauthor=K.+M.+Phamauthor=D.+J.+Leuckauthor=K.+A.+Cowen&title=An+improved+method+for+reductive+alkylation+of+amines+using+titanium%28IV%29+isopropoxide+and+sodium+cyanoborohydride"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjo00295a060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00295a060%26sid%3Dliteratum%253Aachs%26aulast%3DMattson%26aufirst%3DR.%2BJ.%26aulast%3DPham%26aufirst%3DK.%2BM.%26aulast%3DLeuck%26aufirst%3DD.%2BJ.%26aulast%3DCowen%26aufirst%3DK.%2BA.%26atitle%3DAn%2520improved%2520method%2520for%2520reductive%2520alkylation%2520of%2520amines%2520using%2520titanium%2528IV%2529%2520isopropoxide%2520and%2520sodium%2520cyanoborohydride%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1990%26volume%3D55%26spage%3D2552%26epage%3D2554" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Williams, N. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bamert, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walden, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilks, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fantino, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossjohn, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucet, I. S.</span><span> </span><span class="NLM_article-title">Dissecting specificity in the Janus kinases: the structures of JAK-specific inhibitors complexed to the JAK1 and JAK2 protein tyrosine kinase domains</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">387</span><span class="NLM_x">, </span> <span class="NLM_fpage">219</span><span class="NLM_x">–</span> <span class="NLM_lpage">232</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm501262q&amp;key=10.1016%2Fj.jmb.2009.01.041" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm501262q&amp;key=19361440" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm501262q&amp;key=1%3ACAS%3A528%3ADC%252BD1MXivVegtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=387&publication_year=2009&pages=219-232&author=N.+K.+Williamsauthor=R.+S.+Bamertauthor=O.+Patelauthor=C.+Wangauthor=P.+M.+Waldenauthor=A.+F.+Wilksauthor=E.+Fantinoauthor=J.+Rossjohnauthor=I.+S.+Lucet&title=Dissecting+specificity+in+the+Janus+kinases%3A+the+structures+of+JAK-specific+inhibitors+complexed+to+the+JAK1+and+JAK2+protein+tyrosine+kinase+domains"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Dissecting Specificity in the Janus Kinases: The Structures of JAK-Specific Inhibitors Complexed to the JAK1 and JAK2 Protein Tyrosine Kinase Domains</span></div><div class="casAuthors">Williams, Neal K.; Bamert, Rebecca S.; Patel, Onisha; Wang, Christina; Walden, Patricia M.; Wilks, Andrew F.; Fantino, Emmanuelle; Rossjohn, Jamie; Lucet, Isabelle S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">387</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">219-232</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The Janus kinases (JAKs) are a pivotal family of protein tyrosine kinases (PTKs) that play prominent roles in numerous cytokine signaling pathways, with aberrant JAK activity assocd. with a variety of hematopoietic malignancies, cardiovascular diseases and immune-related disorders.  Whereas the structures of the JAK2 and JAK3 PTK domains have been detd., the structure of the JAK1 PTK domain is unknown.  Here, we report the high-resoln. crystal structures of the "active form" of the JAK1 PTK domain in complex with two JAK inhibitors, a tetracyclic pyridone 2-t-butyl-9-fluoro-3,6-dihydro-7H-benz[h]-imidaz[4,5-f]isoquinoline-7-one (CMP6) and (3R,4R)-3-[4-methyl-3-[N-methyl-N-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl]-3-oxopropionitrile (CP-690,550), and compare them with the corresponding JAK2 PTK inhibitor complexes.  Both inhibitors bound in a similar manner to JAK1, namely buried deep within a constricted ATP-binding site, thereby providing a basis for the potent inhibition of JAK1.  As expected, the mode of inhibitor binding in JAK1 was very similar to that obsd. in JAK2, highlighting the challenges in developing JAK-specific inhibitors that target the ATP-binding site.  Nevertheless, differences surrounding the JAK1 and JAK2 ATP-binding sites were apparent, thereby providing a platform for the rational design of JAK2- and JAK1-specific inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQDLkMkCgiLbVg90H21EOLACvtfcHk0lgLZH_00tz6wg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXivVegtbo%253D&md5=79957755d04323057b5acf7e9d2c56ca</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2009.01.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2009.01.041%26sid%3Dliteratum%253Aachs%26aulast%3DWilliams%26aufirst%3DN.%2BK.%26aulast%3DBamert%26aufirst%3DR.%2BS.%26aulast%3DPatel%26aufirst%3DO.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DWalden%26aufirst%3DP.%2BM.%26aulast%3DWilks%26aufirst%3DA.%2BF.%26aulast%3DFantino%26aufirst%3DE.%26aulast%3DRossjohn%26aufirst%3DJ.%26aulast%3DLucet%26aufirst%3DI.%2BS.%26atitle%3DDissecting%2520specificity%2520in%2520the%2520Janus%2520kinases%253A%2520the%2520structures%2520of%2520JAK-specific%2520inhibitors%2520complexed%2520to%2520the%2520JAK1%2520and%2520JAK2%2520protein%2520tyrosine%2520kinase%2520domains%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2009%26volume%3D387%26spage%3D219%26epage%3D232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Alkorta, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campillo, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rozas, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elguero, J.</span><span> </span><span class="NLM_article-title">Ring Strain and Hydrogen Bond Acidity</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">7759</span><span class="NLM_x">–</span> <span class="NLM_lpage">7763</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo980804l" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=1998&pages=7759-7763&author=I.+Alkortaauthor=N.+Campilloauthor=I.+Rozasauthor=J.+Elguero&title=Ring+Strain+and+Hydrogen+Bond+Acidity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjo980804l&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo980804l%26sid%3Dliteratum%253Aachs%26aulast%3DAlkorta%26aufirst%3DI.%26aulast%3DCampillo%26aufirst%3DN.%26aulast%3DRozas%26aufirst%3DI.%26aulast%3DElguero%26aufirst%3DJ.%26atitle%3DRing%2520Strain%2520and%2520Hydrogen%2520Bond%2520Acidity%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1998%26volume%3D63%26spage%3D7759%26epage%3D7763" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Labadie, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dragovich, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrett, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blair, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergeron, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deshmukh, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eigenbrot, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghilardi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbons, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurley, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenny, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohli, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kulagowski, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liimatta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lupardus, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendonca, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pulk, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shia, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steffek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ubhayakar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ultsch, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Abbema, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zak, M.</span><span> </span><span class="NLM_article-title">Structure-Based Discovery of C-2 Substituted Imidazo-Pyrrolopyridine JAK1 Inhibitors with Improved Selectivity over JAK2</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">7627</span><span class="NLM_x">–</span> <span class="NLM_lpage">7633</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=7627-7633&author=S.+Labadieauthor=P.+S.+Dragovichauthor=K.+Barrettauthor=W.+S.+Blairauthor=P.+Bergeronauthor=C.+Changauthor=G.+Deshmukhauthor=C.+Eigenbrotauthor=N.+Ghilardiauthor=P.+Gibbonsauthor=C.+A.+Hurleyauthor=A.+Johnsonauthor=J.+R.+Kennyauthor=P.+B.+Kohliauthor=J.+J.+Kulagowskiauthor=M.+Liimattaauthor=P.+J.+Lupardusauthor=R.+Mendoncaauthor=J.+M.+Murrayauthor=R.+Pulkauthor=S.+Shiaauthor=M.+Steffekauthor=S.+Ubhayakarauthor=M.+Ultschauthor=A.+van+Abbemaauthor=S.+Wardauthor=M.+Zak&title=Structure-Based+Discovery+of+C-2+Substituted+Imidazo-Pyrrolopyridine+JAK1+Inhibitors+with+Improved+Selectivity+over+JAK2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLabadie%26aufirst%3DS.%26aulast%3DDragovich%26aufirst%3DP.%2BS.%26aulast%3DBarrett%26aufirst%3DK.%26aulast%3DBlair%26aufirst%3DW.%2BS.%26aulast%3DBergeron%26aufirst%3DP.%26aulast%3DChang%26aufirst%3DC.%26aulast%3DDeshmukh%26aufirst%3DG.%26aulast%3DEigenbrot%26aufirst%3DC.%26aulast%3DGhilardi%26aufirst%3DN.%26aulast%3DGibbons%26aufirst%3DP.%26aulast%3DHurley%26aufirst%3DC.%2BA.%26aulast%3DJohnson%26aufirst%3DA.%26aulast%3DKenny%26aufirst%3DJ.%2BR.%26aulast%3DKohli%26aufirst%3DP.%2BB.%26aulast%3DKulagowski%26aufirst%3DJ.%2BJ.%26aulast%3DLiimatta%26aufirst%3DM.%26aulast%3DLupardus%26aufirst%3DP.%2BJ.%26aulast%3DMendonca%26aufirst%3DR.%26aulast%3DMurray%26aufirst%3DJ.%2BM.%26aulast%3DPulk%26aufirst%3DR.%26aulast%3DShia%26aufirst%3DS.%26aulast%3DSteffek%26aufirst%3DM.%26aulast%3DUbhayakar%26aufirst%3DS.%26aulast%3DUltsch%26aufirst%3DM.%26aulast%3Dvan%2BAbbema%26aufirst%3DA.%26aulast%3DWard%26aufirst%3DS.%26aulast%3DZak%26aufirst%3DM.%26atitle%3DStructure-Based%2520Discovery%2520of%2520C-2%2520Substituted%2520Imidazo-Pyrrolopyridine%2520JAK1%2520Inhibitors%2520with%2520Improved%2520Selectivity%2520over%2520JAK2%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D7627%26epage%3D7633" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Zak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurley, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, S. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergeron, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrett, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balazs, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blair, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bull, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chakravarty, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crackett, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deshmukh, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeVoss, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dragovich, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eigenbrot, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellwood, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaines, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghilardi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbons, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gradl, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gribling, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamman, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harstad, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hewitt, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenny, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koehler, M. F. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bir Kohli, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labadie, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liimatta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendonca, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narukulla, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pulk, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reeve, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savage, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shia, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steffek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ubhayakar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Abbema, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aliagas, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avitabile-Woo, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kulagowski, J. J.</span><span> </span><span class="NLM_article-title">Identification of C-2 Hydroxyethyl Imidazopyrrolopyridines as Potent JAK1 Inhibitors with Favorable Physicochemical Properties and High Selectivity over JAK2</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">4764</span><span class="NLM_x">–</span> <span class="NLM_lpage">4785</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm4004895" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=4764-4785&author=M.+Zakauthor=C.+A.+Hurleyauthor=S.+I.+Wardauthor=P.+Bergeronauthor=K.+Barrettauthor=M.+Balazsauthor=W.+S.+Blairauthor=R.+Bullauthor=P.+Chakravartyauthor=C.+Changauthor=P.+Crackettauthor=G.+Deshmukhauthor=J.+DeVossauthor=P.+S.+Dragovichauthor=C.+Eigenbrotauthor=C.+Ellwoodauthor=S.+Gainesauthor=N.+Ghilardiauthor=P.+Gibbonsauthor=S.+Gradlauthor=P.+Griblingauthor=C.+Hammanauthor=E.+Harstadauthor=P.+Hewittauthor=A.+Johnsonauthor=T.+Johnsonauthor=J.+R.+Kennyauthor=M.+F.+T.+Koehlerauthor=P.+Bir+Kohliauthor=S.+Labadieauthor=W.+P.+Leeauthor=J.+Liaoauthor=M.+Liimattaauthor=R.+Mendoncaauthor=R.+Narukullaauthor=R.+Pulkauthor=A.+Reeveauthor=S.+Savageauthor=S.+Shiaauthor=M.+Steffekauthor=S.+Ubhayakarauthor=A.+van+Abbemaauthor=I.+Aliagasauthor=B.+Avitabile-Wooauthor=Y.+Xiaoauthor=J.+Yangauthor=J.+J.+Kulagowski&title=Identification+of+C-2+Hydroxyethyl+Imidazopyrrolopyridines+as+Potent+JAK1+Inhibitors+with+Favorable+Physicochemical+Properties+and+High+Selectivity+over+JAK2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm4004895&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4004895%26sid%3Dliteratum%253Aachs%26aulast%3DZak%26aufirst%3DM.%26aulast%3DHurley%26aufirst%3DC.%2BA.%26aulast%3DWard%26aufirst%3DS.%2BI.%26aulast%3DBergeron%26aufirst%3DP.%26aulast%3DBarrett%26aufirst%3DK.%26aulast%3DBalazs%26aufirst%3DM.%26aulast%3DBlair%26aufirst%3DW.%2BS.%26aulast%3DBull%26aufirst%3DR.%26aulast%3DChakravarty%26aufirst%3DP.%26aulast%3DChang%26aufirst%3DC.%26aulast%3DCrackett%26aufirst%3DP.%26aulast%3DDeshmukh%26aufirst%3DG.%26aulast%3DDeVoss%26aufirst%3DJ.%26aulast%3DDragovich%26aufirst%3DP.%2BS.%26aulast%3DEigenbrot%26aufirst%3DC.%26aulast%3DEllwood%26aufirst%3DC.%26aulast%3DGaines%26aufirst%3DS.%26aulast%3DGhilardi%26aufirst%3DN.%26aulast%3DGibbons%26aufirst%3DP.%26aulast%3DGradl%26aufirst%3DS.%26aulast%3DGribling%26aufirst%3DP.%26aulast%3DHamman%26aufirst%3DC.%26aulast%3DHarstad%26aufirst%3DE.%26aulast%3DHewitt%26aufirst%3DP.%26aulast%3DJohnson%26aufirst%3DA.%26aulast%3DJohnson%26aufirst%3DT.%26aulast%3DKenny%26aufirst%3DJ.%2BR.%26aulast%3DKoehler%26aufirst%3DM.%2BF.%2BT.%26aulast%3DBir%2BKohli%26aufirst%3DP.%26aulast%3DLabadie%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DW.%2BP.%26aulast%3DLiao%26aufirst%3DJ.%26aulast%3DLiimatta%26aufirst%3DM.%26aulast%3DMendonca%26aufirst%3DR.%26aulast%3DNarukulla%26aufirst%3DR.%26aulast%3DPulk%26aufirst%3DR.%26aulast%3DReeve%26aufirst%3DA.%26aulast%3DSavage%26aufirst%3DS.%26aulast%3DShia%26aufirst%3DS.%26aulast%3DSteffek%26aufirst%3DM.%26aulast%3DUbhayakar%26aufirst%3DS.%26aulast%3Dvan%2BAbbema%26aufirst%3DA.%26aulast%3DAliagas%26aufirst%3DI.%26aulast%3DAvitabile-Woo%26aufirst%3DB.%26aulast%3DXiao%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DKulagowski%26aufirst%3DJ.%2BJ.%26atitle%3DIdentification%2520of%2520C-2%2520Hydroxyethyl%2520Imidazopyrrolopyridines%2520as%2520Potent%2520JAK1%2520Inhibitors%2520with%2520Favorable%2520Physicochemical%2520Properties%2520and%2520High%2520Selectivity%2520over%2520JAK2%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D4764%26epage%3D4785" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Yu, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pistillo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Archibeque, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han Lee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, B.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schenkel, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geuns-Meyer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emkey, R.</span><span> </span><span class="NLM_article-title">Differential Selectivity of JAK2 Inhibitors in Enzymatic and Cellular Settings</span> <span class="citation_source-journal">Exp. Hematol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">491</span><span class="NLM_x">–</span> <span class="NLM_lpage">500</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm501262q&amp;key=10.1016%2Fj.exphem.2013.01.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm501262q&amp;key=23340136" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm501262q&amp;key=1%3ACAS%3A528%3ADC%252BC3sXlt1Cjsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2013&pages=491-500&author=V.+Yuauthor=J.+Pistilloauthor=I.+Archibequeauthor=J.+Han+Leeauthor=B.-C.+Sunauthor=L.+B.+Schenkelauthor=S.+Geuns-Meyerauthor=L.+Liuauthor=R.+Emkey&title=Differential+Selectivity+of+JAK2+Inhibitors+in+Enzymatic+and+Cellular+Settings"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Differential selectivity of JAK2 inhibitors in enzymatic and cellular settings</span></div><div class="casAuthors">Yu, Violeta; Pistillo, Jeanne; Archibeque, Ivonne; Han Lee, Josie; Sun, Bee-Chun; Schenkel, Laurie B.; Geuns-Meyer, Stephanie; Liu, Liqin; Emkey, Renee</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Hematology (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">491-500</span>CODEN:
                <span class="NLM_cas:coden">EXHMA6</span>;
        ISSN:<span class="NLM_cas:issn">0301-472X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Small mol. inhibitors of Janus kinase (JAK) family members (JAK1, JAK2, JAK3, and Tyk2) are currently being pursued as potential new modes of therapy for a variety of diseases, including the inhibition of JAK2 for the treatment of myeloproliferative disorders.  Selective inhibition within the JAK family can be beneficial in avoiding undesirable side effects (e.g., immunosuppression) caused by parallel inhibition of other JAK members.  In an effort to design an assay paradigm for the development of JAK2 selective inhibitors, we investigated whether compd. selectivity differed between cellular and purified enzyme environments.  A set of JAK2 inhibitors was tested in a high-throughput JAK family cell assay suite and in corresponding purified enzyme assays.  The high-throughput JAK cell assay suite comprises Ba/F3 cells individually expressing translocated ETS leukemia (TEL) fusions of each JAK family member (TEL-JAK Ba/F3) and an AlphaScreen phosphorylated-STAT5 (pSTAT5) immunoassay.  Compd. potencies from the TEL-JAK Ba/F3 pSTAT5 assays were similar to those detd. in downstream cell proliferation measurements and more physiol. relevant cytokine-induced pSTAT5 PBMC assays.  However, compd. selectivity data between cell and purified enzyme assays were discrepant because of different potency shifts between cell and purified enzyme values for each JAK family member.  For any JAK small mol. development program, our results suggest that relying solely on enzyme potency and selectivity data may be misleading.  Adopting the high-throughput TEL-JAK Ba/F3 pSTAT5 cell assay suite in lead development paradigms should provide a more meaningful understanding of selectivity and facilitate the development of more selective JAK inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpeI8srzB4fFLVg90H21EOLACvtfcHk0lhiRYiqQjLCpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXlt1Cjsr0%253D&md5=99806814ea6433ff1bf336df0105e4b2</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.exphem.2013.01.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.exphem.2013.01.005%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DV.%26aulast%3DPistillo%26aufirst%3DJ.%26aulast%3DArchibeque%26aufirst%3DI.%26aulast%3DHan%2BLee%26aufirst%3DJ.%26aulast%3DSun%26aufirst%3DB.-C.%26aulast%3DSchenkel%26aufirst%3DL.%2BB.%26aulast%3DGeuns-Meyer%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DEmkey%26aufirst%3DR.%26atitle%3DDifferential%2520Selectivity%2520of%2520JAK2%2520Inhibitors%2520in%2520Enzymatic%2520and%2520Cellular%2520Settings%26jtitle%3DExp.%2520Hematol.%26date%3D2013%26volume%3D41%26spage%3D491%26epage%3D500" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Schenkel, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deak, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doherty, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emkey, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunaydin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loberg, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olivieri, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pistillo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wells, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geuns-Meyer, S.</span><span> </span><span class="NLM_article-title">Discovery of Potent and Highly Selective Thienopyridine Janus Kinase 2 Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">8440</span><span class="NLM_x">–</span> <span class="NLM_lpage">8450</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm200911r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=8440-8450&author=L.+B.+Schenkelauthor=X.+Huangauthor=A.+Chengauthor=H.+L.+Deakauthor=E.+Dohertyauthor=R.+Emkeyauthor=Y.+Guauthor=H.+Gunaydinauthor=J.+L.+Kimauthor=J.+Leeauthor=R.+Lobergauthor=P.+Olivieriauthor=J.+Pistilloauthor=J.+Tangauthor=Q.+Wanauthor=H.-L.+Wangauthor=S.-W.+Wangauthor=M.+C.+Wellsauthor=B.+Wuauthor=V.+Yuauthor=L.+Liuauthor=S.+Geuns-Meyer&title=Discovery+of+Potent+and+Highly+Selective+Thienopyridine+Janus+Kinase+2+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm200911r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200911r%26sid%3Dliteratum%253Aachs%26aulast%3DSchenkel%26aufirst%3DL.%2BB.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DCheng%26aufirst%3DA.%26aulast%3DDeak%26aufirst%3DH.%2BL.%26aulast%3DDoherty%26aufirst%3DE.%26aulast%3DEmkey%26aufirst%3DR.%26aulast%3DGu%26aufirst%3DY.%26aulast%3DGunaydin%26aufirst%3DH.%26aulast%3DKim%26aufirst%3DJ.%2BL.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DLoberg%26aufirst%3DR.%26aulast%3DOlivieri%26aufirst%3DP.%26aulast%3DPistillo%26aufirst%3DJ.%26aulast%3DTang%26aufirst%3DJ.%26aulast%3DWan%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DH.-L.%26aulast%3DWang%26aufirst%3DS.-W.%26aulast%3DWells%26aufirst%3DM.%2BC.%26aulast%3DWu%26aufirst%3DB.%26aulast%3DYu%26aufirst%3DV.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DGeuns-Meyer%26aufirst%3DS.%26atitle%3DDiscovery%2520of%2520Potent%2520and%2520Highly%2520Selective%2520Thienopyridine%2520Janus%2520Kinase%25202%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D8440%26epage%3D8450" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">van ’t Klooster, G.; Van Rompaey, L.; Menet, C.; Namour, F.; Vanhoutte, F.; van der Aar, E.; Clement-Lacroix, P.; Galien, R.; Nelles, L.; Guerin, C.; Smets, B.; Brys, R.; Feyen, J.; Wigerinck, P.</span><span> </span><span class="NLM_article-title">Preclinical Pharmacology and Early Clinical Evaluation of GLPG0634, a Selective JAK1 Inhibitor for the Treatment of Rheumatoid Arthritis</span>. <span class="NLM_conf-name">EULAR 2011</span>, <span class="NLM_conf-loc">London</span>, <span class="NLM_conf-date">May 25–28, 2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=van+%E2%80%99t+Klooster%2C+G.%3B+Van+Rompaey%2C+L.%3B+Menet%2C+C.%3B+Namour%2C+F.%3B+Vanhoutte%2C+F.%3B+van+der+Aar%2C+E.%3B+Clement-Lacroix%2C+P.%3B+Galien%2C+R.%3B+Nelles%2C+L.%3B+Guerin%2C+C.%3B+Smets%2C+B.%3B+Brys%2C+R.%3B+Feyen%2C+J.%3B+Wigerinck%2C+P.+Preclinical+Pharmacology+and+Early+Clinical+Evaluation+of+GLPG0634%2C+a+Selective+JAK1+Inhibitor+for+the+Treatment+of+Rheumatoid+Arthritis.+EULAR+2011%2C+London%2C+May+25%E2%80%9328%2C+2011."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2B%25E2%2580%2599t%2BKlooster%26aufirst%3DG.%26atitle%3DPreclinical%2520Pharmacology%2520and%2520Early%2520Clinical%2520Evaluation%2520of%2520GLPG0634%252C%2520a%2520Selective%2520JAK1%2520Inhibitor%2520for%2520the%2520Treatment%2520of%2520Rheumatoid%2520Arthritis" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Van Rompaey, L.; Clement-Lacroix, P.; Galien, R.; van der Aar, E.; Nelles, L.; Smets, B.; Dupont, S.; Christophe, T.; Conrath, K.; Brys, R.; van ’t Klooster, G.; Fletcher, S.; Feyen, J.; Menet, C.</span><span> </span><span class="NLM_article-title">GLPG0634, a Janus Kinase Inhibitor for the Treatment of Rheumatoid Arthritis</span>. <span class="NLM_conf-name">WIR</span>, <span class="NLM_conf-date">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Van+Rompaey%2C+L.%3B+Clement-Lacroix%2C+P.%3B+Galien%2C+R.%3B+van+der+Aar%2C+E.%3B+Nelles%2C+L.%3B+Smets%2C+B.%3B+Dupont%2C+S.%3B+Christophe%2C+T.%3B+Conrath%2C+K.%3B+Brys%2C+R.%3B+van+%E2%80%99t+Klooster%2C+G.%3B+Fletcher%2C+S.%3B+Feyen%2C+J.%3B+Menet%2C+C.+GLPG0634%2C+a+Janus+Kinase+Inhibitor+for+the+Treatment+of+Rheumatoid+Arthritis.+WIR%2C+2011."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BRompaey%26aufirst%3DL.%26atitle%3DGLPG0634%252C%2520a%2520Janus%2520Kinase%2520Inhibitor%2520for%2520the%2520Treatment%2520of%2520Rheumatoid%2520Arthritis" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Namour, F.; Galien, R.; Vanhoutte, F.; Wigerink, P.; van’t Klooster, G.</span><span> </span><span class="NLM_article-title">An Active Metabolite Contributes to the Pharmacodynamics and Efficacy of GLPG0634, a Selective JAK1 Inhibitor</span>. <span class="NLM_conf-name">American College of Rheumatology Annual Meeting</span>, <span class="NLM_conf-loc">San Diego</span>, <span class="NLM_conf-name">October 25–30, 2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Namour%2C+F.%3B+Galien%2C+R.%3B+Vanhoutte%2C+F.%3B+Wigerink%2C+P.%3B+van%E2%80%99t+Klooster%2C+G.+An+Active+Metabolite+Contributes+to+the+Pharmacodynamics+and+Efficacy+of+GLPG0634%2C+a+Selective+JAK1+Inhibitor.+American+College+of+Rheumatology+Annual+Meeting%2C+San+Diego%2C+October+25%E2%80%9330%2C+2013."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DNamour%26aufirst%3DF.%26atitle%3DAn%2520Active%2520Metabolite%2520Contributes%2520to%2520the%2520Pharmacodynamics%2520and%2520Efficacy%2520of%2520GLPG0634%252C%2520a%2520Selective%2520JAK1%2520Inhibitor" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">van’t Klooster, G. A. E.; Brys, R. C. X.; Van Rompaey, L. J. C.; Namour, F. S.</span><span> </span><span class="NLM_article-title">Aminotriazolopyridine for Use in the Treatment of Inflammation, and Pharmaceutical Compositions Thereof. UY34855 (A)</span>. WO2013189771 (A1), <span class="NLM_month">January</span><span class="NLM_day">31</span>,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=G.+A.+E.+van%E2%80%99t+Klooster&author=R.+C.+X.+Brys&author=L.+J.+C.+Van+Rompaey&author=F.+S.+Namour&title=Aminotriazolopyridine+for+Use+in+the+Treatment+of+Inflammation%2C+and+Pharmaceutical+Compositions+Thereof.+UY34855+%28A%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%25E2%2580%2599t%2BKlooster%26aufirst%3DG.%2BA.%2BE.%26atitle%3DAminotriazolopyridine%2520for%2520Use%2520in%2520the%2520Treatment%2520of%2520Inflammation%252C%2520and%2520Pharmaceutical%2520Compositions%2520Thereof.%2520UY34855%2520%2528A%2529%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 59 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Eunsun Park, Sun Joo Lee, Heegyum Moon, Jongmi Park, Hyeonho Jeon, Ji Sun Hwang, Hayoung Hwang, Ki Bum Hong, Seung-Hee Han, Sun Choi, <span class="NLM_string-name hlFld-ContribAuthor">Soosung Kang</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and Biological Evaluation of N-Methyl-pyrrolo[2,3-b]pyridine-5-carboxamide Derivatives as JAK1-Selective Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (2)
                                     , 958-979. <a href="https://doi.org/10.1021/acs.jmedchem.0c01026" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01026</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01026%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Band%252BBiological%252BEvaluation%252Bof%252BN-Methyl-pyrrolo%25255B2%25252C3-b%25255Dpyridine-5-carboxamide%252BDerivatives%252Bas%252BJAK1-Selective%252BInhibitors%26aulast%3DPark%26aufirst%3DEunsun%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D16062020%26date%3D11012021%26volume%3D64%26issue%3D2%26spage%3D958%26epage%3D979" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Kristi A. Leonard, Lisa A. Madge, Paul J. Krawczuk, Aihua Wang, Kevin D. Kreutter, Genesis M. Bacani, Wenying Chai, Russell C. Smith, Mark S. Tichenor, Michael C. Harris, Ravi Malaviya, Mark Seierstad, Marguerite E. Johnson, Jennifer D. Venable, Suzie Kim, Gavin C. Hirst, Ashok S. Mathur, Tadimeti S. Rao, James P. Edwards, Michele C. Rizzolio, <span class="NLM_string-name hlFld-ContribAuthor">Tatiana Koudriakova</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of a Gut-Restricted JAK Inhibitor for the Treatment of Inflammatory Bowel Disease. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (6)
                                     , 2915-2929. <a href="https://doi.org/10.1021/acs.jmedchem.9b01439" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01439</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01439&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01439%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Ba%252BGut-Restricted%252BJAK%252BInhibitor%252Bfor%252Bthe%252BTreatment%252Bof%252BInflammatory%252BBowel%252BDisease%26aulast%3DLeonard%26aufirst%3DKristi%2BA.%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D30082019%26date%3D16032020%26date%3D05032020%26volume%3D63%26issue%3D6%26spage%3D2915%26epage%3D2929" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Stephen T. Wrobleski, Ryan Moslin, Shuqun Lin, Yanlei Zhang, Steven Spergel, James Kempson, John S. Tokarski, Joann Strnad, Adriana Zupa-Fernandez, Lihong Cheng, David Shuster, Kathleen Gillooly, Xiaoxia Yang, Elizabeth Heimrich, Kim W. McIntyre, Charu Chaudhry, Javed Khan, Max Ruzanov, Jeffrey Tredup, Dawn Mulligan, Dianlin Xie, Huadong Sun, Christine Huang, Celia D’Arienzo, Nelly Aranibar, Manoj Chiney, Anjaneya Chimalakonda, William J. Pitts, Louis Lombardo, Percy H. Carter, James R. Burke, <span class="NLM_string-name hlFld-ContribAuthor">David S. Weinstein</span>. </span><span class="cited-content_cbyCitation_article-title">Highly Selective Inhibition of Tyrosine Kinase 2 (TYK2) for the Treatment of Autoimmune Diseases: Discovery of the Allosteric Inhibitor BMS-986165. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (20)
                                     , 8973-8995. <a href="https://doi.org/10.1021/acs.jmedchem.9b00444" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00444</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00444&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00444%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DHighly%252BSelective%252BInhibition%252Bof%252BTyrosine%252BKinase%252B2%252B%252528TYK2%252529%252Bfor%252Bthe%252BTreatment%252Bof%252BAutoimmune%252BDiseases%25253A%252BDiscovery%252Bof%252Bthe%252BAllosteric%252BInhibitor%252BBMS-986165%26aulast%3DWrobleski%26aufirst%3DStephen%2BT.%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D14032019%26date%3D18072019%26volume%3D62%26issue%3D20%26spage%3D8973%26epage%3D8995" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Steven H. Spergel, Michael E. Mertzman, James Kempson, Junqing Guo, Sylwia Stachura, Lauren Haque, Jonathan S. Lippy, Rosemary F. Zhang, Michael Galella, Sidney Pitt, Guoxiang Shen, Aberra Fura, Kathleen Gillooly, Kim W. McIntyre, Vicky Tang, John Tokarski, John S. Sack, Javed Khan, Percy H. Carter, Joel C. Barrish, Steven G. Nadler, Luisa M. Salter-Cid, Gary L. Schieven, Stephen T. Wrobleski, <span class="NLM_string-name hlFld-ContribAuthor">William J. Pitts</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of a JAK1/3 Inhibitor and Use of a Prodrug To Demonstrate Efficacy in a Model of Rheumatoid Arthritis. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>10 </em>
                                    (3)
                                     , 306-311. <a href="https://doi.org/10.1021/acsmedchemlett.8b00508" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.8b00508</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.8b00508&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.8b00508%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Ba%252BJAK1%25252F3%252BInhibitor%252Band%252BUse%252Bof%252Ba%252BProdrug%252BTo%252BDemonstrate%252BEfficacy%252Bin%252Ba%252BModel%252Bof%252BRheumatoid%252BArthritis%26aulast%3DSpergel%26aufirst%3DSteven%2BH.%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D26102018%26date%3D07022019%26date%3D13022019%26volume%3D10%26issue%3D3%26spage%3D306%26epage%3D311" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Marian C. Bryan, <span class="NLM_string-name hlFld-ContribAuthor">Naomi S. Rajapaksa</span>. </span><span class="cited-content_cbyCitation_article-title">Kinase Inhibitors for the Treatment of Immunological Disorders: Recent Advances. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (20)
                                     , 9030-9058. <a href="https://doi.org/10.1021/acs.jmedchem.8b00667" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00667</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00667&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00667%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DKinase%252BInhibitors%252Bfor%252Bthe%252BTreatment%252Bof%252BImmunological%252BDisorders%25253A%252BRecent%252BAdvances%26aulast%3DBryan%26aufirst%3DMarian%2BC.%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D26042018%26date%3D15062018%26date%3D05062018%26volume%3D61%26issue%3D20%26spage%3D9030%26epage%3D9058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Wentao Yu, Yubing Huang, Jianxiao Li, Xiaodong Tang, Wanqing Wu, <span class="NLM_string-name hlFld-ContribAuthor">Huanfeng Jiang</span>. </span><span class="cited-content_cbyCitation_article-title">Copper-Catalyzed Aerobic Oxidative [3+2] Annulation for the Synthesis of 5-Amino/Imino-Substituted 1,2,4-Thiadiazoles through C–N/N–S Bond Formation. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2018,</strong> <em>83 </em>
                                    (16)
                                     , 9334-9343. <a href="https://doi.org/10.1021/acs.joc.8b01292" title="DOI URL">https://doi.org/10.1021/acs.joc.8b01292</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.8b01292&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.8b01292%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DCopper-Catalyzed%252BAerobic%252BOxidative%252B%25255B3%25252B2%25255D%252BAnnulation%252Bfor%252Bthe%252BSynthesis%252Bof%252B5-Amino%25252FImino-Substituted%252B1%25252C2%25252C4-Thiadiazoles%252Bthrough%252BC%2525E2%252580%252593N%25252FN%2525E2%252580%252593S%252BBond%252BFormation%26aulast%3DYu%26aufirst%3DWentao%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D20052018%26date%3D30072018%26date%3D18072018%26volume%3D83%26issue%3D16%26spage%3D9334%26epage%3D9343" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wenxuan  Song</span>, <span class="hlFld-ContribAuthor ">Lijiang  Shi</span>, <span class="hlFld-ContribAuthor ">Lei  Gao</span>, <span class="hlFld-ContribAuthor ">Peijun  Hu</span>, <span class="hlFld-ContribAuthor ">Haichuan  Mu</span>, <span class="hlFld-ContribAuthor ">Zhenyuan  Xia</span>, <span class="hlFld-ContribAuthor ">Jinhai  Huang</span>, and <span class="hlFld-ContribAuthor ">Jianhua  Su</span>  . </span><span class="cited-content_cbyCitation_article-title">[1,2,4]Triazolo[1,5-a]pyridine as Building Blocks for Universal Host Materials for High-Performance Red, Green, Blue and White Phosphorescent Organic Light-Emitting Devices. </span><span class="cited-content_cbyCitation_journal-name">ACS Applied Materials & Interfaces</span><span> <strong>2018,</strong> <em>10 </em>
                                    (6)
                                     , 5714-5722. <a href="https://doi.org/10.1021/acsami.7b18202" title="DOI URL">https://doi.org/10.1021/acsami.7b18202</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsami.7b18202&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsami.7b18202%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Applied%2520Materials%2520%2526%2520Interfaces%26atitle%3D%25255B1%25252C2%25252C4%25255DTriazolo%25255B1%25252C5-a%25255Dpyridine%252Bas%252BBuilding%252BBlocks%252Bfor%252BUniversal%252BHost%252BMaterials%252Bfor%252BHigh-Performance%252BRed%25252C%252BGreen%25252C%252BBlue%252Band%252BWhite%252BPhosphorescent%252BOrganic%252BLight-Emitting%252BDevices%26aulast%3DSong%26aufirst%3DWenxuan%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D30112017%26date%3D25012018%26date%3D05022018%26date%3D14022018%26date%3D25012018%26volume%3D10%26issue%3D6%26spage%3D5714%26epage%3D5722" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tony  Siu</span>, <span class="hlFld-ContribAuthor ">Jason  Brubaker</span>, <span class="hlFld-ContribAuthor ">Peter  Fuller</span>, <span class="hlFld-ContribAuthor ">Luis  Torres</span>, <span class="hlFld-ContribAuthor ">Hongbo  Zeng</span>, <span class="hlFld-ContribAuthor ">Joshua  Close</span>, <span class="hlFld-ContribAuthor ">Dawn M.  Mampreian</span>, <span class="hlFld-ContribAuthor ">Feng  Shi</span>, <span class="hlFld-ContribAuthor ">Duan  Liu</span>, <span class="hlFld-ContribAuthor ">Xavier  Fradera</span>, <span class="hlFld-ContribAuthor ">Kevin  Johnson</span>, <span class="hlFld-ContribAuthor ">Nathan  Bays</span>, <span class="hlFld-ContribAuthor ">Elma  Kadic</span>, <span class="hlFld-ContribAuthor ">Fang  He</span>, <span class="hlFld-ContribAuthor ">Peter  Goldenblatt</span>, <span class="hlFld-ContribAuthor ">Lynsey  Shaffer</span>, <span class="hlFld-ContribAuthor ">Sangita B.  Patel</span>, <span class="hlFld-ContribAuthor ">Charles A.  Lesburg</span>, <span class="hlFld-ContribAuthor ">Carla  Alpert</span>, <span class="hlFld-ContribAuthor ">Lauren  Dorosh</span>, <span class="hlFld-ContribAuthor ">Sujal V.  Deshmukh</span>, <span class="hlFld-ContribAuthor ">Hongshi  Yu</span>, <span class="hlFld-ContribAuthor ">Joel  Klappenbach</span>, <span class="hlFld-ContribAuthor ">Fiona  Elwood</span>, <span class="hlFld-ContribAuthor ">Christopher J.  Dinsmore</span>, <span class="hlFld-ContribAuthor ">Rafael  Fernandez</span>, <span class="hlFld-ContribAuthor ">Lily  Moy</span>, and <span class="hlFld-ContribAuthor ">Jonathan R.  Young</span>  . </span><span class="cited-content_cbyCitation_article-title">The Discovery of 3-((4-Chloro-3-methoxyphenyl)amino)-1-((3R,4S)-4-cyanotetrahydro-2H-pyran-3-yl)-1H-pyrazole-4-carboxamide, a Highly Ligand Efficient and Efficacious Janus Kinase 1 Selective Inhibitor with Favorable Pharmacokinetic Properties. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (23)
                                     , 9676-9690. <a href="https://doi.org/10.1021/acs.jmedchem.7b01135" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01135</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01135&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01135%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DThe%252BDiscovery%252Bof%252B3-%252528%2525284-Chloro-3-methoxyphenyl%252529amino%252529-1-%252528%2525283R%25252C4S%252529-4-cyanotetrahydro-2H-pyran-3-yl%252529-1H-pyrazole-4-carboxamide%25252C%252Ba%252BHighly%252BLigand%252BEfficient%252Band%252BEfficacious%252BJanus%252BKinase%252B1%252BSelective%252BInhibitor%252Bwith%252BFavorable%252BPharmacokinetic%252BProperties%26aulast%3DSiu%26aufirst%3DTony%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D04082017%26date%3D04122017%26date%3D14122017%26date%3D20112017%26volume%3D60%26issue%3D23%26spage%3D9676%26epage%3D9690" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Harold  Moloney</span>, <span class="hlFld-ContribAuthor ">Nicholas A.  Magnus</span>, <span class="hlFld-ContribAuthor ">Jonas Y.  Buser</span>, and <span class="hlFld-ContribAuthor ">Matthew C.  Embry</span>  . </span><span class="cited-content_cbyCitation_article-title">Cyclization of Methyl-Coumalate-Derived Methyl 1-Benzamido-6-oxo-1,6-dihydropyridine-3-carboxylates: Assembly of the [1,2,4]Triazolo[1,5-a]pyridine Ring System. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2017,</strong> <em>82 </em>
                                    (12)
                                     , 6279-6288. <a href="https://doi.org/10.1021/acs.joc.7b00873" title="DOI URL">https://doi.org/10.1021/acs.joc.7b00873</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.7b00873&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.7b00873%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DCyclization%252Bof%252BMethyl-Coumalate-Derived%252BMethyl%252B1-Benzamido-6-oxo-1%25252C6-dihydropyridine-3-carboxylates%25253A%252BAssembly%252Bof%252Bthe%252B%25255B1%25252C2%25252C4%25255DTriazolo%25255B1%25252C5-a%25255Dpyridine%252BRing%252BSystem%26aulast%3DMoloney%26aufirst%3DHarold%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D12042017%26date%3D02062017%26date%3D16062017%26date%3D12052017%26volume%3D82%26issue%3D12%26spage%3D6279%26epage%3D6288" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Ana S. Newton, Luca Deiana, David E. Puleo, José A. Cisneros, Kara J. Cutrona, Joseph Schlessinger, <span class="NLM_string-name hlFld-ContribAuthor">William L. Jorgensen</span>. </span><span class="cited-content_cbyCitation_article-title">JAK2 JH2 Fluorescence Polarization Assay and Crystal Structures for Complexes with Three Small Molecules. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>8 </em>
                                    (6)
                                     , 614-617. <a href="https://doi.org/10.1021/acsmedchemlett.7b00154" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.7b00154</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.7b00154&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.7b00154%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DJAK2%252BJH2%252BFluorescence%252BPolarization%252BAssay%252Band%252BCrystal%252BStructures%252Bfor%252BComplexes%252Bwith%252BThree%252BSmall%252BMolecules%26aulast%3DNewton%26aufirst%3DAna%2BS.%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D03042017%26date%3D17052017%26date%3D22052017%26date%3D17052017%26volume%3D8%26issue%3D6%26spage%3D614%26epage%3D617" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Komala  Pandurangan</span>, <span class="hlFld-ContribAuthor ">Anna B.  Aletti</span>, <span class="hlFld-ContribAuthor ">Devis  Montroni</span>, <span class="hlFld-ContribAuthor ">Jonathan. A.  Kitchen</span>, <span class="hlFld-ContribAuthor ">Miguel  Martínez-Calvo</span>, <span class="hlFld-ContribAuthor ">Salvador  Blasco</span>, <span class="hlFld-ContribAuthor ">Thorfinnur  Gunnlaugsson</span>, and <span class="hlFld-ContribAuthor ">Eoin M.  Scanlan</span>  . </span><span class="cited-content_cbyCitation_article-title">Supramolecular Anion Recognition Mediates One-Pot Synthesis of 3-Amino-[1,2,4]-triazolo Pyridines from Thiosemicarbazides. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2017,</strong> <em>19 </em>
                                    (5)
                                     , 1068-1071. <a href="https://doi.org/10.1021/acs.orglett.6b03645" title="DOI URL">https://doi.org/10.1021/acs.orglett.6b03645</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.6b03645&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.6b03645%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DSupramolecular%252BAnion%252BRecognition%252BMediates%252BOne-Pot%252BSynthesis%252Bof%252B3-Amino-%25255B1%25252C2%25252C4%25255D-triazolo%252BPyridines%252Bfrom%252BThiosemicarbazides%26aulast%3DPandurangan%26aufirst%3DKomala%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D10012017%26date%3D21022017%26date%3D03032017%26volume%3D19%26issue%3D5%26spage%3D1068%26epage%3D1071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lina  Song</span>, <span class="hlFld-ContribAuthor ">Xianhai  Tian</span>, <span class="hlFld-ContribAuthor ">Zhigang  Lv</span>, <span class="hlFld-ContribAuthor ">Ertong  Li</span>, <span class="hlFld-ContribAuthor ">Jie  Wu</span>, <span class="hlFld-ContribAuthor ">Yangxue  Liu</span>, <span class="hlFld-ContribAuthor ">Wenquan  Yu</span>, and <span class="hlFld-ContribAuthor ">Junbiao  Chang</span>  . </span><span class="cited-content_cbyCitation_article-title">I2/KI-Mediated Oxidative N–N Bond Formation for the Synthesis of 1,5-Fused 1,2,4-Triazoles from N-Aryl Amidines. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2015,</strong> <em>80 </em>
                                    (14)
                                     , 7219-7225. <a href="https://doi.org/10.1021/acs.joc.5b01183" title="DOI URL">https://doi.org/10.1021/acs.joc.5b01183</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.5b01183&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.5b01183%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DI2%25252FKI-Mediated%252BOxidative%252BN%2525E2%252580%252593N%252BBond%252BFormation%252Bfor%252Bthe%252BSynthesis%252Bof%252B1%25252C5-Fused%252B1%25252C2%25252C4-Triazoles%252Bfrom%252BN-Aryl%252BAmidines%26aulast%3DSong%26aufirst%3DLina%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D27052015%26date%3D06072015%26date%3D17072015%26date%3D26062015%26volume%3D80%26issue%3D14%26spage%3D7219%26epage%3D7225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maria Chiara  Pismataro</span>, <span class="hlFld-ContribAuthor ">Tommaso  Felicetti</span>, <span class="hlFld-ContribAuthor ">Chiara  Bertagnin</span>, <span class="hlFld-ContribAuthor ">Maria Giulia  Nizi</span>, <span class="hlFld-ContribAuthor ">Anna  Bonomini</span>, <span class="hlFld-ContribAuthor ">Maria Letizia  Barreca</span>, <span class="hlFld-ContribAuthor ">Violetta  Cecchetti</span>, <span class="hlFld-ContribAuthor ">Dirk  Jochmans</span>, <span class="hlFld-ContribAuthor ">Steven  De Jonghe</span>, <span class="hlFld-ContribAuthor ">Johan  Neyts</span>, <span class="hlFld-ContribAuthor ">Arianna  Loregian</span>, <span class="hlFld-ContribAuthor ">Oriana  Tabarrini</span>, <span class="hlFld-ContribAuthor ">Serena  Massari</span>. </span><span class="cited-content_cbyCitation_article-title">1,2,4-Triazolo[1,5-a]pyrimidines: Efficient one-step synthesis and functionalization as influenza polymerase PA-PB1 interaction disruptors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>221 </em>, 113494. <a href="https://doi.org/10.1016/j.ejmech.2021.113494" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113494</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113494&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113494%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3D1%25252C2%25252C4-Triazolo%25255B1%25252C5-a%25255Dpyrimidines%25253A%252BEfficient%252Bone-step%252Bsynthesis%252Band%252Bfunctionalization%252Bas%252Binfluenza%252Bpolymerase%252BPA-PB1%252Binteraction%252Bdisruptors%26aulast%3DPismataro%26aufirst%3DMaria%2BChiara%26date%3D2021%26volume%3D221%26spage%3D113494" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maria Gabriella  Raimondo</span>, <span class="hlFld-ContribAuthor ">Martina  Biggioggero</span>, <span class="hlFld-ContribAuthor ">Lavinia Agra  Coletto</span>, <span class="hlFld-ContribAuthor ">Andreas  Ramming</span>, <span class="hlFld-ContribAuthor ">Roberto  Caporali</span>, <span class="hlFld-ContribAuthor ">Ennio Giulio  Favalli</span>. </span><span class="cited-content_cbyCitation_article-title">Clinical pharmacology of filgotinib in the treatment of rheumatoid arthritis: current insights. </span><span class="cited-content_cbyCitation_journal-name">Expert Review of Clinical Pharmacology</span><span> <strong>2021,</strong> <em>14 </em>
                                    (6)
                                     , 661-670. <a href="https://doi.org/10.1080/17512433.2021.1913050" title="DOI URL">https://doi.org/10.1080/17512433.2021.1913050</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/17512433.2021.1913050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F17512433.2021.1913050%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Review%2520of%2520Clinical%2520Pharmacology%26atitle%3DClinical%252Bpharmacology%252Bof%252Bfilgotinib%252Bin%252Bthe%252Btreatment%252Bof%252Brheumatoid%252Barthritis%25253A%252Bcurrent%252Binsights%26aulast%3DRaimondo%26aufirst%3DMaria%2BGabriella%26date%3D2021%26date%3D2021%26volume%3D14%26issue%3D6%26spage%3D661%26epage%3D670" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shahin  Shams</span>, <span class="hlFld-ContribAuthor ">Joseph M.  Martinez</span>, <span class="hlFld-ContribAuthor ">John R. D.  Dawson</span>, <span class="hlFld-ContribAuthor ">Juan  Flores</span>, <span class="hlFld-ContribAuthor ">Marina  Gabriel</span>, <span class="hlFld-ContribAuthor ">Gustavo  Garcia</span>, <span class="hlFld-ContribAuthor ">Amanda  Guevara</span>, <span class="hlFld-ContribAuthor ">Kaitlin  Murray</span>, <span class="hlFld-ContribAuthor ">Noah  Pacifici</span>, <span class="hlFld-ContribAuthor ">Maxemiliano V.  Vargas</span>, <span class="hlFld-ContribAuthor ">Taylor  Voelker</span>, <span class="hlFld-ContribAuthor ">Johannes W.  Hell</span>, <span class="hlFld-ContribAuthor ">Judith F.  Ashouri</span>. </span><span class="cited-content_cbyCitation_article-title">The Therapeutic Landscape of Rheumatoid Arthritis: Current State and Future Directions. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Pharmacology</span><span> <strong>2021,</strong> <em>12 </em><a href="https://doi.org/10.3389/fphar.2021.680043" title="DOI URL">https://doi.org/10.3389/fphar.2021.680043</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fphar.2021.680043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffphar.2021.680043%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Pharmacology%26atitle%3DThe%252BTherapeutic%252BLandscape%252Bof%252BRheumatoid%252BArthritis%25253A%252BCurrent%252BState%252Band%252BFuture%252BDirections%26aulast%3DShams%26aufirst%3DShahin%26date%3D2021%26date%3D2021%26volume%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wenjun  Du</span>, <span class="hlFld-ContribAuthor ">Fuli  Zhang</span>, <span class="hlFld-ContribAuthor ">Pei  Yan</span>, <span class="hlFld-ContribAuthor ">Qingfu  Lai</span>, <span class="hlFld-ContribAuthor ">Junjian  Li</span>, <span class="hlFld-ContribAuthor ">Daqian  Zhu</span>, <span class="hlFld-ContribAuthor ">Lianbao  Ye</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, Activity Evaluation and Molecular Docking Study of Novel Janus kinase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2021,</strong> <em>6 </em>
                                    (17)
                                     , 4212-4216. <a href="https://doi.org/10.1002/slct.202100707" title="DOI URL">https://doi.org/10.1002/slct.202100707</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.202100707&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.202100707%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DDesign%25252C%252BSynthesis%25252C%252BActivity%252BEvaluation%252Band%252BMolecular%252BDocking%252BStudy%252Bof%252BNovel%252BJanus%252Bkinase%252BInhibitors%26aulast%3DDu%26aufirst%3DWenjun%26date%3D2021%26date%3D2021%26volume%3D6%26issue%3D17%26spage%3D4212%26epage%3D4216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Robert M.  Borzilleri</span>, <span class="hlFld-ContribAuthor ">Amy C.  Hart</span>, <span class="hlFld-ContribAuthor ">Ryan  Moslin</span>, <span class="hlFld-ContribAuthor ">John S.  Tokarski</span>, <span class="hlFld-ContribAuthor ">Stephen T.  Wrobleski</span>. </span><span class="cited-content_cbyCitation_article-title">JAK
              Family Inhibitors for Autoimmune Diseases. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 1-86. <a href="https://doi.org/10.1002/0471266949.bmc279" title="DOI URL">https://doi.org/10.1002/0471266949.bmc279</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/0471266949.bmc279&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F0471266949.bmc279%26sid%3Dliteratum%253Aachs%26atitle%3DJAK%252BFamily%252BInhibitors%252Bfor%252BAutoimmune%252BDiseases%26aulast%3DBorzilleri%26aufirst%3DRobert%2BM.%26date%3D2021%26date%3D2021%26spage%3D1%26epage%3D86%26pub%3DWiley%26atitle%3DBurger%252527s%252BMedicinal%252BChemistry%252Band%252BDrug%252BDiscovery%26aulast%3DAbraham%26aufirst%3DDonald%2BJ.%26date%3D2003%26date%3D2003%26volume%3D64" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aleksey Yu.  Vorob′ev</span>, <span class="hlFld-ContribAuthor ">Gennady I.  Borodkin</span>, <span class="hlFld-ContribAuthor ">Rodion V.  Andreev</span>, <span class="hlFld-ContribAuthor ">Vyacheslav G.  Shubin</span>. </span><span class="cited-content_cbyCitation_article-title">1,3-Dipolar cycloaddition of cyanopyridines to heterocyclic N-imines: experimental and theoretical study. </span><span class="cited-content_cbyCitation_journal-name">Chemistry of Heterocyclic Compounds</span><span> <strong>2021,</strong> <em>57 </em>
                                    (3)
                                     , 284-291. <a href="https://doi.org/10.1007/s10593-021-02905-7" title="DOI URL">https://doi.org/10.1007/s10593-021-02905-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10593-021-02905-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10593-021-02905-7%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520of%2520Heterocyclic%2520Compounds%26atitle%3D1%25252C3-Dipolar%252Bcycloaddition%252Bof%252Bcyanopyridines%252Bto%252Bheterocyclic%252BN-imines%25253A%252Bexperimental%252Band%252Btheoretical%252Bstudy%26aulast%3DVorob%25E2%2580%25B2ev%26aufirst%3DAleksey%2BYu.%26date%3D2021%26date%3D2021%26volume%3D57%26issue%3D3%26spage%3D284%26epage%3D291" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hillol  Khatua</span>, <span class="hlFld-ContribAuthor ">Sandip Kumar  Das</span>, <span class="hlFld-ContribAuthor ">Satyajit  Roy</span>, <span class="hlFld-ContribAuthor ">Buddhadeb  Chattopadhyay</span>. </span><span class="cited-content_cbyCitation_article-title">Dual Reactivity of 1,2,3,4‐Tetrazole: Manganese‐Catalyzed Click Reaction and Denitrogenative Annulation. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2021,</strong> <em>133 </em>
                                    (1)
                                     , 308-316. <a href="https://doi.org/10.1002/ange.202009078" title="DOI URL">https://doi.org/10.1002/ange.202009078</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.202009078&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.202009078%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DDual%252BReactivity%252Bof%252B1%25252C2%25252C3%25252C4%2525E2%252580%252590Tetrazole%25253A%252BManganese%2525E2%252580%252590Catalyzed%252BClick%252BReaction%252Band%252BDenitrogenative%252BAnnulation%26aulast%3DKhatua%26aufirst%3DHillol%26date%3D2021%26date%3D2020%26volume%3D133%26issue%3D1%26spage%3D308%26epage%3D316" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hillol  Khatua</span>, <span class="hlFld-ContribAuthor ">Sandip Kumar  Das</span>, <span class="hlFld-ContribAuthor ">Satyajit  Roy</span>, <span class="hlFld-ContribAuthor ">Buddhadeb  Chattopadhyay</span>. </span><span class="cited-content_cbyCitation_article-title">Dual Reactivity of 1,2,3,4‐Tetrazole: Manganese‐Catalyzed Click Reaction and Denitrogenative Annulation. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2021,</strong> <em>60 </em>
                                    (1)
                                     , 304-312. <a href="https://doi.org/10.1002/anie.202009078" title="DOI URL">https://doi.org/10.1002/anie.202009078</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.202009078&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.202009078%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DDual%252BReactivity%252Bof%252B1%25252C2%25252C3%25252C4%2525E2%252580%252590Tetrazole%25253A%252BManganese%2525E2%252580%252590Catalyzed%252BClick%252BReaction%252Band%252BDenitrogenative%252BAnnulation%26aulast%3DKhatua%26aufirst%3DHillol%26date%3D2021%26date%3D2020%26volume%3D60%26issue%3D1%26spage%3D304%26epage%3D312" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Johanna  Sens</span>, <span class="hlFld-ContribAuthor ">Dirk  Hoffmann</span>, <span class="hlFld-ContribAuthor ">Lucas  Lange</span>, <span class="hlFld-ContribAuthor ">Philippe  Vollmer Barbosa</span>, <span class="hlFld-ContribAuthor ">Michael  Morgan</span>, <span class="hlFld-ContribAuthor ">Christine S.  Falk</span>, <span class="hlFld-ContribAuthor ">Axel  Schambach</span>. </span><span class="cited-content_cbyCitation_article-title">Knockout-Induced Pluripotent Stem Cells for Disease and Therapy Modeling of IL-10-Associated Primary Immunodeficiencies. </span><span class="cited-content_cbyCitation_journal-name">Human Gene Therapy</span><span> <strong>2021,</strong> <em>32 </em>
                                    (1-2)
                                     , 77-95. <a href="https://doi.org/10.1089/hum.2020.235" title="DOI URL">https://doi.org/10.1089/hum.2020.235</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1089/hum.2020.235&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1089%2Fhum.2020.235%26sid%3Dliteratum%253Aachs%26jtitle%3DHuman%2520Gene%2520Therapy%26atitle%3DKnockout-Induced%252BPluripotent%252BStem%252BCells%252Bfor%252BDisease%252Band%252BTherapy%252BModeling%252Bof%252BIL-10-Associated%252BPrimary%252BImmunodeficiencies%26aulast%3DSens%26aufirst%3DJohanna%26date%3D2021%26volume%3D32%26issue%3D1-2%26spage%3D77%26epage%3D95" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alicia  Regueiro-Ren</span>. </span><span class="cited-content_cbyCitation_article-title">Cyclic sulfoxides and sulfones in drug design. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 1-30. <a href="https://doi.org/10.1016/bs.aihch.2020.10.003" title="DOI URL">https://doi.org/10.1016/bs.aihch.2020.10.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/bs.aihch.2020.10.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fbs.aihch.2020.10.003%26sid%3Dliteratum%253Aachs%26atitle%3DCyclic%252Bsulfoxides%252Band%252Bsulfones%252Bin%252Bdrug%252Bdesign%26aulast%3DRegueiro-Ren%26aufirst%3DAlicia%26date%3D2021%26spage%3D1%26epage%3D30%26pub%3DElsevier%26atitle%3DApplications%252Bof%252BHeterocycles%252Bin%252Bthe%252BDesign%252Bof%252BDrugs%252Band%252BAgricultural%252BProducts%26date%3D2021%26volume%3D134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hyung-Ook  Kim</span>. </span><span class="cited-content_cbyCitation_article-title">Development of JAK inhibitors for the treatment of immune-mediated diseases: kinase-targeted inhibitors and pseudokinase-targeted inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Archives of Pharmacal Research</span><span> <strong>2020,</strong> <em>43 </em>
                                    (11)
                                     , 1173-1186. <a href="https://doi.org/10.1007/s12272-020-01282-7" title="DOI URL">https://doi.org/10.1007/s12272-020-01282-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s12272-020-01282-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs12272-020-01282-7%26sid%3Dliteratum%253Aachs%26jtitle%3DArchives%2520of%2520Pharmacal%2520Research%26atitle%3DDevelopment%252Bof%252BJAK%252Binhibitors%252Bfor%252Bthe%252Btreatment%252Bof%252Bimmune-mediated%252Bdiseases%25253A%252Bkinase-targeted%252Binhibitors%252Band%252Bpseudokinase-targeted%252Binhibitors%26aulast%3DKim%26aufirst%3DHyung-Ook%26date%3D2020%26date%3D2020%26volume%3D43%26issue%3D11%26spage%3D1173%26epage%3D1186" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Biao  Nie</span>, <span class="hlFld-ContribAuthor ">Wanqing  Wu</span>, <span class="hlFld-ContribAuthor ">Yingjun  Zhang</span>, <span class="hlFld-ContribAuthor ">Huanfeng  Jiang</span>, <span class="hlFld-ContribAuthor ">Ji  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances in the synthesis of bridgehead (or ring-junction) nitrogen heterocycles
              via
              transition metal-catalyzed C–H bond activation and functionalization. </span><span class="cited-content_cbyCitation_journal-name">Organic Chemistry Frontiers</span><span> <strong>2020,</strong> <em>7 </em>
                                    (19)
                                     , 3067-3099. <a href="https://doi.org/10.1039/D0QO00510J" title="DOI URL">https://doi.org/10.1039/D0QO00510J</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0QO00510J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0QO00510J%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Chemistry%2520Frontiers%26atitle%3DRecent%252Badvances%252Bin%252Bthe%252Bsynthesis%252Bof%252Bbridgehead%252B%252528or%252Bring-junction%252529%252Bnitrogen%252Bheterocycles%252Bvia%252Btransition%252Bmetal-catalyzed%252BC%2525E2%252580%252593H%252Bbond%252Bactivation%252Band%252Bfunctionalization%26aulast%3DNie%26aufirst%3DBiao%26date%3D2020%26date%3D2020%26volume%3D7%26issue%3D19%26spage%3D3067%26epage%3D3099" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sanjiv  Singh</span>, <span class="hlFld-ContribAuthor ">Shantanu  Singh</span>. </span><span class="cited-content_cbyCitation_article-title">JAK-STAT inhibitors: Immersing therapeutic approach for management of rheumatoid arthritis. </span><span class="cited-content_cbyCitation_journal-name">International Immunopharmacology</span><span> <strong>2020,</strong> <em>86 </em>, 106731. <a href="https://doi.org/10.1016/j.intimp.2020.106731" title="DOI URL">https://doi.org/10.1016/j.intimp.2020.106731</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.intimp.2020.106731&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.intimp.2020.106731%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Immunopharmacology%26atitle%3DJAK-STAT%252Binhibitors%25253A%252BImmersing%252Btherapeutic%252Bapproach%252Bfor%252Bmanagement%252Bof%252Brheumatoid%252Barthritis%26aulast%3DSingh%26aufirst%3DSanjiv%26date%3D2020%26volume%3D86%26spage%3D106731" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kuan  Lu</span>, <span class="hlFld-ContribAuthor ">Weibin  Wu</span>, <span class="hlFld-ContribAuthor ">Cunlong  Zhang</span>, <span class="hlFld-ContribAuthor ">Zijian  Liu</span>, <span class="hlFld-ContribAuthor ">Boren  Xiao</span>, <span class="hlFld-ContribAuthor ">Zigao  Yuan</span>, <span class="hlFld-ContribAuthor ">Anqi  Li</span>, <span class="hlFld-ContribAuthor ">Dawei  Chen</span>, <span class="hlFld-ContribAuthor ">Xin  Zhai</span>, <span class="hlFld-ContribAuthor ">Yuyang  Jiang</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of triazolo [1,5-a] pyridine derivatives as novel JAK1/2 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>30 </em>
                                    (14)
                                     , 127225. <a href="https://doi.org/10.1016/j.bmcl.2020.127225" title="DOI URL">https://doi.org/10.1016/j.bmcl.2020.127225</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2020.127225&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2020.127225%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Btriazolo%252B%25255B1%25252C5-a%25255D%252Bpyridine%252Bderivatives%252Bas%252Bnovel%252BJAK1%25252F2%252Binhibitors%26aulast%3DLu%26aufirst%3DKuan%26date%3D2020%26volume%3D30%26issue%3D14%26spage%3D127225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jacopo  Angelini</span>, <span class="hlFld-ContribAuthor ">Rossella  Talotta</span>, <span class="hlFld-ContribAuthor ">Rossana  Roncato</span>, <span class="hlFld-ContribAuthor ">Giulia  Fornasier</span>, <span class="hlFld-ContribAuthor ">Giorgia  Barbiero</span>, <span class="hlFld-ContribAuthor ">Lisa  Dal Cin</span>, <span class="hlFld-ContribAuthor ">Serena  Brancati</span>, <span class="hlFld-ContribAuthor ">Francesco  Scaglione</span>. </span><span class="cited-content_cbyCitation_article-title">JAK-Inhibitors for the Treatment of Rheumatoid Arthritis: A Focus on the Present and an Outlook on the Future. </span><span class="cited-content_cbyCitation_journal-name">Biomolecules</span><span> <strong>2020,</strong> <em>10 </em>
                                    (7)
                                     , 1002. <a href="https://doi.org/10.3390/biom10071002" title="DOI URL">https://doi.org/10.3390/biom10071002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/biom10071002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fbiom10071002%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomolecules%26atitle%3DJAK-Inhibitors%252Bfor%252Bthe%252BTreatment%252Bof%252BRheumatoid%252BArthritis%25253A%252BA%252BFocus%252Bon%252Bthe%252BPresent%252Band%252Ban%252BOutlook%252Bon%252Bthe%252BFuture%26aulast%3DAngelini%26aufirst%3DJacopo%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D7%26spage%3D1002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yeongjin  Gwon</span>, <span class="hlFld-ContribAuthor ">May  Mo</span>, <span class="hlFld-ContribAuthor ">Ming‐Hui  Chen</span>, <span class="hlFld-ContribAuthor ">Zhiyi  Chi</span>, <span class="hlFld-ContribAuthor ">Juan  Li</span>, <span class="hlFld-ContribAuthor ">Amy H.  Xia</span>, <span class="hlFld-ContribAuthor ">Joseph G.  Ibrahim</span>. </span><span class="cited-content_cbyCitation_article-title">Network meta‐regression for ordinal outcomes: Applications in comparing Crohn's disease treatments. </span><span class="cited-content_cbyCitation_journal-name">Statistics in Medicine</span><span> <strong>2020,</strong> <em>39 </em>
                                    (13)
                                     , 1846-1870. <a href="https://doi.org/10.1002/sim.8518" title="DOI URL">https://doi.org/10.1002/sim.8518</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/sim.8518&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fsim.8518%26sid%3Dliteratum%253Aachs%26jtitle%3DStatistics%2520in%2520Medicine%26atitle%3DNetwork%252Bmeta%2525E2%252580%252590regression%252Bfor%252Bordinal%252Boutcomes%25253A%252BApplications%252Bin%252Bcomparing%252BCrohn%252527s%252Bdisease%252Btreatments%26aulast%3DGwon%26aufirst%3DYeongjin%26date%3D2020%26date%3D2020%26volume%3D39%26issue%3D13%26spage%3D1846%26epage%3D1870" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Emiko  Mizoguchi</span>, <span class="hlFld-ContribAuthor ">Daren  Low</span>, <span class="hlFld-ContribAuthor ">Yui  Ezaki</span>, <span class="hlFld-ContribAuthor ">Toshiyuki  Okada</span>. </span><span class="cited-content_cbyCitation_article-title">Recent updates on the basic mechanisms and pathogenesis of inflammatory bowel diseases in experimental animal models. </span><span class="cited-content_cbyCitation_journal-name">Intestinal Research</span><span> <strong>2020,</strong> <em>18 </em>
                                    (2)
                                     , 151-167. <a href="https://doi.org/10.5217/ir.2019.09154" title="DOI URL">https://doi.org/10.5217/ir.2019.09154</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.5217/ir.2019.09154&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.5217%2Fir.2019.09154%26sid%3Dliteratum%253Aachs%26jtitle%3DIntestinal%2520Research%26atitle%3DRecent%252Bupdates%252Bon%252Bthe%252Bbasic%252Bmechanisms%252Band%252Bpathogenesis%252Bof%252Binflammatory%252Bbowel%252Bdiseases%252Bin%252Bexperimental%252Banimal%252Bmodels%26aulast%3DMizoguchi%26aufirst%3DEmiko%26date%3D2020%26volume%3D18%26issue%3D2%26spage%3D151%26epage%3D167" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Liqiang  Hao</span>, <span class="hlFld-ContribAuthor ">Guodong  Wang</span>, <span class="hlFld-ContribAuthor ">Jian  Sun</span>, <span class="hlFld-ContribAuthor ">Jun  Xu</span>, <span class="hlFld-ContribAuthor ">Hongshuang  Li</span>, <span class="hlFld-ContribAuthor ">Guiyun  Duan</span>, <span class="hlFld-ContribAuthor ">Chengcai  Xia</span>, <span class="hlFld-ContribAuthor ">Pengfei  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">From Phenylhydrazone to 1
              H
              ‐1,2,4‐Triazoles via Nitrification, Reduction and Cyclization. </span><span class="cited-content_cbyCitation_journal-name">Advanced Synthesis & Catalysis</span><span> <strong>2020,</strong> <em>362 </em>
                                    (8)
                                     , 1657-1662. <a href="https://doi.org/10.1002/adsc.201901563" title="DOI URL">https://doi.org/10.1002/adsc.201901563</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adsc.201901563&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadsc.201901563%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Synthesis%2520%2526%2520Catalysis%26atitle%3DFrom%252BPhenylhydrazone%252Bto%252B1%252BH%252B%2525E2%252580%2525901%25252C2%25252C4%2525E2%252580%252590Triazoles%252Bvia%252BNitrification%25252C%252BReduction%252Band%252BCyclization%26aulast%3DHao%26aufirst%3DLiqiang%26date%3D2020%26date%3D2020%26volume%3D362%26issue%3D8%26spage%3D1657%26epage%3D1662" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pengfei  Xu</span>, <span class="hlFld-ContribAuthor ">Pei  Shen</span>, <span class="hlFld-ContribAuthor ">Bin  Yu</span>, <span class="hlFld-ContribAuthor ">Xi  Xu</span>, <span class="hlFld-ContribAuthor ">Raoling  Ge</span>, <span class="hlFld-ContribAuthor ">Xinying  Cheng</span>, <span class="hlFld-ContribAuthor ">Qiuyu  Chen</span>, <span class="hlFld-ContribAuthor ">Jinlei  Bian</span>, <span class="hlFld-ContribAuthor ">Zhiyu  Li</span>, <span class="hlFld-ContribAuthor ">JuBo  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Janus kinases (JAKs): The efficient therapeutic targets for autoimmune diseases and myeloproliferative disorders. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>192 </em>, 112155. <a href="https://doi.org/10.1016/j.ejmech.2020.112155" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112155</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112155&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112155%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DJanus%252Bkinases%252B%252528JAKs%252529%25253A%252BThe%252Befficient%252Btherapeutic%252Btargets%252Bfor%252Bautoimmune%252Bdiseases%252Band%252Bmyeloproliferative%252Bdisorders%26aulast%3DXu%26aufirst%3DPengfei%26date%3D2020%26volume%3D192%26spage%3D112155" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mark  Zak</span>, <span class="hlFld-ContribAuthor ">Hart S.  Dengler</span>, <span class="hlFld-ContribAuthor ">Naomi S.  Rajapaksa</span>. </span><span class="cited-content_cbyCitation_article-title">Inhaled Janus Kinase (JAK) inhibitors for the treatment of asthma. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>29 </em>
                                    (20)
                                     , 126658. <a href="https://doi.org/10.1016/j.bmcl.2019.126658" title="DOI URL">https://doi.org/10.1016/j.bmcl.2019.126658</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2019.126658&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2019.126658%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DInhaled%252BJanus%252BKinase%252B%252528JAK%252529%252Binhibitors%252Bfor%252Bthe%252Btreatment%252Bof%252Basthma%26aulast%3DZak%26aufirst%3DMark%26date%3D2019%26volume%3D29%26issue%3D20%26spage%3D126658" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aleksey Yu.  Vorob’ev</span>. </span><span class="cited-content_cbyCitation_article-title">Methods of synthesis of [1,2,4]triazolo[1,5-а]pyridines (microreview). </span><span class="cited-content_cbyCitation_journal-name">Chemistry of Heterocyclic Compounds</span><span> <strong>2019,</strong> <em>55 </em>
                                    (8)
                                     , 695-697. <a href="https://doi.org/10.1007/s10593-019-02522-5" title="DOI URL">https://doi.org/10.1007/s10593-019-02522-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10593-019-02522-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10593-019-02522-5%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520of%2520Heterocyclic%2520Compounds%26atitle%3DMethods%252Bof%252Bsynthesis%252Bof%252B%25255B1%25252C2%25252C4%25255Dtriazolo%25255B1%25252C5-%2525D0%2525B0%25255Dpyridines%252B%252528microreview%252529%26aulast%3DVorob%25E2%2580%2599ev%26aufirst%3DAleksey%2BYu.%26date%3D2019%26date%3D2019%26volume%3D55%26issue%3D8%26spage%3D695%26epage%3D697" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kevin S.  Currie</span>, <span class="hlFld-ContribAuthor ">Leena  Patel</span>, <span class="hlFld-ContribAuthor ">Kassandra F.  Sedillo</span>. </span><span class="cited-content_cbyCitation_article-title">Small-molecule agents for the treatment of inflammatory bowel disease. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>29 </em>
                                    (16)
                                     , 2034-2041. <a href="https://doi.org/10.1016/j.bmcl.2019.06.042" title="DOI URL">https://doi.org/10.1016/j.bmcl.2019.06.042</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2019.06.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2019.06.042%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSmall-molecule%252Bagents%252Bfor%252Bthe%252Btreatment%252Bof%252Binflammatory%252Bbowel%252Bdisease%26aulast%3DCurrie%26aufirst%3DKevin%2BS.%26date%3D2019%26volume%3D29%26issue%3D16%26spage%3D2034%26epage%3D2041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yong  Li</span>, <span class="hlFld-ContribAuthor ">Zenghui  Ye</span>, <span class="hlFld-ContribAuthor ">Na  Chen</span>, <span class="hlFld-ContribAuthor ">Zhenkun  Chen</span>, <span class="hlFld-ContribAuthor ">Fengzhi  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Intramolecular electrochemical dehydrogenative N–N bond formation for the synthesis of 1,2,4-triazolo[1,5-
              a
              ]pyridines. </span><span class="cited-content_cbyCitation_journal-name">Green Chemistry</span><span> <strong>2019,</strong> <em>21 </em>
                                    (15)
                                     , 4035-4039. <a href="https://doi.org/10.1039/C9GC01895F" title="DOI URL">https://doi.org/10.1039/C9GC01895F</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9GC01895F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9GC01895F%26sid%3Dliteratum%253Aachs%26jtitle%3DGreen%2520Chemistry%26atitle%3DIntramolecular%252Belectrochemical%252Bdehydrogenative%252BN%2525E2%252580%252593N%252Bbond%252Bformation%252Bfor%252Bthe%252Bsynthesis%252Bof%252B1%25252C2%25252C4-triazolo%25255B1%25252C5-%252Ba%252B%25255Dpyridines%26aulast%3DLi%26aufirst%3DYong%26date%3D2019%26date%3D2019%26volume%3D21%26issue%3D15%26spage%3D4035%26epage%3D4039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Francesca  Musumeci</span>, <span class="hlFld-ContribAuthor ">Chiara  Greco</span>, <span class="hlFld-ContribAuthor ">Ilaria  Giacchello</span>, <span class="hlFld-ContribAuthor ">Anna Lucia  Fallacara</span>, <span class="hlFld-ContribAuthor ">Munjed M.  Ibrahim</span>, <span class="hlFld-ContribAuthor ">Giancarlo  Grossi</span>, <span class="hlFld-ContribAuthor ">Chiara  Brullo</span>, <span class="hlFld-ContribAuthor ">Silvia  Schenone</span>. </span><span class="cited-content_cbyCitation_article-title">An Update on JAK Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Current Medicinal Chemistry</span><span> <strong>2019,</strong> <em>26 </em>
                                    (10)
                                     , 1806-1832. <a href="https://doi.org/10.2174/0929867325666180327093502" title="DOI URL">https://doi.org/10.2174/0929867325666180327093502</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/0929867325666180327093502&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F0929867325666180327093502%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Medicinal%2520Chemistry%26atitle%3DAn%252BUpdate%252Bon%252BJAK%252BInhibitors%26aulast%3DMusumeci%26aufirst%3DFrancesca%26date%3D2019%26volume%3D26%26issue%3D10%26spage%3D1806%26epage%3D1832" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yazhou  Wang</span>, <span class="hlFld-ContribAuthor ">Wei  Huang</span>, <span class="hlFld-ContribAuthor ">Minhang  Xin</span>, <span class="hlFld-ContribAuthor ">Pan  Chen</span>, <span class="hlFld-ContribAuthor ">Li  Gui</span>, <span class="hlFld-ContribAuthor ">Xinxin  Zhao</span>, <span class="hlFld-ContribAuthor ">Xinrong  Zhu</span>, <span class="hlFld-ContribAuthor ">Hongpeng  Luo</span>, <span class="hlFld-ContribAuthor ">Xin  Cong</span>, <span class="hlFld-ContribAuthor ">Jia  Wang</span>, <span class="hlFld-ContribAuthor ">Fei  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of potent anti-inflammatory 4-(4,5,6,7-tetrahydrofuro[3,2-c]pyridin-2-yl) pyrimidin-2-amines for use as Janus kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2019,</strong> <em>27 </em>
                                    (12)
                                     , 2592-2597. <a href="https://doi.org/10.1016/j.bmc.2019.03.048" title="DOI URL">https://doi.org/10.1016/j.bmc.2019.03.048</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2019.03.048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2019.03.048%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bpotent%252Banti-inflammatory%252B4-%2525284%25252C5%25252C6%25252C7-tetrahydrofuro%25255B3%25252C2-c%25255Dpyridin-2-yl%252529%252Bpyrimidin-2-amines%252Bfor%252Buse%252Bas%252BJanus%252Bkinase%252Binhibitors%26aulast%3DWang%26aufirst%3DYazhou%26date%3D2019%26volume%3D27%26issue%3D12%26spage%3D2592%26epage%3D2597" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anniina  T. Virtanen</span>, <span class="hlFld-ContribAuthor ">Teemu  Haikarainen</span>, <span class="hlFld-ContribAuthor ">Juuli  Raivola</span>, <span class="hlFld-ContribAuthor ">Olli  Silvennoinen</span>. </span><span class="cited-content_cbyCitation_article-title">Selective JAKinibs: Prospects in Inflammatory and Autoimmune Diseases. </span><span class="cited-content_cbyCitation_journal-name">BioDrugs</span><span> <strong>2019,</strong> <em>33 </em>
                                    (1)
                                     , 15-32. <a href="https://doi.org/10.1007/s40259-019-00333-w" title="DOI URL">https://doi.org/10.1007/s40259-019-00333-w</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s40259-019-00333-w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs40259-019-00333-w%26sid%3Dliteratum%253Aachs%26jtitle%3DBioDrugs%26atitle%3DSelective%252BJAKinibs%25253A%252BProspects%252Bin%252BInflammatory%252Band%252BAutoimmune%252BDiseases%26aulast%3DT.%2BVirtanen%26aufirst%3DAnniina%26date%3D2019%26date%3D2019%26volume%3D33%26issue%3D1%26spage%3D15%26epage%3D32" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ming-Hui  Qi</span>, <span class="hlFld-ContribAuthor ">Qiao-Dan  Zhang</span>, <span class="hlFld-ContribAuthor ">Yang  Liu</span>, <span class="hlFld-ContribAuthor ">Fu-Zheng  Ren</span>, <span class="hlFld-ContribAuthor ">Guo-Bin  Ren</span>. </span><span class="cited-content_cbyCitation_article-title">Four solid forms of filgotinib hydrochloride: Insight into the crystal structures, properties, stability, and solid-state transitions. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Structure</span><span> <strong>2019,</strong> <em>1178 </em>, 242-250. <a href="https://doi.org/10.1016/j.molstruc.2018.10.023" title="DOI URL">https://doi.org/10.1016/j.molstruc.2018.10.023</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molstruc.2018.10.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molstruc.2018.10.023%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Structure%26atitle%3DFour%252Bsolid%252Bforms%252Bof%252Bfilgotinib%252Bhydrochloride%25253A%252BInsight%252Binto%252Bthe%252Bcrystal%252Bstructures%25252C%252Bproperties%25252C%252Bstability%25252C%252Band%252Bsolid-state%252Btransitions%26aulast%3DQi%26aufirst%3DMing-Hui%26date%3D2019%26volume%3D1178%26spage%3D242%26epage%3D250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yue-Wei  Sun</span>, <span class="hlFld-ContribAuthor ">Yue-Ming  Bei</span>, <span class="hlFld-ContribAuthor ">Lan-Zhi  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">A catalyst-free four-component domino reaction for the synthesis of functionalized 3-acyl-1,5-benzodiazepines. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2019,</strong> <em>17 </em>
                                    (4)
                                     , 930-938. <a href="https://doi.org/10.1039/C8OB02903B" title="DOI URL">https://doi.org/10.1039/C8OB02903B</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8OB02903B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8OB02903B%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DA%252Bcatalyst-free%252Bfour-component%252Bdomino%252Breaction%252Bfor%252Bthe%252Bsynthesis%252Bof%252Bfunctionalized%252B3-acyl-1%25252C5-benzodiazepines%26aulast%3DSun%26aufirst%3DYue-Wei%26date%3D2019%26date%3D2019%26volume%3D17%26issue%3D4%26spage%3D930%26epage%3D938" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gunther  Fischer</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances in 1,2,4-triazolo[1,5-a]pyrimidine chemistry. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 1-101. <a href="https://doi.org/10.1016/bs.aihch.2018.10.002" title="DOI URL">https://doi.org/10.1016/bs.aihch.2018.10.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/bs.aihch.2018.10.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fbs.aihch.2018.10.002%26sid%3Dliteratum%253Aachs%26atitle%3DRecent%252Badvances%252Bin%252B1%25252C2%25252C4-triazolo%25255B1%25252C5-a%25255Dpyrimidine%252Bchemistry%26aulast%3DFischer%26aufirst%3DGunther%26date%3D2019%26spage%3D1%26epage%3D101%26pub%3DElsevier%26date%3D2019%26volume%3D128" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Carlos J.A.  Ribeiro</span>, <span class="hlFld-ContribAuthor ">Jayakanth  Kankanala</span>, <span class="hlFld-ContribAuthor ">Jiashu  Xie</span>, <span class="hlFld-ContribAuthor ">Jessica  Williams</span>, <span class="hlFld-ContribAuthor ">Hideki  Aihara</span>, <span class="hlFld-ContribAuthor ">Zhengqiang  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Triazolopyrimidine and triazolopyridine scaffolds as TDP2 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>29 </em>
                                    (2)
                                     , 257-261. <a href="https://doi.org/10.1016/j.bmcl.2018.11.044" title="DOI URL">https://doi.org/10.1016/j.bmcl.2018.11.044</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2018.11.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2018.11.044%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DTriazolopyrimidine%252Band%252Btriazolopyridine%252Bscaffolds%252Bas%252BTDP2%252Binhibitors%26aulast%3DRibeiro%26aufirst%3DCarlos%2BJ.A.%26date%3D2019%26volume%3D29%26issue%3D2%26spage%3D257%26epage%3D261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yingying  Chai</span>, <span class="hlFld-ContribAuthor ">Changfu  Li</span>, <span class="hlFld-ContribAuthor ">Liying  Meng</span>, <span class="hlFld-ContribAuthor ">Xinglong  Zhou</span>, <span class="hlFld-ContribAuthor ">Zhenqiang  Xia</span>, <span class="hlFld-ContribAuthor ">Weimin  Li</span>, <span class="hlFld-ContribAuthor ">Yang  He</span>. </span><span class="cited-content_cbyCitation_article-title">The Diverse supramolecular synthons formed by 2-subsituted 5-morpholinomethylphenyl Triazolo[1,5-a]pyridines in solid state. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Structure</span><span> <strong>2019,</strong> <em>1176 </em>, 149-156. <a href="https://doi.org/10.1016/j.molstruc.2018.08.088" title="DOI URL">https://doi.org/10.1016/j.molstruc.2018.08.088</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molstruc.2018.08.088&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molstruc.2018.08.088%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Structure%26atitle%3DThe%252BDiverse%252Bsupramolecular%252Bsynthons%252Bformed%252Bby%252B2-subsituted%252B5-morpholinomethylphenyl%252BTriazolo%25255B1%25252C5-a%25255Dpyridines%252Bin%252Bsolid%252Bstate%26aulast%3DChai%26aufirst%3DYingying%26date%3D2019%26volume%3D1176%26spage%3D149%26epage%3D156" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shufeng  Jiao</span>, <span class="hlFld-ContribAuthor ">Zhen  Wang</span>, <span class="hlFld-ContribAuthor ">Qiongli  Zhao</span>, <span class="hlFld-ContribAuthor ">Wenquan  Yu</span>, <span class="hlFld-ContribAuthor ">Junbiao  Chang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of fused 3-amino-1,2,4-triazoles via sequential addition of aryl hydrazines to isothiocyanates and I 2 -mediated cyclodesulfurization. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2018,</strong> <em>74 </em>
                                    (24)
                                     , 3069-3073. <a href="https://doi.org/10.1016/j.tet.2018.05.009" title="DOI URL">https://doi.org/10.1016/j.tet.2018.05.009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2018.05.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2018.05.009%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DSynthesis%252Bof%252Bfused%252B3-amino-1%25252C2%25252C4-triazoles%252Bvia%252Bsequential%252Baddition%252Bof%252Baryl%252Bhydrazines%252Bto%252Bisothiocyanates%252Band%252BI%252B2%252B-mediated%252Bcyclodesulfurization%26aulast%3DJiao%26aufirst%3DShufeng%26date%3D2018%26volume%3D74%26issue%3D24%26spage%3D3069%26epage%3D3073" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chieyeon  Chough</span>, <span class="hlFld-ContribAuthor ">Misuk  Joung</span>, <span class="hlFld-ContribAuthor ">Sunmin  Lee</span>, <span class="hlFld-ContribAuthor ">Jaemin  Lee</span>, <span class="hlFld-ContribAuthor ">Jong Hoon  Kim</span>, <span class="hlFld-ContribAuthor ">B. Moon  Kim</span>. </span><span class="cited-content_cbyCitation_article-title">Development of selective inhibitors for the treatment of rheumatoid arthritis: (R)-3-(3-(Methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)pyrrolidin-1-yl)-3-oxopropanenitrile as a JAK1-selective inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2018,</strong> <em>26 </em>
                                    (8)
                                     , 1495-1510. <a href="https://doi.org/10.1016/j.bmc.2018.01.021" title="DOI URL">https://doi.org/10.1016/j.bmc.2018.01.021</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2018.01.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2018.01.021%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDevelopment%252Bof%252Bselective%252Binhibitors%252Bfor%252Bthe%252Btreatment%252Bof%252Brheumatoid%252Barthritis%25253A%252B%252528R%252529-3-%2525283-%252528Methyl%2525287H-pyrrolo%25255B2%25252C3-d%25255Dpyrimidin-4-yl%252529amino%252529pyrrolidin-1-yl%252529-3-oxopropanenitrile%252Bas%252Ba%252BJAK1-selective%252Binhibitor%26aulast%3DChough%26aufirst%3DChieyeon%26date%3D2018%26volume%3D26%26issue%3D8%26spage%3D1495%26epage%3D1510" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pieter  Hindryckx</span>, <span class="hlFld-ContribAuthor ">Niels  Vande Casteele</span>, <span class="hlFld-ContribAuthor ">Gregor  Novak</span>, <span class="hlFld-ContribAuthor ">Reena  Khanna</span>, <span class="hlFld-ContribAuthor ">Geert  D’Haens</span>, <span class="hlFld-ContribAuthor ">William J  Sandborn</span>, <span class="hlFld-ContribAuthor ">Silvio  Danese</span>, <span class="hlFld-ContribAuthor ">Vipul  Jairath</span>, <span class="hlFld-ContribAuthor ">Brian G  Feagan</span>. </span><span class="cited-content_cbyCitation_article-title">The Expanding Therapeutic Armamentarium for Inflammatory Bowel Disease: How to Choose the Right Drug[s] for Our Patients?. </span><span class="cited-content_cbyCitation_journal-name">Journal of Crohn's and Colitis</span><span> <strong>2018,</strong> <em>12 </em>
                                    (1)
                                     , 105-119. <a href="https://doi.org/10.1093/ecco-jcc/jjx117" title="DOI URL">https://doi.org/10.1093/ecco-jcc/jjx117</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/ecco-jcc/jjx117&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Fecco-jcc%2Fjjx117%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Crohn%2527s%2520and%2520Colitis%26atitle%3DThe%252BExpanding%252BTherapeutic%252BArmamentarium%252Bfor%252BInflammatory%252BBowel%252BDisease%25253A%252BHow%252Bto%252BChoose%252Bthe%252BRight%252BDrug%25255Bs%25255D%252Bfor%252BOur%252BPatients%25253F%26aulast%3DHindryckx%26aufirst%3DPieter%26date%3D2018%26date%3D2017%26volume%3D12%26issue%3D1%26spage%3D105%26epage%3D119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chieyeon  Chough</span>, <span class="hlFld-ContribAuthor ">Sunmin  Lee</span>, <span class="hlFld-ContribAuthor ">Misuk  Joung</span>, <span class="hlFld-ContribAuthor ">Jaemin  Lee</span>, <span class="hlFld-ContribAuthor ">Jong Hoon  Kim</span>, <span class="hlFld-ContribAuthor ">B. Moon  Kim</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and evaluation of (
              R
              )-3-(7-(methyl(7
              H
              -pyrrolo[2,3-
              d
              ]pyrimidin-4-yl)amino)-5-azaspiro[2.4]heptan-5-yl)-3-oxopropanenitrile as a JAK1-selective inhibitor. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2018,</strong> <em>9 </em>
                                    (3)
                                     , 477-489. <a href="https://doi.org/10.1039/C7MD00568G" title="DOI URL">https://doi.org/10.1039/C7MD00568G</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7MD00568G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7MD00568G%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bevaluation%252Bof%252B%252528%252BR%252B%252529-3-%2525287-%252528methyl%2525287%252BH%252B-pyrrolo%25255B2%25252C3-%252Bd%252B%25255Dpyrimidin-4-yl%252529amino%252529-5-azaspiro%25255B2.4%25255Dheptan-5-yl%252529-3-oxopropanenitrile%252Bas%252Ba%252BJAK1-selective%252Binhibitor%26aulast%3DChough%26aufirst%3DChieyeon%26date%3D2018%26date%3D2018%26volume%3D9%26issue%3D3%26spage%3D477%26epage%3D489" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Changfu  Li</span>, <span class="hlFld-ContribAuthor ">Yingying  Chai</span>, <span class="hlFld-ContribAuthor ">Xinglong  Zhou</span>, <span class="hlFld-ContribAuthor ">Zhen  Shen</span>, <span class="hlFld-ContribAuthor ">Beibei  Ma</span>, <span class="hlFld-ContribAuthor ">Bojiang  Chen</span>, <span class="hlFld-ContribAuthor ">Ridong  Huang</span>, <span class="hlFld-ContribAuthor ">Hai  Chen</span>, <span class="hlFld-ContribAuthor ">Weimin  Li</span>, <span class="hlFld-ContribAuthor ">Yang  He</span>. </span><span class="cited-content_cbyCitation_article-title">Choice of hydrogen bonds or halogen bonds by 2-halogenated 5-morpholinomethylphenyl triazolo[1,5-
              a
              ]pyridine. </span><span class="cited-content_cbyCitation_journal-name">CrystEngComm</span><span> <strong>2018,</strong> <em>20 </em>
                                    (22)
                                     , 3006-3010. <a href="https://doi.org/10.1039/C8CE00423D" title="DOI URL">https://doi.org/10.1039/C8CE00423D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8CE00423D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8CE00423D%26sid%3Dliteratum%253Aachs%26jtitle%3DCrystEngComm%26atitle%3DChoice%252Bof%252Bhydrogen%252Bbonds%252Bor%252Bhalogen%252Bbonds%252Bby%252B2-halogenated%252B5-morpholinomethylphenyl%252Btriazolo%25255B1%25252C5-%252Ba%252B%25255Dpyridine%26aulast%3DLi%26aufirst%3DChangfu%26date%3D2018%26date%3D2018%26volume%3D20%26issue%3D22%26spage%3D3006%26epage%3D3010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniella M.  Schwartz</span>, <span class="hlFld-ContribAuthor ">Yuka  Kanno</span>, <span class="hlFld-ContribAuthor ">Alejandro  Villarino</span>, <span class="hlFld-ContribAuthor ">Michael  Ward</span>, <span class="hlFld-ContribAuthor ">Massimo  Gadina</span>, <span class="hlFld-ContribAuthor ">John J.  O'Shea</span>. </span><span class="cited-content_cbyCitation_article-title">JAK inhibition as a therapeutic strategy for immune and inflammatory diseases. </span><span class="cited-content_cbyCitation_journal-name">Nature Reviews Drug Discovery</span><span> <strong>2017,</strong> <em>16 </em>
                                    (12)
                                     , 843-862. <a href="https://doi.org/10.1038/nrd.2017.201" title="DOI URL">https://doi.org/10.1038/nrd.2017.201</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/nrd.2017.201&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fnrd.2017.201%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Reviews%2520Drug%2520Discovery%26atitle%3DJAK%252Binhibition%252Bas%252Ba%252Btherapeutic%252Bstrategy%252Bfor%252Bimmune%252Band%252Binflammatory%252Bdiseases%26aulast%3DSchwartz%26aufirst%3DDaniella%2BM.%26date%3D2017%26date%3D2017%26volume%3D16%26issue%3D12%26spage%3D843%26epage%3D862" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peter C.  Taylor</span>, <span class="hlFld-ContribAuthor ">Maha  Abdul Azeez</span>, <span class="hlFld-ContribAuthor ">Serafim  Kiriakidis</span>. </span><span class="cited-content_cbyCitation_article-title">Filgotinib for the treatment of rheumatoid arthritis. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Investigational Drugs</span><span> <strong>2017,</strong> <em>26 </em>
                                    (10)
                                     , 1181-1187. <a href="https://doi.org/10.1080/13543784.2017.1372422" title="DOI URL">https://doi.org/10.1080/13543784.2017.1372422</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543784.2017.1372422&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543784.2017.1372422%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Investigational%2520Drugs%26atitle%3DFilgotinib%252Bfor%252Bthe%252Btreatment%252Bof%252Brheumatoid%252Barthritis%26aulast%3DTaylor%26aufirst%3DPeter%2BC.%26date%3D2017%26date%3D2017%26volume%3D26%26issue%3D10%26spage%3D1181%26epage%3D1187" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kazuhiko  Shien</span>, <span class="hlFld-ContribAuthor ">Vassiliki A.  Papadimitrakopoulou</span>, <span class="hlFld-ContribAuthor ">Dennis  Ruder</span>, <span class="hlFld-ContribAuthor ">Carmen  Behrens</span>, <span class="hlFld-ContribAuthor ">Li  Shen</span>, <span class="hlFld-ContribAuthor ">Neda  Kalhor</span>, <span class="hlFld-ContribAuthor ">Juhee  Song</span>, <span class="hlFld-ContribAuthor ">J. Jack  Lee</span>, <span class="hlFld-ContribAuthor ">Jing  Wang</span>, <span class="hlFld-ContribAuthor ">Ximing  Tang</span>, <span class="hlFld-ContribAuthor ">Roy S.  Herbst</span>, <span class="hlFld-ContribAuthor ">Shinichi  Toyooka</span>, <span class="hlFld-ContribAuthor ">Luc  Girard</span>, <span class="hlFld-ContribAuthor ">John D.  Minna</span>, <span class="hlFld-ContribAuthor ">Jonathan M.  Kurie</span>, <span class="hlFld-ContribAuthor ">Ignacio I.  Wistuba</span>, <span class="hlFld-ContribAuthor ">Julie G.  Izzo</span>. </span><span class="cited-content_cbyCitation_article-title">JAK1/STAT3 Activation through a Proinflammatory Cytokine Pathway Leads to Resistance to Molecularly Targeted Therapy in Non–Small Cell Lung Cancer. </span><span class="cited-content_cbyCitation_journal-name">Molecular Cancer Therapeutics</span><span> <strong>2017,</strong> <em>16 </em>
                                    (10)
                                     , 2234-2245. <a href="https://doi.org/10.1158/1535-7163.MCT-17-0148" title="DOI URL">https://doi.org/10.1158/1535-7163.MCT-17-0148</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1535-7163.MCT-17-0148&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1535-7163.MCT-17-0148%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Cancer%2520Therapeutics%26atitle%3DJAK1%25252FSTAT3%252BActivation%252Bthrough%252Ba%252BProinflammatory%252BCytokine%252BPathway%252BLeads%252Bto%252BResistance%252Bto%252BMolecularly%252BTargeted%252BTherapy%252Bin%252BNon%2525E2%252580%252593Small%252BCell%252BLung%252BCancer%26aulast%3DShien%26aufirst%3DKazuhiko%26date%3D2017%26date%3D2017%26volume%3D16%26issue%3D10%26spage%3D2234%26epage%3D2245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">John  Hynes</span>, <span class="hlFld-ContribAuthor ">Hong  Wu</span>, <span class="hlFld-ContribAuthor ">James  Kempson</span>, <span class="hlFld-ContribAuthor ">James J.-W.  Duan</span>, <span class="hlFld-ContribAuthor ">Zhonghui  Lu</span>, <span class="hlFld-ContribAuthor ">Bin  Jiang</span>, <span class="hlFld-ContribAuthor ">Sylwia  Stachura</span>, <span class="hlFld-ContribAuthor ">John S.  Tokarski</span>, <span class="hlFld-ContribAuthor ">John S.  Sack</span>, <span class="hlFld-ContribAuthor ">Javed A.  Khan</span>, <span class="hlFld-ContribAuthor ">Jonathan S.  Lippy</span>, <span class="hlFld-ContribAuthor ">Rosemary F.  Zhang</span>, <span class="hlFld-ContribAuthor ">Sidney  Pitt</span>, <span class="hlFld-ContribAuthor ">Guoxiang  Shen</span>, <span class="hlFld-ContribAuthor ">Kate  Gillooly</span>, <span class="hlFld-ContribAuthor ">Kim  McIntyre</span>, <span class="hlFld-ContribAuthor ">Percy H.  Carter</span>, <span class="hlFld-ContribAuthor ">Joel C.  Barrish</span>, <span class="hlFld-ContribAuthor ">Steven G.  Nadler</span>, <span class="hlFld-ContribAuthor ">Luisa M.  Salter-Cid</span>, <span class="hlFld-ContribAuthor ">Aberra  Fura</span>, <span class="hlFld-ContribAuthor ">Gary L.  Schieven</span>, <span class="hlFld-ContribAuthor ">William J.  Pitts</span>, <span class="hlFld-ContribAuthor ">Stephen T.  Wrobleski</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of potent and efficacious pyrrolopyridazines as dual JAK1/3 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (14)
                                     , 3101-3106. <a href="https://doi.org/10.1016/j.bmcl.2017.05.043" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.05.043</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.05.043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.05.043%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Bpotent%252Band%252Befficacious%252Bpyrrolopyridazines%252Bas%252Bdual%252BJAK1%25252F3%252Binhibitors%26aulast%3DHynes%26aufirst%3DJohn%26date%3D2017%26volume%3D27%26issue%3D14%26spage%3D3101%26epage%3D3106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jason G.  Kettle</span>, <span class="hlFld-ContribAuthor ">Annika  Åstrand</span>, <span class="hlFld-ContribAuthor ">Matthew  Catley</span>, <span class="hlFld-ContribAuthor ">Neil P.  Grimster</span>, <span class="hlFld-ContribAuthor ">Magnus  Nilsson</span>, <span class="hlFld-ContribAuthor ">Qibin  Su</span>, <span class="hlFld-ContribAuthor ">Richard  Woessner</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibitors of JAK-family kinases: an update on the patent literature 2013-2015, part 1. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2017,</strong> <em>27 </em>
                                    (2)
                                     , 127-143. <a href="https://doi.org/10.1080/13543776.2017.1252753" title="DOI URL">https://doi.org/10.1080/13543776.2017.1252753</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543776.2017.1252753&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543776.2017.1252753%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DInhibitors%252Bof%252BJAK-family%252Bkinases%25253A%252Ban%252Bupdate%252Bon%252Bthe%252Bpatent%252Bliterature%252B2013-2015%25252C%252Bpart%252B1%26aulast%3DKettle%26aufirst%3DJason%2BG.%26date%3D2017%26date%3D2016%26volume%3D27%26issue%3D2%26spage%3D127%26epage%3D143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Joel  Pekow</span>. </span><span class="cited-content_cbyCitation_article-title">IBD Therapies: Coming Attractions. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 183-204. <a href="https://doi.org/10.1007/978-3-319-53763-4_11" title="DOI URL">https://doi.org/10.1007/978-3-319-53763-4_11</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-319-53763-4_11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-319-53763-4_11%26sid%3Dliteratum%253Aachs%26atitle%3DIBD%252BTherapies%25253A%252BComing%252BAttractions%26aulast%3DPekow%26aufirst%3DJoel%26date%3D2017%26date%3D2017%26spage%3D183%26epage%3D204%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DInflammatory%252BBowel%252BDisease%26aulast%3DCohen%26aufirst%3DRussell%2BD.%26date%3D2017%26volume%3D114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Séverine  Vermeire</span>, <span class="hlFld-ContribAuthor ">Stefan  Schreiber</span>, <span class="hlFld-ContribAuthor ">Robert  Petryka</span>, <span class="hlFld-ContribAuthor ">Tanja  Kuehbacher</span>, <span class="hlFld-ContribAuthor ">Xavier  Hebuterne</span>, <span class="hlFld-ContribAuthor ">Xavier  Roblin</span>, <span class="hlFld-ContribAuthor ">Maria  Klopocka</span>, <span class="hlFld-ContribAuthor ">Adrian  Goldis</span>, <span class="hlFld-ContribAuthor ">Maria  Wisniewska-Jarosinska</span>, <span class="hlFld-ContribAuthor ">Andrey  Baranovsky</span>, <span class="hlFld-ContribAuthor ">Robert  Sike</span>, <span class="hlFld-ContribAuthor ">Kremena  Stoyanova</span>, <span class="hlFld-ContribAuthor ">Chantal  Tasset</span>, <span class="hlFld-ContribAuthor ">Annegret  Van der Aa</span>, <span class="hlFld-ContribAuthor ">Pille  Harrison</span>. </span><span class="cited-content_cbyCitation_article-title">Clinical remission in patients with moderate-to-severe Crohn's disease treated with filgotinib (the FITZROY study): results from a phase 2, double-blind, randomised, placebo-controlled trial. </span><span class="cited-content_cbyCitation_journal-name">The Lancet</span><span> <strong>2017,</strong> <em>389 </em>
                                    (10066)
                                     , 266-275. <a href="https://doi.org/10.1016/S0140-6736(16)32537-5" title="DOI URL">https://doi.org/10.1016/S0140-6736(16)32537-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/S0140-6736(16)32537-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FS0140-6736%2816%2932537-5%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Lancet%26atitle%3DClinical%252Bremission%252Bin%252Bpatients%252Bwith%252Bmoderate-to-severe%252BCrohn%252527s%252Bdisease%252Btreated%252Bwith%252Bfilgotinib%252B%252528the%252BFITZROY%252Bstudy%252529%25253A%252Bresults%252Bfrom%252Ba%252Bphase%252B2%25252C%252Bdouble-blind%25252C%252Brandomised%25252C%252Bplacebo-controlled%252Btrial%26aulast%3DVermeire%26aufirst%3DS%25C3%25A9verine%26date%3D2017%26volume%3D389%26issue%3D10066%26spage%3D266%26epage%3D275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qiu-Chao  Mu</span>, <span class="hlFld-ContribAuthor ">Ji-Yuan  Lv</span>, <span class="hlFld-ContribAuthor ">Mu-Yi  Chen</span>, <span class="hlFld-ContribAuthor ">Xing-Feng  Bai</span>, <span class="hlFld-ContribAuthor ">Jing  Chen</span>, <span class="hlFld-ContribAuthor ">Chun-Gu  Xia</span>, <span class="hlFld-ContribAuthor ">Li-Wen  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Bimetallic copper and zinc-catalyzed oxidative cycloaddition of 3-aminopyridazines and nitriles: a direct synthesis of 1,2,4-triazolo[1,5-b]pyridazines via C–N and N–N bond-forming process. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2017,</strong> <em>7 </em>
                                    (59)
                                     , 37208-37213. <a href="https://doi.org/10.1039/C7RA06727E" title="DOI URL">https://doi.org/10.1039/C7RA06727E</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7RA06727E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7RA06727E%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DBimetallic%252Bcopper%252Band%252Bzinc-catalyzed%252Boxidative%252Bcycloaddition%252Bof%252B3-aminopyridazines%252Band%252Bnitriles%25253A%252Ba%252Bdirect%252Bsynthesis%252Bof%252B1%25252C2%25252C4-triazolo%25255B1%25252C5-b%25255Dpyridazines%252Bvia%252BC%2525E2%252580%252593N%252Band%252BN%2525E2%252580%252593N%252Bbond-forming%252Bprocess%26aulast%3DMu%26aufirst%3DQiu-Chao%26date%3D2017%26date%3D2017%26volume%3D7%26issue%3D59%26spage%3D37208%26epage%3D37213" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Robert  Roskoski</span>. </span><span class="cited-content_cbyCitation_article-title">Janus kinase (JAK) inhibitors in the treatment of inflammatory and neoplastic diseases. </span><span class="cited-content_cbyCitation_journal-name">Pharmacological Research</span><span> <strong>2016,</strong> <em>111 </em>, 784-803. <a href="https://doi.org/10.1016/j.phrs.2016.07.038" title="DOI URL">https://doi.org/10.1016/j.phrs.2016.07.038</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.phrs.2016.07.038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.phrs.2016.07.038%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacological%2520Research%26atitle%3DJanus%252Bkinase%252B%252528JAK%252529%252Binhibitors%252Bin%252Bthe%252Btreatment%252Bof%252Binflammatory%252Band%252Bneoplastic%252Bdiseases%26aulast%3DRoskoski%26aufirst%3DRobert%26date%3D2016%26volume%3D111%26spage%3D784%26epage%3D803" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kyung Hwan  Oh</span>, <span class="hlFld-ContribAuthor ">Seong Min  Kim</span>, <span class="hlFld-ContribAuthor ">Mi Jung  Lee</span>, <span class="hlFld-ContribAuthor ">Jin Kyoon  Park</span>. </span><span class="cited-content_cbyCitation_article-title">Palladium-Catalyzed Direct Arylations of 1,2-Azolo[1,5-
              a
              ]pyridines using Copper(I) Chloride as a Lewis Acid Activator and the Synthesis of 2,6-Disubstituted Pyridines. </span><span class="cited-content_cbyCitation_journal-name">Advanced Synthesis & Catalysis</span><span> <strong>2015,</strong> <em>357 </em>
                                    (18)
                                     , 3927-3935. <a href="https://doi.org/10.1002/adsc.201500726" title="DOI URL">https://doi.org/10.1002/adsc.201500726</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adsc.201500726&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadsc.201500726%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Synthesis%2520%2526%2520Catalysis%26atitle%3DPalladium-Catalyzed%252BDirect%252BArylations%252Bof%252B1%25252C2-Azolo%25255B1%25252C5-%252Ba%252B%25255Dpyridines%252Busing%252BCopper%252528I%252529%252BChloride%252Bas%252Ba%252BLewis%252BAcid%252BActivator%252Band%252Bthe%252BSynthesis%252Bof%252B2%25252C6-Disubstituted%252BPyridines%26aulast%3DOh%26aufirst%3DKyung%2BHwan%26date%3D2015%26date%3D2015%26volume%3D357%26issue%3D18%26spage%3D3927%26epage%3D3935" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael  Friedman</span>, <span class="hlFld-ContribAuthor ">Kristine E.  Frank</span>, <span class="hlFld-ContribAuthor ">Ana  Aguirre</span>, <span class="hlFld-ContribAuthor ">Maria A.  Argiriadi</span>, <span class="hlFld-ContribAuthor ">Heather  Davis</span>, <span class="hlFld-ContribAuthor ">Jeremy J.  Edmunds</span>, <span class="hlFld-ContribAuthor ">Dawn M.  George</span>, <span class="hlFld-ContribAuthor ">Jonathan S.  George</span>, <span class="hlFld-ContribAuthor ">Eric  Goedken</span>, <span class="hlFld-ContribAuthor ">Bryan  Fiamengo</span>, <span class="hlFld-ContribAuthor ">Deborah  Hyland</span>, <span class="hlFld-ContribAuthor ">Bin  Li</span>, <span class="hlFld-ContribAuthor ">Anwar  Murtaza</span>, <span class="hlFld-ContribAuthor ">Michael  Morytko</span>, <span class="hlFld-ContribAuthor ">Gagandeep  Somal</span>, <span class="hlFld-ContribAuthor ">Kent  Stewart</span>, <span class="hlFld-ContribAuthor ">Edit  Tarcsa</span>, <span class="hlFld-ContribAuthor ">Stacy  Van Epps</span>, <span class="hlFld-ContribAuthor ">Jeffrey  Voss</span>, <span class="hlFld-ContribAuthor ">Lu  Wang</span>, <span class="hlFld-ContribAuthor ">Kevin  Woller</span>, <span class="hlFld-ContribAuthor ">Neil  Wishart</span>. </span><span class="cited-content_cbyCitation_article-title">Structure activity optimization of 6H-pyrrolo[2,3-e][1,2,4]triazolo[4,3-a]pyrazines as Jak1 kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>25 </em>
                                    (20)
                                     , 4399-4404. <a href="https://doi.org/10.1016/j.bmcl.2015.09.020" title="DOI URL">https://doi.org/10.1016/j.bmcl.2015.09.020</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2015.09.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2015.09.020%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DStructure%252Bactivity%252Boptimization%252Bof%252B6H-pyrrolo%25255B2%25252C3-e%25255D%25255B1%25252C2%25252C4%25255Dtriazolo%25255B4%25252C3-a%25255Dpyrazines%252Bas%252BJak1%252Bkinase%252Binhibitors%26aulast%3DFriedman%26aufirst%3DMichael%26date%3D2015%26volume%3D25%26issue%3D20%26spage%3D4399%26epage%3D4404" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm501262q/20141120/images/medium/jm-2014-01262q_0020.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm501262q/20141120/images/large/jm-2014-01262q_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501262q&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm501262q/20141120/images/medium/jm-2014-01262q_0024.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm501262q/20141120/images/large/jm-2014-01262q_0024.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Tofacitinib, <b>1</b>; ruxolitinib, <b>2</b>. *Biochemical IC<sub>50</sub> determination: recombinant JAK1 (Invitrogen), JAK2 (Carna Biosciences). The ATP concentration was equivalent to <i>K</i><sub>m</sub> value.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm501262q/20141120/images/large/jm-2014-01262q_0024.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501262q&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm501262q/20141120/images/medium/jm-2014-01262q_0025.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm501262q/20141120/images/large/jm-2014-01262q_0025.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Compound <b>3</b>, hit identified during our HTS. *LiPE (lipophilic efficiency) = pIC<sub>50</sub> – xlogP3.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm501262q/20141120/images/large/jm-2014-01262q_0025.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501262q&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm501262q/20141120/images/medium/jm-2014-01262q_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm501262q/20141120/images/large/jm-2014-01262q_0004.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of the Triazolo-pyridine Scaffold<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm501262q/20141120/images/large/jm-2014-01262q_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501262q&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(i) Ethoxycarbonyl isothiocyanate, DCM, RT; (ii) hydroxylamine hydrochloride, DIPEA, EtOH/MeOH, reflux.</p></p></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm501262q/20141120/images/medium/jm-2014-01262q_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm501262q/20141120/images/large/jm-2014-01262q_0005.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of the Triazolo-pyridine Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm501262q/20141120/images/large/jm-2014-01262q_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501262q&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(i) <i>para</i>-Methoxyphenyl boronic acid, Pd(dppf)Cl<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane/water, 100 °C; (ii) (a) acid chloride, Et<sub>3</sub>N, CH<sub>3</sub>CN, followed by NH<sub>3</sub> (7N) in MeOH, (b) 4-nitrophenyl chloroformate, DIPEA, methylamine, DCM, (c) aldehyde, Ti(O<i>i</i>Pr)<sub>4</sub>, Na(CN)BH<sub>3</sub>, EtOH;<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> (iii) HI (57% aqueous solution); NaNO<sub>2</sub>, DMSO; (iv) Pd(OAc)<sub>2</sub>, Cs<sub>2</sub>CO<sub>3</sub>, BINAP, aniline, 1,4-dioxane or toluene; (v) Pd(dppf)Cl<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, boronic acid, 1,4-dioxane; (vi) cyclopropanecarbonyl chloride, Et<sub>3</sub>N, CH<sub>3</sub>CN; (vii) <i>para</i>-methoxyphenyl boronic acid, Pd(dppf)Cl<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane/water, 100 °C.</p></p></figure><figure data-id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm501262q/20141120/images/medium/jm-2014-01262q_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm501262q/20141120/images/large/jm-2014-01262q_0006.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of the Compound <b>49</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm501262q/20141120/images/large/jm-2014-01262q_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501262q&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(i) ethoxycarbonyl isothiocyanate, DCM, RT; (ii) hydroxylamine hydrochloride, DIPEA, EtOH/MeOH, reflux; (iii) acid chloride, Et<sub>3</sub>N, CH<sub>3</sub>CN; (iv) <i>para</i>-ethoxyphenyl boronic acid, Pd(dppf)Cl<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane/water, 100 °C.</p></p></figure><figure data-id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm501262q/20141120/images/medium/jm-2014-01262q_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm501262q/20141120/images/large/jm-2014-01262q_0007.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Compound <b>51</b>, Triazolo-pyrimidine Scaffold<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm501262q/20141120/images/large/jm-2014-01262q_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501262q&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(i) <i>para</i>-Ethoxyphenyl boronic acid, Pd(dppf)Cl<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane/water, 100 °C; (ii) ethoxycarbonyl isothiocyanate, DCM, RT; (iii) hydroxylamine hydrochloride, DIPEA, EtOH/MeOH, reflux; (iv) acid chloride, Et<sub>3</sub>N, CH<sub>3</sub>CN</p></p></figure><figure data-id="sch5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm501262q/20141120/images/medium/jm-2014-01262q_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm501262q/20141120/images/large/jm-2014-01262q_0008.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of Compound <b>53</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm501262q/20141120/images/large/jm-2014-01262q_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501262q&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(i) 150 °C, MW (<i>W</i><sub>max</sub>, 300; <i>P</i><sub>max</sub>, 150 PSI); (ii) EtOH, 100 °C; (iii) acid chloride, Et<sub>3</sub>N, CH<sub>3</sub>CN</p></p></figure><figure data-id="fig3" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm501262q/20141120/images/medium/jm-2014-01262q_0026.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm501262q/20141120/images/large/jm-2014-01262q_0026.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (A) Model of compound <b>3</b> docked in the JAK1 JH1 kinase domain. (B) Model of compound <b>3</b> docked in the JAK1 JH1 kinase domain. Molecular surface and side chains of residues within 5 Å of compound <b>3</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm501262q/20141120/images/large/jm-2014-01262q_0026.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501262q&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm501262q/20141120/images/medium/jm-2014-01262q_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm501262q/20141120/images/large/jm-2014-01262q_0001.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (A) Crystal structure of JAK2 with compound <b>65</b>. (B) Detailed view of the X-ray crystal structure of compound <b>65</b> bound to the ATP-binding site of JAK2. Presumed hydrogen bonds involving compound <b>65</b> are represented as yellow lines with interatomic distances indicated in angstroms (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4P7E">4P7E</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm501262q/20141120/images/large/jm-2014-01262q_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501262q&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm501262q/20141120/images/medium/jm-2014-01262q_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm501262q/20141120/images/large/jm-2014-01262q_0002.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. CIA rat model.<a onclick="showRef(event, 'ref8 ref27'); return false;" href="javascript:void(0);" class="ref ref8 ref27">(8, 27)</a> Difference between the clinical score at day 0 and day 15 (meta-analysis of combined data obtained for the three studies after 15 d of treatment). E, etanercept; V, vehicle. 65 doses are indicated on the <i>x</i>-axis. The numbers of animals used to obtain a meta-analysis score for V, E, 0.1, 0.3, 1, 3, 10, and 30 mg/kg were 29, 10, 20, 20, 29, 20, 10, and 29, respectively. *<i>p</i>, 0.05; **<i>p</i>, 0.01; ***<i>p</i>, 0.001 versus vehicle, Student <i>t</i> test). Copyright 2013. The American Association of Immunologists, Inc.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm501262q/20141120/images/large/jm-2014-01262q_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501262q&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm501262q/20141120/images/medium/jm-2014-01262q_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm501262q/20141120/images/large/jm-2014-01262q_0003.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Steady state PK (day 9) of 65 in rat CIA. WBA IC<sub>50</sub> pSAT1/IL6 and GM_CSF/pSTAT5 are indicated.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm501262q/20141120/images/large/jm-2014-01262q_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501262q&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch6" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm501262q/20141120/images/medium/jm-2014-01262q_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm501262q/20141120/images/large/jm-2014-01262q_0009.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Structure of Compound <b>66</b>, Metabolite of Compound <b>65</b><a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm501262q/20141120/images/large/jm-2014-01262q_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501262q&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i84">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_21275" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_21275" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 29 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">O’Shea, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plenge, R.</span><span> </span><span class="NLM_article-title">JAK and STAT Signaling Molecules in Immunoregulation and Immune-Mediated Disease</span> <span class="citation_source-journal">Immunity</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">542</span><span class="NLM_x">–</span> <span class="NLM_lpage">550</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2012&pages=542-550&author=J.+J.+O%E2%80%99Sheaauthor=R.+Plenge&title=JAK+and+STAT+Signaling+Molecules+in+Immunoregulation+and+Immune-Mediated+Disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DJ.%2BJ.%26aulast%3DPlenge%26aufirst%3DR.%26atitle%3DJAK%2520and%2520STAT%2520Signaling%2520Molecules%2520in%2520Immunoregulation%2520and%2520Immune-Mediated%2520Disease%26jtitle%3DImmunity%26date%3D2012%26volume%3D36%26spage%3D542%26epage%3D550" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">West, K.</span><span> </span><span class="NLM_article-title">CP-690550, a JAK3 Inhibitor as an Immunosuppressant for the Treatment of Rheumatoid Arthritis, Transplant Rejection, Psoriasis and Other Immune-Mediated Disorders</span> <span class="citation_source-journal">Curr. Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">491</span><span class="NLM_x">–</span> <span class="NLM_lpage">504</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2009&pages=491-504&author=K.+West&title=CP-690550%2C+a+JAK3+Inhibitor+as+an+Immunosuppressant+for+the+Treatment+of+Rheumatoid+Arthritis%2C+Transplant+Rejection%2C+Psoriasis+and+Other+Immune-Mediated+Disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWest%26aufirst%3DK.%26atitle%3DCP-690550%252C%2520a%2520JAK3%2520Inhibitor%2520as%2520an%2520Immunosuppressant%2520for%2520the%2520Treatment%2520of%2520Rheumatoid%2520Arthritis%252C%2520Transplant%2520Rejection%252C%2520Psoriasis%2520and%2520Other%2520Immune-Mediated%2520Disorders%26jtitle%3DCurr.%2520Opin.%2520Invest.%2520Drugs%26date%3D2009%26volume%3D10%26spage%3D491%26epage%3D504" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Clark, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flanagan, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Telliez, J.-B.</span><span> </span><span class="NLM_article-title">Discovery and Development of Janus Kinase (JAK) Inhibitors for Inflammatory Diseases</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">5023</span><span class="NLM_x">–</span> <span class="NLM_lpage">5038</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm401490p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm501262q&amp;key=1%3ACAS%3A528%3ADC%252BC2cXotVCjsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=5023-5038&author=J.+D.+Clarkauthor=M.+E.+Flanaganauthor=J.-B.+Telliez&title=Discovery+and+Development+of+Janus+Kinase+%28JAK%29+Inhibitors+for+Inflammatory+Diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Development of Janus Kinase (JAK) Inhibitors for Inflammatory Diseases</span></div><div class="casAuthors">Clark, James D.; Flanagan, Mark E.; Telliez, Jean-Baptiste</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5023-5038</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The Janus kinases (JAKs) are a family of intracellular tyrosine kinases that play an essential role in the signaling of numerous cytokines that have been implicated in the pathogenesis of inflammatory diseases.  As a consequence, the JAKs have received significant attention in recent years from the pharmaceutical and biotechnol. industries as therapeutic targets.  Here, we provide a review of the JAK pathways, the structure, function, and activation of the JAK enzymes followed by a detailed look at the JAK inhibitors currently in the clinic or approved for these indications.  Finally, a perspective is provided on what the past decade of research with JAK inhibitors for inflammatory indications has taught along with thoughts on what the future may hold in terms of addressing the opportunities and challenges that remain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3f7W5g8N6brVg90H21EOLACvtfcHk0lhmvckCCcN9Eg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXotVCjsA%253D%253D&md5=6763ae2d46f52ddcda23e235a60634ae</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1021%2Fjm401490p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401490p%26sid%3Dliteratum%253Aachs%26aulast%3DClark%26aufirst%3DJ.%2BD.%26aulast%3DFlanagan%26aufirst%3DM.%2BE.%26aulast%3DTelliez%26aufirst%3DJ.-B.%26atitle%3DDiscovery%2520and%2520Development%2520of%2520Janus%2520Kinase%2520%2528JAK%2529%2520Inhibitors%2520for%2520Inflammatory%2520Diseases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D5023%26epage%3D5038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Rodig, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meraz, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lampe, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riley, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arthur, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheehan, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pennica, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, E. M.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreiber, R. D.</span><span> </span><span class="NLM_article-title">Disruption of the Jak1 Gene Demonstrates Obligatory and Nonredundant Roles of the Jaks in Cytokine-Induced Biologic Responses</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">93</span><span class="NLM_x">, </span> <span class="NLM_fpage">373</span><span class="NLM_x">–</span> <span class="NLM_lpage">383</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=1998&pages=373-383&author=S.+J.+Rodigauthor=M.+A.+Merazauthor=J.+M.+Whiteauthor=P.+A.+Lampeauthor=J.+K.+Rileyauthor=C.+D.+Arthurauthor=K.+L.+Kingauthor=K.+C.+Sheehanauthor=L.+Yinauthor=D.+Pennicaauthor=E.+M.+Johnsonauthor=R.+D.+Schreiber&title=Disruption+of+the+Jak1+Gene+Demonstrates+Obligatory+and+Nonredundant+Roles+of+the+Jaks+in+Cytokine-Induced+Biologic+Responses"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRodig%26aufirst%3DS.%2BJ.%26aulast%3DMeraz%26aufirst%3DM.%2BA.%26aulast%3DWhite%26aufirst%3DJ.%2BM.%26aulast%3DLampe%26aufirst%3DP.%2BA.%26aulast%3DRiley%26aufirst%3DJ.%2BK.%26aulast%3DArthur%26aufirst%3DC.%2BD.%26aulast%3DKing%26aufirst%3DK.%2BL.%26aulast%3DSheehan%26aufirst%3DK.%2BC.%26aulast%3DYin%26aufirst%3DL.%26aulast%3DPennica%26aufirst%3DD.%26aulast%3DJohnson%26aufirst%3DE.%2BM.%26aulast%3DSchreiber%26aufirst%3DR.%2BD.%26atitle%3DDisruption%2520of%2520the%2520Jak1%2520Gene%2520Demonstrates%2520Obligatory%2520and%2520Nonredundant%2520Roles%2520of%2520the%2520Jaks%2520in%2520Cytokine-Induced%2520Biologic%2520Responses%26jtitle%3DCell%26date%3D1998%26volume%3D93%26spage%3D373%26epage%3D383" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Shouda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanada, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wakioka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oishi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyoshi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Komiya, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kosai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanakawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashimoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagata, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshimura, A.</span><span> </span><span class="NLM_article-title">Induction of the Cytokine Signal Regulator SOCS3/CIS3 as a Therapeutic Strategy for Treating Inflammatory Arthritis</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">108</span><span class="NLM_x">, </span> <span class="NLM_fpage">1781</span><span class="NLM_x">–</span> <span class="NLM_lpage">1788</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2001&pages=1781-1788&author=T.+Shoudaauthor=T.+Yoshidaauthor=T.+Hanadaauthor=T.+Wakiokaauthor=M.+Oishiauthor=K.+Miyoshiauthor=S.+Komiyaauthor=K.+Kosaiauthor=Y.+Hanakawaauthor=K.+Hashimotoauthor=K.+Nagataauthor=A.+Yoshimura&title=Induction+of+the+Cytokine+Signal+Regulator+SOCS3%2FCIS3+as+a+Therapeutic+Strategy+for+Treating+Inflammatory+Arthritis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShouda%26aufirst%3DT.%26aulast%3DYoshida%26aufirst%3DT.%26aulast%3DHanada%26aufirst%3DT.%26aulast%3DWakioka%26aufirst%3DT.%26aulast%3DOishi%26aufirst%3DM.%26aulast%3DMiyoshi%26aufirst%3DK.%26aulast%3DKomiya%26aufirst%3DS.%26aulast%3DKosai%26aufirst%3DK.%26aulast%3DHanakawa%26aufirst%3DY.%26aulast%3DHashimoto%26aufirst%3DK.%26aulast%3DNagata%26aufirst%3DK.%26aulast%3DYoshimura%26aufirst%3DA.%26atitle%3DInduction%2520of%2520the%2520Cytokine%2520Signal%2520Regulator%2520SOCS3%252FCIS3%2520as%2520a%2520Therapeutic%2520Strategy%2520for%2520Treating%2520Inflammatory%2520Arthritis%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2001%26volume%3D108%26spage%3D1781%26epage%3D1788" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Haan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rolvering, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raulf, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapp, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drückes, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thoma, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behrmann, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zerwes, H.-G.</span><span> </span><span class="NLM_article-title">Jak1 Has a Dominant Role over Jak3 in Signal Transduction through Γc-Containing Cytokine Receptors</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">314</span><span class="NLM_x">–</span> <span class="NLM_lpage">323</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm501262q&amp;key=10.1016%2Fj.chembiol.2011.01.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm501262q&amp;key=21439476" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm501262q&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjvFSrtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=314-323&author=C.+Haanauthor=C.+Rolveringauthor=F.+Raulfauthor=M.+Kappauthor=P.+Dr%C3%BCckesauthor=G.+Thomaauthor=I.+Behrmannauthor=H.-G.+Zerwes&title=Jak1+Has+a+Dominant+Role+over+Jak3+in+Signal+Transduction+through+%CE%93c-Containing+Cytokine+Receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Jak1 Has a Dominant Role over Jak3 in Signal Transduction through γc-Containing Cytokine Receptors</span></div><div class="casAuthors">Haan, Claude; Rolvering, Catherine; Raulf, Friedrich; Kapp, Manuela; Drueckes, Peter; Thoma, Gebhard; Behrmann, Iris; Zerwes, Hans-Guenter</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">314-323</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: Genetic deficiency of Jak3 leads to abrogation of signal transduction through the common gamma chain (γc) and thus to immunodeficiency suggesting that specific inhibition of Jak3 kinase may result in immunosuppression.  Jak1 cooperates with Jak3 in signaling through γc-contg. receptors.  Unexpectedly, a Jak3-selective inhibitor was less efficient in abolishing STAT5 phosphorylation than pan-Jak inhibitors.  We therefore explored the roles of Jak1 and Jak3 kinase functionality in signaling using a reconstituted system.  The presence of kinase-inactive Jak1 but not kinase-inactive Jak3 resulted in complete abolishment of STAT5 phosphorylation.  Specific inhibition of the "analog-sensitive" mutant AS-Jak1 but not AS-Jak3 by the ATP-competitive analog 1NM-PP1 abrogated IL-2 signaling, corroborating the data with the selective Jak3 inhibitor.  Jak1 thus plays a dominant role over Jak3 and these data challenge the notion that selective ATP-competitive Jak3 kinase inhibitors will be effective.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUv04vX29Zk7Vg90H21EOLACvtfcHk0ljWPKzc0OppzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjvFSrtrw%253D&md5=0109f316cfe0bee40f80a79f244e6ba5</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2011.01.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2011.01.012%26sid%3Dliteratum%253Aachs%26aulast%3DHaan%26aufirst%3DC.%26aulast%3DRolvering%26aufirst%3DC.%26aulast%3DRaulf%26aufirst%3DF.%26aulast%3DKapp%26aufirst%3DM.%26aulast%3DDr%25C3%25BCckes%26aufirst%3DP.%26aulast%3DThoma%26aufirst%3DG.%26aulast%3DBehrmann%26aufirst%3DI.%26aulast%3DZerwes%26aufirst%3DH.-G.%26atitle%3DJak1%2520Has%2520a%2520Dominant%2520Role%2520over%2520Jak3%2520in%2520Signal%2520Transduction%2520through%2520%25CE%2593c-Containing%2520Cytokine%2520Receptors%26jtitle%3DChem.%2520Biol.%26date%3D2011%26volume%3D18%26spage%3D314%26epage%3D323" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Ghoreschi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jesson, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghosh, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alsup, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warner, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steward-Tharp, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gadina, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minnerly, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Storer, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaBranche, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radi, Z. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dowty, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Head, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kishore, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Shea, J. J.</span><span> </span><span class="NLM_article-title">Modulation of Innate and Adaptive Immune Responses by Tofacitinib (CP-690,550)</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">186</span><span class="NLM_x">, </span> <span class="NLM_fpage">4234</span><span class="NLM_x">–</span> <span class="NLM_lpage">4243</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=186&publication_year=2011&pages=4234-4243&author=K.+Ghoreschiauthor=M.+I.+Jessonauthor=X.+Liauthor=J.+L.+Leeauthor=S.+Ghoshauthor=J.+W.+Alsupauthor=J.+D.+Warnerauthor=M.+Tanakaauthor=S.+M.+Steward-Tharpauthor=M.+Gadinaauthor=C.+J.+Thomasauthor=J.+C.+Minnerlyauthor=C.+E.+Storerauthor=T.+P.+LaBrancheauthor=Z.+A.+Radiauthor=M.+E.+Dowtyauthor=R.+D.+Headauthor=D.+M.+Meyerauthor=N.+Kishoreauthor=J.+J.+O%E2%80%99Shea&title=Modulation+of+Innate+and+Adaptive+Immune+Responses+by+Tofacitinib+%28CP-690%2C550%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGhoreschi%26aufirst%3DK.%26aulast%3DJesson%26aufirst%3DM.%2BI.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DLee%26aufirst%3DJ.%2BL.%26aulast%3DGhosh%26aufirst%3DS.%26aulast%3DAlsup%26aufirst%3DJ.%2BW.%26aulast%3DWarner%26aufirst%3DJ.%2BD.%26aulast%3DTanaka%26aufirst%3DM.%26aulast%3DSteward-Tharp%26aufirst%3DS.%2BM.%26aulast%3DGadina%26aufirst%3DM.%26aulast%3DThomas%26aufirst%3DC.%2BJ.%26aulast%3DMinnerly%26aufirst%3DJ.%2BC.%26aulast%3DStorer%26aufirst%3DC.%2BE.%26aulast%3DLaBranche%26aufirst%3DT.%2BP.%26aulast%3DRadi%26aufirst%3DZ.%2BA.%26aulast%3DDowty%26aufirst%3DM.%2BE.%26aulast%3DHead%26aufirst%3DR.%2BD.%26aulast%3DMeyer%26aufirst%3DD.%2BM.%26aulast%3DKishore%26aufirst%3DN.%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DJ.%2BJ.%26atitle%3DModulation%2520of%2520Innate%2520and%2520Adaptive%2520Immune%2520Responses%2520by%2520Tofacitinib%2520%2528CP-690%252C550%2529%26jtitle%3DJ.%2520Immunol.%26date%3D2011%26volume%3D186%26spage%3D4234%26epage%3D4243" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Van Rompaey, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galien, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Aar, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clement-Lacroix, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelles, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smets, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lepescheux, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christophe, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conrath, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vandeghinste, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vayssiere, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Vos, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fletcher, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brys, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van ’t Klooster, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feyen, J. H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menet, C.</span><span> </span><span class="NLM_article-title">Preclinical Characterization of GLPG0634, a Selective Inhibitor of JAK1, for the Treatment of Inflammatory Diseases</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">191</span><span class="NLM_x">, </span> <span class="NLM_fpage">3568</span><span class="NLM_x">–</span> <span class="NLM_lpage">3577</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=191&publication_year=2013&pages=3568-3577&author=L.+Van+Rompaeyauthor=R.+Galienauthor=E.+M.+van+der+Aarauthor=P.+Clement-Lacroixauthor=L.+Nellesauthor=B.+Smetsauthor=L.+Lepescheuxauthor=T.+Christopheauthor=K.+Conrathauthor=N.+Vandeghinsteauthor=B.+Vayssiereauthor=S.+De+Vosauthor=S.+Fletcherauthor=R.+Brysauthor=G.+van+%E2%80%99t+Kloosterauthor=J.+H.+M.+Feyenauthor=C.+Menet&title=Preclinical+Characterization+of+GLPG0634%2C+a+Selective+Inhibitor+of+JAK1%2C+for+the+Treatment+of+Inflammatory+Diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BRompaey%26aufirst%3DL.%26aulast%3DGalien%26aufirst%3DR.%26aulast%3Dvan%2Bder%2BAar%26aufirst%3DE.%2BM.%26aulast%3DClement-Lacroix%26aufirst%3DP.%26aulast%3DNelles%26aufirst%3DL.%26aulast%3DSmets%26aufirst%3DB.%26aulast%3DLepescheux%26aufirst%3DL.%26aulast%3DChristophe%26aufirst%3DT.%26aulast%3DConrath%26aufirst%3DK.%26aulast%3DVandeghinste%26aufirst%3DN.%26aulast%3DVayssiere%26aufirst%3DB.%26aulast%3DDe%2BVos%26aufirst%3DS.%26aulast%3DFletcher%26aufirst%3DS.%26aulast%3DBrys%26aufirst%3DR.%26aulast%3Dvan%2B%25E2%2580%2599t%2BKlooster%26aufirst%3DG.%26aulast%3DFeyen%26aufirst%3DJ.%2BH.%2BM.%26aulast%3DMenet%26aufirst%3DC.%26atitle%3DPreclinical%2520Characterization%2520of%2520GLPG0634%252C%2520a%2520Selective%2520Inhibitor%2520of%2520JAK1%252C%2520for%2520the%2520Treatment%2520of%2520Inflammatory%2520Diseases%26jtitle%3DJ.%2520Immunol.%26date%3D2013%26volume%3D191%26spage%3D3568%26epage%3D3577" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Shimoda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aoki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyamoto, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shibamori, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamashita, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Numata, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takase, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shibata, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asano, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gondo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sekiguchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakayama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakayama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niho, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakayama, K.</span><span> </span><span class="NLM_article-title">Tyk2 Plays a Restricted Role in IFN Alpha Signaling, Although It Is Required for IL-12-Mediated T Cell Function</span> <span class="citation_source-journal">Immunity</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">561</span><span class="NLM_x">–</span> <span class="NLM_lpage">571</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2000&pages=561-571&author=K.+Shimodaauthor=K.+Katoauthor=K.+Aokiauthor=T.+Matsudaauthor=A.+Miyamotoauthor=M.+Shibamoriauthor=M.+Yamashitaauthor=A.+Numataauthor=K.+Takaseauthor=S.+Kobayashiauthor=S.+Shibataauthor=Y.+Asanoauthor=H.+Gondoauthor=K.+Sekiguchiauthor=K.+Nakayamaauthor=T.+Nakayamaauthor=T.+Okamuraauthor=S.+Okamuraauthor=Y.+Nihoauthor=K.+Nakayama&title=Tyk2+Plays+a+Restricted+Role+in+IFN+Alpha+Signaling%2C+Although+It+Is+Required+for+IL-12-Mediated+T+Cell+Function"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShimoda%26aufirst%3DK.%26aulast%3DKato%26aufirst%3DK.%26aulast%3DAoki%26aufirst%3DK.%26aulast%3DMatsuda%26aufirst%3DT.%26aulast%3DMiyamoto%26aufirst%3DA.%26aulast%3DShibamori%26aufirst%3DM.%26aulast%3DYamashita%26aufirst%3DM.%26aulast%3DNumata%26aufirst%3DA.%26aulast%3DTakase%26aufirst%3DK.%26aulast%3DKobayashi%26aufirst%3DS.%26aulast%3DShibata%26aufirst%3DS.%26aulast%3DAsano%26aufirst%3DY.%26aulast%3DGondo%26aufirst%3DH.%26aulast%3DSekiguchi%26aufirst%3DK.%26aulast%3DNakayama%26aufirst%3DK.%26aulast%3DNakayama%26aufirst%3DT.%26aulast%3DOkamura%26aufirst%3DT.%26aulast%3DOkamura%26aufirst%3DS.%26aulast%3DNiho%26aufirst%3DY.%26aulast%3DNakayama%26aufirst%3DK.%26atitle%3DTyk2%2520Plays%2520a%2520Restricted%2520Role%2520in%2520IFN%2520Alpha%2520Signaling%252C%2520Although%2520It%2520Is%2520Required%2520for%2520IL-12-Mediated%2520T%2520Cell%2520Function%26jtitle%3DImmunity%26date%3D2000%26volume%3D13%26spage%3D561%26epage%3D571" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Parganas, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stravopodis, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Topham, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marine, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teglund, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanin, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bodner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colamonici, O. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Deursen, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grosveld, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ihle, J. N.</span><span> </span><span class="NLM_article-title">Jak2 Is Essential for Signaling through a Variety of Cytokine Receptors</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">93</span><span class="NLM_x">, </span> <span class="NLM_fpage">385</span><span class="NLM_x">–</span> <span class="NLM_lpage">395</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=1998&pages=385-395&author=E.+Parganasauthor=D.+Wangauthor=D.+Stravopodisauthor=D.+J.+Tophamauthor=J.+C.+Marineauthor=S.+Teglundauthor=E.+F.+Vaninauthor=S.+Bodnerauthor=O.+R.+Colamoniciauthor=J.+M.+van+Deursenauthor=G.+Grosveldauthor=J.+N.+Ihle&title=Jak2+Is+Essential+for+Signaling+through+a+Variety+of+Cytokine+Receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DParganas%26aufirst%3DE.%26aulast%3DWang%26aufirst%3DD.%26aulast%3DStravopodis%26aufirst%3DD.%26aulast%3DTopham%26aufirst%3DD.%2BJ.%26aulast%3DMarine%26aufirst%3DJ.%2BC.%26aulast%3DTeglund%26aufirst%3DS.%26aulast%3DVanin%26aufirst%3DE.%2BF.%26aulast%3DBodner%26aufirst%3DS.%26aulast%3DColamonici%26aufirst%3DO.%2BR.%26aulast%3Dvan%2BDeursen%26aufirst%3DJ.%2BM.%26aulast%3DGrosveld%26aufirst%3DG.%26aulast%3DIhle%26aufirst%3DJ.%2BN.%26atitle%3DJak2%2520Is%2520Essential%2520for%2520Signaling%2520through%2520a%2520Variety%2520of%2520Cytokine%2520Receptors%26jtitle%3DCell%26date%3D1998%26volume%3D93%26spage%3D385%26epage%3D395" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Sohn, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrett, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Abbema, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohli, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanda, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macleod, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurley, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kulagowski, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewin-Koh, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dengler, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghilardi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blair, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magnuson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, L. C.</span><span> </span><span class="NLM_article-title">A Restricted Role for TYK2 Catalytic Activity in Human Cytokine Responses Revealed by Novel TYK2-Selective Inhibitors</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">191</span><span class="NLM_x">, </span> <span class="NLM_fpage">2205</span><span class="NLM_x">–</span> <span class="NLM_lpage">2216</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=191&publication_year=2013&pages=2205-2216&author=S.+J.+Sohnauthor=K.+Barrettauthor=A.+Van+Abbemaauthor=C.+Changauthor=P.+B.+Kohliauthor=H.+Kandaauthor=J.+Smithauthor=Y.+Laiauthor=A.+Zhouauthor=B.+Zhangauthor=W.+Yangauthor=K.+Williamsauthor=C.+Macleodauthor=C.+A.+Hurleyauthor=J.+J.+Kulagowskiauthor=N.+Lewin-Kohauthor=H.+S.+Denglerauthor=A.+R.+Johnsonauthor=N.+Ghilardiauthor=M.+Zakauthor=J.+Liangauthor=W.+S.+Blairauthor=S.+Magnusonauthor=L.+C.+Wu&title=A+Restricted+Role+for+TYK2+Catalytic+Activity+in+Human+Cytokine+Responses+Revealed+by+Novel+TYK2-Selective+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSohn%26aufirst%3DS.%2BJ.%26aulast%3DBarrett%26aufirst%3DK.%26aulast%3DVan%2BAbbema%26aufirst%3DA.%26aulast%3DChang%26aufirst%3DC.%26aulast%3DKohli%26aufirst%3DP.%2BB.%26aulast%3DKanda%26aufirst%3DH.%26aulast%3DSmith%26aufirst%3DJ.%26aulast%3DLai%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DB.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DWilliams%26aufirst%3DK.%26aulast%3DMacleod%26aufirst%3DC.%26aulast%3DHurley%26aufirst%3DC.%2BA.%26aulast%3DKulagowski%26aufirst%3DJ.%2BJ.%26aulast%3DLewin-Koh%26aufirst%3DN.%26aulast%3DDengler%26aufirst%3DH.%2BS.%26aulast%3DJohnson%26aufirst%3DA.%2BR.%26aulast%3DGhilardi%26aufirst%3DN.%26aulast%3DZak%26aufirst%3DM.%26aulast%3DLiang%26aufirst%3DJ.%26aulast%3DBlair%26aufirst%3DW.%2BS.%26aulast%3DMagnuson%26aufirst%3DS.%26aulast%3DWu%26aufirst%3DL.%2BC.%26atitle%3DA%2520Restricted%2520Role%2520for%2520TYK2%2520Catalytic%2520Activity%2520in%2520Human%2520Cytokine%2520Responses%2520Revealed%2520by%2520Novel%2520TYK2-Selective%2520Inhibitors%26jtitle%3DJ.%2520Immunol.%26date%3D2013%26volume%3D191%26spage%3D2205%26epage%3D2216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Kremer, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bloom, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breedveld, F. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coombs, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fletcher, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gruben, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krishnaswami, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgos-Vargas, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilkinson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zerbini, C. A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zwillich, S. H.</span><span> </span><span class="NLM_article-title">The Safety and Efficacy of a JAK Inhibitor in Patients with Active Rheumatoid Arthritis: Results of a Double-Blind, Placebo-Controlled Phase IIa Trial of Three Dosage Levels of CP-690,550 versus Placebo</span> <span class="citation_source-journal">Arthritis Rheum.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">1895</span><span class="NLM_x">–</span> <span class="NLM_lpage">1905</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm501262q&amp;key=10.1002%2Fart.24567" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm501262q&amp;key=19565475" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm501262q&amp;key=1%3ACAS%3A528%3ADC%252BD1MXptlKktLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2009&pages=1895-1905&author=J.+M.+Kremerauthor=B.+J.+Bloomauthor=F.+C.+Breedveldauthor=J.+H.+Coombsauthor=M.+P.+Fletcherauthor=D.+Grubenauthor=S.+Krishnaswamiauthor=R.+Burgos-Vargasauthor=B.+Wilkinsonauthor=C.+A.+F.+Zerbiniauthor=S.+H.+Zwillich&title=The+Safety+and+Efficacy+of+a+JAK+Inhibitor+in+Patients+with+Active+Rheumatoid+Arthritis%3A+Results+of+a+Double-Blind%2C+Placebo-Controlled+Phase+IIa+Trial+of+Three+Dosage+Levels+of+CP-690%2C550+versus+Placebo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">The safety and efficacy of a JAK inhibitor in patients with active rheumatoid arthritis: results of a double-blind, placebo-controlled phase IIa trial of three dosage levels of CP-690,550 versus placebo</span></div><div class="casAuthors">Kremer, Joel M.; Bloom, Bradley J.; Breedveld, Ferdinand C.; Coombs, John H.; Fletcher, Mark P.; Gruben, David; Krishnaswami, Sriram; Burgos-Vargas, Ruben; Wilkinson, Bethanie; Zerbini, Cristiano A. F.; Zwillich, Samuel H.</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis & Rheumatism</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1895-1905</span>CODEN:
                <span class="NLM_cas:coden">ARHEAW</span>;
        ISSN:<span class="NLM_cas:issn">0004-3591</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">To det. the efficacy, safety, and tolerability of 3 different dosages of CP-690,550, a potent, orally active JAK inhibitor, in patients with active rheumatoid arthritis (RA) in whom methotrexate, etanercept, infliximab, or adalimumab caused an inadequate or toxic response.  Patients (n = 264) were randomized equally to receive placebo, 5 mg of CP-690,550,15 mg of CP-690,550, or 30 mg of CP-690,550 twice daily for 6 wk, and were followed up for an addnl. 6 wk after treatment.  The primary efficacy end point was the American College of Rheumatol. 20% improvement criteria (ACR20) response rate at 6 wk.  By week 6, the ACR20 response rates were 70.5%, 81.2%, and 76.8% in the 5 mg, 15 mg, and 30 mg twice daily groups, resp., compared with 29.2% in the placebo group (P < 0.001).  Improvements in disease activity in CP-690,550-treated patients compared with placebo were seen in all treatment groups as early as week 1.  ACR50 and ACR70 response rates significantly improved in all treatment groups by week 4.  The most common adverse events reported were headache and nausea.  The infection rate in both the 15 mg twice daily group and the 30 mg twice daily group was 30.4% (vs. 26.2% in the placebo group).  No opportunistic infections or deaths occurred.  Increases in mean low-d. lipoprotein cholesterol and high-d. lipoprotein cholesterol levels, and increases in mean serum creatinine level (0.04-0.06 mg/dL) were seen in all CP-690,550 treatment arms.  Our findings indicate that CP-690,550 is efficacious in the treatment of RA, resulting in rapid, statistically significant, and clin. meaningful redns. in the signs and symptoms of RA.  Further studies of CP-690,550 in RA are warranted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBhxBhh_mG7rVg90H21EOLACvtfcHk0lgqXHjH5NVH4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXptlKktLg%253D&md5=ab5fb34e43d8643871560c67bbbca07d</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1002%2Fart.24567&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.24567%26sid%3Dliteratum%253Aachs%26aulast%3DKremer%26aufirst%3DJ.%2BM.%26aulast%3DBloom%26aufirst%3DB.%2BJ.%26aulast%3DBreedveld%26aufirst%3DF.%2BC.%26aulast%3DCoombs%26aufirst%3DJ.%2BH.%26aulast%3DFletcher%26aufirst%3DM.%2BP.%26aulast%3DGruben%26aufirst%3DD.%26aulast%3DKrishnaswami%26aufirst%3DS.%26aulast%3DBurgos-Vargas%26aufirst%3DR.%26aulast%3DWilkinson%26aufirst%3DB.%26aulast%3DZerbini%26aufirst%3DC.%2BA.%2BF.%26aulast%3DZwillich%26aufirst%3DS.%2BH.%26atitle%3DThe%2520Safety%2520and%2520Efficacy%2520of%2520a%2520JAK%2520Inhibitor%2520in%2520Patients%2520with%2520Active%2520Rheumatoid%2520Arthritis%253A%2520Results%2520of%2520a%2520Double-Blind%252C%2520Placebo-Controlled%2520Phase%2520IIa%2520Trial%2520of%2520Three%2520Dosage%2520Levels%2520of%2520CP-690%252C550%2520versus%2520Placebo%26jtitle%3DArthritis%2520Rheum.%26date%3D2009%26volume%3D60%26spage%3D1895%26epage%3D1905" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Tefferi, A.</span><span> </span><span class="NLM_article-title">JAK Inhibitors for Myeloproliferative Neoplasms: Clarifying Facts from Myths</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">119</span><span class="NLM_x">, </span> <span class="NLM_fpage">2721</span><span class="NLM_x">–</span> <span class="NLM_lpage">2730</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2012&pages=2721-2730&author=A.+Tefferi&title=JAK+Inhibitors+for+Myeloproliferative+Neoplasms%3A+Clarifying+Facts+from+Myths"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTefferi%26aufirst%3DA.%26atitle%3DJAK%2520Inhibitors%2520for%2520Myeloproliferative%2520Neoplasms%253A%2520Clarifying%2520Facts%2520from%2520Myths%26jtitle%3DBlood%26date%3D2012%26volume%3D119%26spage%3D2721%26epage%3D2730" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Park, S. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wamsley, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bae, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choe, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slayton, W. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oh, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, K.-U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sayeski, P. P.</span><span> </span><span class="NLM_article-title">Conditional Deletion of Jak2 Reveals an Essential Role in Hematopoiesis throughout Mouse Ontogeny: Implications for Jak2 Inhibition in Humans</span> <span class="citation_source-journal">PloS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">e59675</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e59675&author=S.+O.+Parkauthor=H.+L.+Wamsleyauthor=K.+Baeauthor=Z.+Huauthor=X.+Liauthor=S.+Choeauthor=W.+B.+Slaytonauthor=S.+P.+Ohauthor=K.-U.+Wagnerauthor=P.+P.+Sayeski&title=Conditional+Deletion+of+Jak2+Reveals+an+Essential+Role+in+Hematopoiesis+throughout+Mouse+Ontogeny%3A+Implications+for+Jak2+Inhibition+in+Humans"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DS.%2BO.%26aulast%3DWamsley%26aufirst%3DH.%2BL.%26aulast%3DBae%26aufirst%3DK.%26aulast%3DHu%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DChoe%26aufirst%3DS.%26aulast%3DSlayton%26aufirst%3DW.%2BB.%26aulast%3DOh%26aufirst%3DS.%2BP.%26aulast%3DWagner%26aufirst%3DK.-U.%26aulast%3DSayeski%26aufirst%3DP.%2BP.%26atitle%3DConditional%2520Deletion%2520of%2520Jak2%2520Reveals%2520an%2520Essential%2520Role%2520in%2520Hematopoiesis%2520throughout%2520Mouse%2520Ontogeny%253A%2520Implications%2520for%2520Jak2%2520Inhibition%2520in%2520Humans%26jtitle%3DPloS%2520One%26date%3D2013%26volume%3D8%26spage%3De59675" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">O’Shea, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holland, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staudt, L. M.</span><span> </span><span class="NLM_article-title">JAKs and STATs in Immunity, Immunodeficiency, and Cancer</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">368</span><span class="NLM_x">, </span> <span class="NLM_fpage">161</span><span class="NLM_x">–</span> <span class="NLM_lpage">170</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm501262q&amp;key=10.1056%2FNEJMra1202117" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm501262q&amp;key=23301733" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm501262q&amp;key=1%3ACAS%3A528%3ADC%252BC3sXovVyhuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=368&publication_year=2013&pages=161-170&author=J.+J.+O%E2%80%99Sheaauthor=S.+M.+Hollandauthor=L.+M.+Staudt&title=JAKs+and+STATs+in+Immunity%2C+Immunodeficiency%2C+and+Cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">JAKs and STATs in immunity, immunodeficiency, and cancer</span></div><div class="casAuthors">O'Shea, John J.; Holland, Steven M.; Staudt, Louis M.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">368</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">161-170</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">A review highlights interferon-mediated gene regulation has resulted in a new framework for the study of cell signaling and JAKs STATs in immunity, immunodeficiency, and cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqk1n-UgWrlWrVg90H21EOLACvtfcHk0liL_gnWLcKU0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXovVyhuw%253D%253D&md5=5d87b67f72b721eb0ca9413adf92a7b9</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1056%2FNEJMra1202117&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMra1202117%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DJ.%2BJ.%26aulast%3DHolland%26aufirst%3DS.%2BM.%26aulast%3DStaudt%26aufirst%3DL.%2BM.%26atitle%3DJAKs%2520and%2520STATs%2520in%2520Immunity%252C%2520Immunodeficiency%252C%2520and%2520Cancer%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2013%26volume%3D368%26spage%3D161%26epage%3D170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Cheng, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, L.</span><span> </span><span class="NLM_article-title">Computation of Octanol–Water Partition Coefficients by Guiding an Additive Model with Knowledge</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">2140</span><span class="NLM_x">–</span> <span class="NLM_lpage">2148</span></span><div class="citationLinks">[<a href="/doi/10.1021/ci700257y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm501262q&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1KisbvF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2007&pages=2140-2148&author=T.+Chengauthor=Y.+Zhaoauthor=X.+Liauthor=F.+Linauthor=Y.+Xuauthor=X.+Zhangauthor=Y.+Liauthor=R.+Wangauthor=L.+Lai&title=Computation+of+Octanol%E2%80%93Water+Partition+Coefficients+by+Guiding+an+Additive+Model+with+Knowledge"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Computation of Octanol-Water Partition Coefficients by Guiding an Additive Model with Knowledge</span></div><div class="casAuthors">Cheng, Tiejun; Zhao, Yuan; Li, Xun; Lin, Fu; Xu, Yong; Zhang, Xinglong; Li, Yan; Wang, Renxiao; Lai, Luhua</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2140-2148</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We have developed a new method, i.e., XLOGP3, for logP computation.  XLOGP3 predicts the logP value of a query compd. by using the known logP value of a ref. compd. as a starting point.  The difference in the logP values of the query compd. and the ref. compd. is then estd. by an additive model.  The additive model implemented in XLOGP3 uses a total of 87 atom/group types and two correction factors as descriptors.  It is calibrated on a training set of 8199 org. compds. with reliable logP data through a multivariate linear regression anal.  For a given query compd., the compd. showing the highest structural similarity in the training set will be selected as the ref. compd.  Structural similarity is quantified based on topol. torsion descriptors.  XLOGP3 has been tested along with its predecessor, i.e., XLOGP2, as well as several popular logP methods on two independent test sets: one contains 406 small-mol. drugs approved by the FDA and the other contains 219 oligopeptides.  On both test sets, XLOGP3 produces more accurate predictions than most of the other methods with av. unsigned errors of 0.24-0.51 units.  Compared to conventional additive methods, XLOGP3 does not rely on an extensive classification of fragments and correction factors in order to improve accuracy.  It is also able to utilize the ever-increasing exptl. measured logP data more effectively.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUq0p6A6frurVg90H21EOLACvtfcHk0li1TplvOJqMQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1KisbvF&md5=492b857ffa462283dace225c7dcb9ad5</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fci700257y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci700257y%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DT.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DLin%26aufirst%3DF.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DR.%26aulast%3DLai%26aufirst%3DL.%26atitle%3DComputation%2520of%2520Octanol%25E2%2580%2593Water%2520Partition%2520Coefficients%2520by%2520Guiding%2520an%2520Additive%2520Model%2520with%2520Knowledge%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2007%26volume%3D47%26spage%3D2140%26epage%3D2148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Siu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pastor, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrett, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berry, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blair, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eigenbrot, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghilardi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbons, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurley, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenny, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cyrus Khojasteh, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyssikatos, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magnuson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pulk, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsui, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ultsch, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sampath, D.</span><span> </span><span class="NLM_article-title">2-Amino-[1,2,4]triazolo[1,5-<i>a</i>]pyridines as JAK2 Inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">5014</span><span class="NLM_x">–</span> <span class="NLM_lpage">5021</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=5014-5021&author=M.+Siuauthor=R.+Pastorauthor=W.+Liuauthor=K.+Barrettauthor=M.+Berryauthor=W.+S.+Blairauthor=C.+Changauthor=J.+Z.+Chenauthor=C.+Eigenbrotauthor=N.+Ghilardiauthor=P.+Gibbonsauthor=H.+Heauthor=C.+A.+Hurleyauthor=J.+R.+Kennyauthor=S.+Cyrus+Khojastehauthor=H.+Leauthor=L.+Leeauthor=J.+P.+Lyssikatosauthor=S.+Magnusonauthor=R.+Pulkauthor=V.+Tsuiauthor=M.+Ultschauthor=Y.+Xiaoauthor=B.+Zhuauthor=D.+Sampath&title=2-Amino-%5B1%2C2%2C4%5Dtriazolo%5B1%2C5-a%5Dpyridines+as+JAK2+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSiu%26aufirst%3DM.%26aulast%3DPastor%26aufirst%3DR.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DBarrett%26aufirst%3DK.%26aulast%3DBerry%26aufirst%3DM.%26aulast%3DBlair%26aufirst%3DW.%2BS.%26aulast%3DChang%26aufirst%3DC.%26aulast%3DChen%26aufirst%3DJ.%2BZ.%26aulast%3DEigenbrot%26aufirst%3DC.%26aulast%3DGhilardi%26aufirst%3DN.%26aulast%3DGibbons%26aufirst%3DP.%26aulast%3DHe%26aufirst%3DH.%26aulast%3DHurley%26aufirst%3DC.%2BA.%26aulast%3DKenny%26aufirst%3DJ.%2BR.%26aulast%3DCyrus%2BKhojasteh%26aufirst%3DS.%26aulast%3DLe%26aufirst%3DH.%26aulast%3DLee%26aufirst%3DL.%26aulast%3DLyssikatos%26aufirst%3DJ.%2BP.%26aulast%3DMagnuson%26aufirst%3DS.%26aulast%3DPulk%26aufirst%3DR.%26aulast%3DTsui%26aufirst%3DV.%26aulast%3DUltsch%26aufirst%3DM.%26aulast%3DXiao%26aufirst%3DY.%26aulast%3DZhu%26aufirst%3DB.%26aulast%3DSampath%26aufirst%3DD.%26atitle%3D2-Amino-%255B1%252C2%252C4%255Dtriazolo%255B1%252C5-a%255Dpyridines%2520as%2520JAK2%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D5014%26epage%3D5021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Nettekoven, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Püllmann, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmitt, S.</span><span> </span><span class="NLM_article-title">Synthetic Access to 2-Amido-5-aryl-8-methoxy-triazolopyridine and 2-Amido-5-morpholino-8-methoxy-triazolopyridine Derivatives as Potential Inhibitors of the Adenosine Receptor Subtypes</span> <span class="citation_source-journal">Synthesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">2003</span><span class="NLM_x">, </span> <span class="NLM_fpage">1649</span><span class="NLM_x">–</span> <span class="NLM_lpage">1652</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm501262q&amp;key=10.1055%2Fs-2003-40874" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2003&publication_year=2003&pages=1649-1652&author=M.+Nettekovenauthor=B.+P%C3%BCllmannauthor=S.+Schmitt&title=Synthetic+Access+to+2-Amido-5-aryl-8-methoxy-triazolopyridine+and+2-Amido-5-morpholino-8-methoxy-triazolopyridine+Derivatives+as+Potential+Inhibitors+of+the+Adenosine+Receptor+Subtypes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1055%2Fs-2003-40874&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-2003-40874%26sid%3Dliteratum%253Aachs%26aulast%3DNettekoven%26aufirst%3DM.%26aulast%3DP%25C3%25BCllmann%26aufirst%3DB.%26aulast%3DSchmitt%26aufirst%3DS.%26atitle%3DSynthetic%2520Access%2520to%25202-Amido-5-aryl-8-methoxy-triazolopyridine%2520and%25202-Amido-5-morpholino-8-methoxy-triazolopyridine%2520Derivatives%2520as%2520Potential%2520Inhibitors%2520of%2520the%2520Adenosine%2520Receptor%2520Subtypes%26jtitle%3DSynthesis%26date%3D2003%26volume%3D2003%26spage%3D1649%26epage%3D1652" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Mattson, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pham, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leuck, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowen, K. A.</span><span> </span><span class="NLM_article-title">An improved method for reductive alkylation of amines using titanium(IV) isopropoxide and sodium cyanoborohydride</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">2552</span><span class="NLM_x">–</span> <span class="NLM_lpage">2554</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo00295a060" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=1990&pages=2552-2554&author=R.+J.+Mattsonauthor=K.+M.+Phamauthor=D.+J.+Leuckauthor=K.+A.+Cowen&title=An+improved+method+for+reductive+alkylation+of+amines+using+titanium%28IV%29+isopropoxide+and+sodium+cyanoborohydride"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjo00295a060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00295a060%26sid%3Dliteratum%253Aachs%26aulast%3DMattson%26aufirst%3DR.%2BJ.%26aulast%3DPham%26aufirst%3DK.%2BM.%26aulast%3DLeuck%26aufirst%3DD.%2BJ.%26aulast%3DCowen%26aufirst%3DK.%2BA.%26atitle%3DAn%2520improved%2520method%2520for%2520reductive%2520alkylation%2520of%2520amines%2520using%2520titanium%2528IV%2529%2520isopropoxide%2520and%2520sodium%2520cyanoborohydride%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1990%26volume%3D55%26spage%3D2552%26epage%3D2554" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Williams, N. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bamert, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walden, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilks, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fantino, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossjohn, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucet, I. S.</span><span> </span><span class="NLM_article-title">Dissecting specificity in the Janus kinases: the structures of JAK-specific inhibitors complexed to the JAK1 and JAK2 protein tyrosine kinase domains</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">387</span><span class="NLM_x">, </span> <span class="NLM_fpage">219</span><span class="NLM_x">–</span> <span class="NLM_lpage">232</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm501262q&amp;key=10.1016%2Fj.jmb.2009.01.041" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm501262q&amp;key=19361440" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm501262q&amp;key=1%3ACAS%3A528%3ADC%252BD1MXivVegtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=387&publication_year=2009&pages=219-232&author=N.+K.+Williamsauthor=R.+S.+Bamertauthor=O.+Patelauthor=C.+Wangauthor=P.+M.+Waldenauthor=A.+F.+Wilksauthor=E.+Fantinoauthor=J.+Rossjohnauthor=I.+S.+Lucet&title=Dissecting+specificity+in+the+Janus+kinases%3A+the+structures+of+JAK-specific+inhibitors+complexed+to+the+JAK1+and+JAK2+protein+tyrosine+kinase+domains"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Dissecting Specificity in the Janus Kinases: The Structures of JAK-Specific Inhibitors Complexed to the JAK1 and JAK2 Protein Tyrosine Kinase Domains</span></div><div class="casAuthors">Williams, Neal K.; Bamert, Rebecca S.; Patel, Onisha; Wang, Christina; Walden, Patricia M.; Wilks, Andrew F.; Fantino, Emmanuelle; Rossjohn, Jamie; Lucet, Isabelle S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">387</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">219-232</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The Janus kinases (JAKs) are a pivotal family of protein tyrosine kinases (PTKs) that play prominent roles in numerous cytokine signaling pathways, with aberrant JAK activity assocd. with a variety of hematopoietic malignancies, cardiovascular diseases and immune-related disorders.  Whereas the structures of the JAK2 and JAK3 PTK domains have been detd., the structure of the JAK1 PTK domain is unknown.  Here, we report the high-resoln. crystal structures of the "active form" of the JAK1 PTK domain in complex with two JAK inhibitors, a tetracyclic pyridone 2-t-butyl-9-fluoro-3,6-dihydro-7H-benz[h]-imidaz[4,5-f]isoquinoline-7-one (CMP6) and (3R,4R)-3-[4-methyl-3-[N-methyl-N-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl]-3-oxopropionitrile (CP-690,550), and compare them with the corresponding JAK2 PTK inhibitor complexes.  Both inhibitors bound in a similar manner to JAK1, namely buried deep within a constricted ATP-binding site, thereby providing a basis for the potent inhibition of JAK1.  As expected, the mode of inhibitor binding in JAK1 was very similar to that obsd. in JAK2, highlighting the challenges in developing JAK-specific inhibitors that target the ATP-binding site.  Nevertheless, differences surrounding the JAK1 and JAK2 ATP-binding sites were apparent, thereby providing a platform for the rational design of JAK2- and JAK1-specific inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQDLkMkCgiLbVg90H21EOLACvtfcHk0lipODXnnKX-Dw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXivVegtbo%253D&md5=79957755d04323057b5acf7e9d2c56ca</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2009.01.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2009.01.041%26sid%3Dliteratum%253Aachs%26aulast%3DWilliams%26aufirst%3DN.%2BK.%26aulast%3DBamert%26aufirst%3DR.%2BS.%26aulast%3DPatel%26aufirst%3DO.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DWalden%26aufirst%3DP.%2BM.%26aulast%3DWilks%26aufirst%3DA.%2BF.%26aulast%3DFantino%26aufirst%3DE.%26aulast%3DRossjohn%26aufirst%3DJ.%26aulast%3DLucet%26aufirst%3DI.%2BS.%26atitle%3DDissecting%2520specificity%2520in%2520the%2520Janus%2520kinases%253A%2520the%2520structures%2520of%2520JAK-specific%2520inhibitors%2520complexed%2520to%2520the%2520JAK1%2520and%2520JAK2%2520protein%2520tyrosine%2520kinase%2520domains%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2009%26volume%3D387%26spage%3D219%26epage%3D232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Alkorta, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campillo, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rozas, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elguero, J.</span><span> </span><span class="NLM_article-title">Ring Strain and Hydrogen Bond Acidity</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">7759</span><span class="NLM_x">–</span> <span class="NLM_lpage">7763</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo980804l" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=1998&pages=7759-7763&author=I.+Alkortaauthor=N.+Campilloauthor=I.+Rozasauthor=J.+Elguero&title=Ring+Strain+and+Hydrogen+Bond+Acidity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjo980804l&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo980804l%26sid%3Dliteratum%253Aachs%26aulast%3DAlkorta%26aufirst%3DI.%26aulast%3DCampillo%26aufirst%3DN.%26aulast%3DRozas%26aufirst%3DI.%26aulast%3DElguero%26aufirst%3DJ.%26atitle%3DRing%2520Strain%2520and%2520Hydrogen%2520Bond%2520Acidity%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1998%26volume%3D63%26spage%3D7759%26epage%3D7763" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Labadie, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dragovich, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrett, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blair, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergeron, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deshmukh, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eigenbrot, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghilardi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbons, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurley, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenny, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohli, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kulagowski, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liimatta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lupardus, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendonca, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pulk, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shia, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steffek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ubhayakar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ultsch, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Abbema, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zak, M.</span><span> </span><span class="NLM_article-title">Structure-Based Discovery of C-2 Substituted Imidazo-Pyrrolopyridine JAK1 Inhibitors with Improved Selectivity over JAK2</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">7627</span><span class="NLM_x">–</span> <span class="NLM_lpage">7633</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=7627-7633&author=S.+Labadieauthor=P.+S.+Dragovichauthor=K.+Barrettauthor=W.+S.+Blairauthor=P.+Bergeronauthor=C.+Changauthor=G.+Deshmukhauthor=C.+Eigenbrotauthor=N.+Ghilardiauthor=P.+Gibbonsauthor=C.+A.+Hurleyauthor=A.+Johnsonauthor=J.+R.+Kennyauthor=P.+B.+Kohliauthor=J.+J.+Kulagowskiauthor=M.+Liimattaauthor=P.+J.+Lupardusauthor=R.+Mendoncaauthor=J.+M.+Murrayauthor=R.+Pulkauthor=S.+Shiaauthor=M.+Steffekauthor=S.+Ubhayakarauthor=M.+Ultschauthor=A.+van+Abbemaauthor=S.+Wardauthor=M.+Zak&title=Structure-Based+Discovery+of+C-2+Substituted+Imidazo-Pyrrolopyridine+JAK1+Inhibitors+with+Improved+Selectivity+over+JAK2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLabadie%26aufirst%3DS.%26aulast%3DDragovich%26aufirst%3DP.%2BS.%26aulast%3DBarrett%26aufirst%3DK.%26aulast%3DBlair%26aufirst%3DW.%2BS.%26aulast%3DBergeron%26aufirst%3DP.%26aulast%3DChang%26aufirst%3DC.%26aulast%3DDeshmukh%26aufirst%3DG.%26aulast%3DEigenbrot%26aufirst%3DC.%26aulast%3DGhilardi%26aufirst%3DN.%26aulast%3DGibbons%26aufirst%3DP.%26aulast%3DHurley%26aufirst%3DC.%2BA.%26aulast%3DJohnson%26aufirst%3DA.%26aulast%3DKenny%26aufirst%3DJ.%2BR.%26aulast%3DKohli%26aufirst%3DP.%2BB.%26aulast%3DKulagowski%26aufirst%3DJ.%2BJ.%26aulast%3DLiimatta%26aufirst%3DM.%26aulast%3DLupardus%26aufirst%3DP.%2BJ.%26aulast%3DMendonca%26aufirst%3DR.%26aulast%3DMurray%26aufirst%3DJ.%2BM.%26aulast%3DPulk%26aufirst%3DR.%26aulast%3DShia%26aufirst%3DS.%26aulast%3DSteffek%26aufirst%3DM.%26aulast%3DUbhayakar%26aufirst%3DS.%26aulast%3DUltsch%26aufirst%3DM.%26aulast%3Dvan%2BAbbema%26aufirst%3DA.%26aulast%3DWard%26aufirst%3DS.%26aulast%3DZak%26aufirst%3DM.%26atitle%3DStructure-Based%2520Discovery%2520of%2520C-2%2520Substituted%2520Imidazo-Pyrrolopyridine%2520JAK1%2520Inhibitors%2520with%2520Improved%2520Selectivity%2520over%2520JAK2%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D7627%26epage%3D7633" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Zak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurley, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, S. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergeron, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrett, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balazs, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blair, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bull, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chakravarty, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crackett, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deshmukh, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeVoss, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dragovich, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eigenbrot, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellwood, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaines, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghilardi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbons, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gradl, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gribling, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamman, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harstad, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hewitt, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenny, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koehler, M. F. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bir Kohli, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labadie, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liimatta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendonca, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narukulla, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pulk, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reeve, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savage, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shia, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steffek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ubhayakar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Abbema, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aliagas, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avitabile-Woo, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kulagowski, J. J.</span><span> </span><span class="NLM_article-title">Identification of C-2 Hydroxyethyl Imidazopyrrolopyridines as Potent JAK1 Inhibitors with Favorable Physicochemical Properties and High Selectivity over JAK2</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">4764</span><span class="NLM_x">–</span> <span class="NLM_lpage">4785</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm4004895" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=4764-4785&author=M.+Zakauthor=C.+A.+Hurleyauthor=S.+I.+Wardauthor=P.+Bergeronauthor=K.+Barrettauthor=M.+Balazsauthor=W.+S.+Blairauthor=R.+Bullauthor=P.+Chakravartyauthor=C.+Changauthor=P.+Crackettauthor=G.+Deshmukhauthor=J.+DeVossauthor=P.+S.+Dragovichauthor=C.+Eigenbrotauthor=C.+Ellwoodauthor=S.+Gainesauthor=N.+Ghilardiauthor=P.+Gibbonsauthor=S.+Gradlauthor=P.+Griblingauthor=C.+Hammanauthor=E.+Harstadauthor=P.+Hewittauthor=A.+Johnsonauthor=T.+Johnsonauthor=J.+R.+Kennyauthor=M.+F.+T.+Koehlerauthor=P.+Bir+Kohliauthor=S.+Labadieauthor=W.+P.+Leeauthor=J.+Liaoauthor=M.+Liimattaauthor=R.+Mendoncaauthor=R.+Narukullaauthor=R.+Pulkauthor=A.+Reeveauthor=S.+Savageauthor=S.+Shiaauthor=M.+Steffekauthor=S.+Ubhayakarauthor=A.+van+Abbemaauthor=I.+Aliagasauthor=B.+Avitabile-Wooauthor=Y.+Xiaoauthor=J.+Yangauthor=J.+J.+Kulagowski&title=Identification+of+C-2+Hydroxyethyl+Imidazopyrrolopyridines+as+Potent+JAK1+Inhibitors+with+Favorable+Physicochemical+Properties+and+High+Selectivity+over+JAK2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm4004895&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4004895%26sid%3Dliteratum%253Aachs%26aulast%3DZak%26aufirst%3DM.%26aulast%3DHurley%26aufirst%3DC.%2BA.%26aulast%3DWard%26aufirst%3DS.%2BI.%26aulast%3DBergeron%26aufirst%3DP.%26aulast%3DBarrett%26aufirst%3DK.%26aulast%3DBalazs%26aufirst%3DM.%26aulast%3DBlair%26aufirst%3DW.%2BS.%26aulast%3DBull%26aufirst%3DR.%26aulast%3DChakravarty%26aufirst%3DP.%26aulast%3DChang%26aufirst%3DC.%26aulast%3DCrackett%26aufirst%3DP.%26aulast%3DDeshmukh%26aufirst%3DG.%26aulast%3DDeVoss%26aufirst%3DJ.%26aulast%3DDragovich%26aufirst%3DP.%2BS.%26aulast%3DEigenbrot%26aufirst%3DC.%26aulast%3DEllwood%26aufirst%3DC.%26aulast%3DGaines%26aufirst%3DS.%26aulast%3DGhilardi%26aufirst%3DN.%26aulast%3DGibbons%26aufirst%3DP.%26aulast%3DGradl%26aufirst%3DS.%26aulast%3DGribling%26aufirst%3DP.%26aulast%3DHamman%26aufirst%3DC.%26aulast%3DHarstad%26aufirst%3DE.%26aulast%3DHewitt%26aufirst%3DP.%26aulast%3DJohnson%26aufirst%3DA.%26aulast%3DJohnson%26aufirst%3DT.%26aulast%3DKenny%26aufirst%3DJ.%2BR.%26aulast%3DKoehler%26aufirst%3DM.%2BF.%2BT.%26aulast%3DBir%2BKohli%26aufirst%3DP.%26aulast%3DLabadie%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DW.%2BP.%26aulast%3DLiao%26aufirst%3DJ.%26aulast%3DLiimatta%26aufirst%3DM.%26aulast%3DMendonca%26aufirst%3DR.%26aulast%3DNarukulla%26aufirst%3DR.%26aulast%3DPulk%26aufirst%3DR.%26aulast%3DReeve%26aufirst%3DA.%26aulast%3DSavage%26aufirst%3DS.%26aulast%3DShia%26aufirst%3DS.%26aulast%3DSteffek%26aufirst%3DM.%26aulast%3DUbhayakar%26aufirst%3DS.%26aulast%3Dvan%2BAbbema%26aufirst%3DA.%26aulast%3DAliagas%26aufirst%3DI.%26aulast%3DAvitabile-Woo%26aufirst%3DB.%26aulast%3DXiao%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DKulagowski%26aufirst%3DJ.%2BJ.%26atitle%3DIdentification%2520of%2520C-2%2520Hydroxyethyl%2520Imidazopyrrolopyridines%2520as%2520Potent%2520JAK1%2520Inhibitors%2520with%2520Favorable%2520Physicochemical%2520Properties%2520and%2520High%2520Selectivity%2520over%2520JAK2%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D4764%26epage%3D4785" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Yu, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pistillo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Archibeque, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han Lee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, B.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schenkel, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geuns-Meyer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emkey, R.</span><span> </span><span class="NLM_article-title">Differential Selectivity of JAK2 Inhibitors in Enzymatic and Cellular Settings</span> <span class="citation_source-journal">Exp. Hematol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">491</span><span class="NLM_x">–</span> <span class="NLM_lpage">500</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm501262q&amp;key=10.1016%2Fj.exphem.2013.01.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm501262q&amp;key=23340136" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm501262q&amp;key=1%3ACAS%3A528%3ADC%252BC3sXlt1Cjsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2013&pages=491-500&author=V.+Yuauthor=J.+Pistilloauthor=I.+Archibequeauthor=J.+Han+Leeauthor=B.-C.+Sunauthor=L.+B.+Schenkelauthor=S.+Geuns-Meyerauthor=L.+Liuauthor=R.+Emkey&title=Differential+Selectivity+of+JAK2+Inhibitors+in+Enzymatic+and+Cellular+Settings"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Differential selectivity of JAK2 inhibitors in enzymatic and cellular settings</span></div><div class="casAuthors">Yu, Violeta; Pistillo, Jeanne; Archibeque, Ivonne; Han Lee, Josie; Sun, Bee-Chun; Schenkel, Laurie B.; Geuns-Meyer, Stephanie; Liu, Liqin; Emkey, Renee</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Hematology (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">491-500</span>CODEN:
                <span class="NLM_cas:coden">EXHMA6</span>;
        ISSN:<span class="NLM_cas:issn">0301-472X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Small mol. inhibitors of Janus kinase (JAK) family members (JAK1, JAK2, JAK3, and Tyk2) are currently being pursued as potential new modes of therapy for a variety of diseases, including the inhibition of JAK2 for the treatment of myeloproliferative disorders.  Selective inhibition within the JAK family can be beneficial in avoiding undesirable side effects (e.g., immunosuppression) caused by parallel inhibition of other JAK members.  In an effort to design an assay paradigm for the development of JAK2 selective inhibitors, we investigated whether compd. selectivity differed between cellular and purified enzyme environments.  A set of JAK2 inhibitors was tested in a high-throughput JAK family cell assay suite and in corresponding purified enzyme assays.  The high-throughput JAK cell assay suite comprises Ba/F3 cells individually expressing translocated ETS leukemia (TEL) fusions of each JAK family member (TEL-JAK Ba/F3) and an AlphaScreen phosphorylated-STAT5 (pSTAT5) immunoassay.  Compd. potencies from the TEL-JAK Ba/F3 pSTAT5 assays were similar to those detd. in downstream cell proliferation measurements and more physiol. relevant cytokine-induced pSTAT5 PBMC assays.  However, compd. selectivity data between cell and purified enzyme assays were discrepant because of different potency shifts between cell and purified enzyme values for each JAK family member.  For any JAK small mol. development program, our results suggest that relying solely on enzyme potency and selectivity data may be misleading.  Adopting the high-throughput TEL-JAK Ba/F3 pSTAT5 cell assay suite in lead development paradigms should provide a more meaningful understanding of selectivity and facilitate the development of more selective JAK inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpeI8srzB4fFLVg90H21EOLACvtfcHk0lgK87X8ElEbUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXlt1Cjsr0%253D&md5=99806814ea6433ff1bf336df0105e4b2</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.exphem.2013.01.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.exphem.2013.01.005%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DV.%26aulast%3DPistillo%26aufirst%3DJ.%26aulast%3DArchibeque%26aufirst%3DI.%26aulast%3DHan%2BLee%26aufirst%3DJ.%26aulast%3DSun%26aufirst%3DB.-C.%26aulast%3DSchenkel%26aufirst%3DL.%2BB.%26aulast%3DGeuns-Meyer%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DEmkey%26aufirst%3DR.%26atitle%3DDifferential%2520Selectivity%2520of%2520JAK2%2520Inhibitors%2520in%2520Enzymatic%2520and%2520Cellular%2520Settings%26jtitle%3DExp.%2520Hematol.%26date%3D2013%26volume%3D41%26spage%3D491%26epage%3D500" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Schenkel, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deak, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doherty, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emkey, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunaydin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loberg, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olivieri, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pistillo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wells, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geuns-Meyer, S.</span><span> </span><span class="NLM_article-title">Discovery of Potent and Highly Selective Thienopyridine Janus Kinase 2 Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">8440</span><span class="NLM_x">–</span> <span class="NLM_lpage">8450</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm200911r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=8440-8450&author=L.+B.+Schenkelauthor=X.+Huangauthor=A.+Chengauthor=H.+L.+Deakauthor=E.+Dohertyauthor=R.+Emkeyauthor=Y.+Guauthor=H.+Gunaydinauthor=J.+L.+Kimauthor=J.+Leeauthor=R.+Lobergauthor=P.+Olivieriauthor=J.+Pistilloauthor=J.+Tangauthor=Q.+Wanauthor=H.-L.+Wangauthor=S.-W.+Wangauthor=M.+C.+Wellsauthor=B.+Wuauthor=V.+Yuauthor=L.+Liuauthor=S.+Geuns-Meyer&title=Discovery+of+Potent+and+Highly+Selective+Thienopyridine+Janus+Kinase+2+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm200911r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200911r%26sid%3Dliteratum%253Aachs%26aulast%3DSchenkel%26aufirst%3DL.%2BB.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DCheng%26aufirst%3DA.%26aulast%3DDeak%26aufirst%3DH.%2BL.%26aulast%3DDoherty%26aufirst%3DE.%26aulast%3DEmkey%26aufirst%3DR.%26aulast%3DGu%26aufirst%3DY.%26aulast%3DGunaydin%26aufirst%3DH.%26aulast%3DKim%26aufirst%3DJ.%2BL.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DLoberg%26aufirst%3DR.%26aulast%3DOlivieri%26aufirst%3DP.%26aulast%3DPistillo%26aufirst%3DJ.%26aulast%3DTang%26aufirst%3DJ.%26aulast%3DWan%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DH.-L.%26aulast%3DWang%26aufirst%3DS.-W.%26aulast%3DWells%26aufirst%3DM.%2BC.%26aulast%3DWu%26aufirst%3DB.%26aulast%3DYu%26aufirst%3DV.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DGeuns-Meyer%26aufirst%3DS.%26atitle%3DDiscovery%2520of%2520Potent%2520and%2520Highly%2520Selective%2520Thienopyridine%2520Janus%2520Kinase%25202%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D8440%26epage%3D8450" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">van ’t Klooster, G.; Van Rompaey, L.; Menet, C.; Namour, F.; Vanhoutte, F.; van der Aar, E.; Clement-Lacroix, P.; Galien, R.; Nelles, L.; Guerin, C.; Smets, B.; Brys, R.; Feyen, J.; Wigerinck, P.</span><span> </span><span class="NLM_article-title">Preclinical Pharmacology and Early Clinical Evaluation of GLPG0634, a Selective JAK1 Inhibitor for the Treatment of Rheumatoid Arthritis</span>. <span class="NLM_conf-name">EULAR 2011</span>, <span class="NLM_conf-loc">London</span>, <span class="NLM_conf-date">May 25–28, 2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=van+%E2%80%99t+Klooster%2C+G.%3B+Van+Rompaey%2C+L.%3B+Menet%2C+C.%3B+Namour%2C+F.%3B+Vanhoutte%2C+F.%3B+van+der+Aar%2C+E.%3B+Clement-Lacroix%2C+P.%3B+Galien%2C+R.%3B+Nelles%2C+L.%3B+Guerin%2C+C.%3B+Smets%2C+B.%3B+Brys%2C+R.%3B+Feyen%2C+J.%3B+Wigerinck%2C+P.+Preclinical+Pharmacology+and+Early+Clinical+Evaluation+of+GLPG0634%2C+a+Selective+JAK1+Inhibitor+for+the+Treatment+of+Rheumatoid+Arthritis.+EULAR+2011%2C+London%2C+May+25%E2%80%9328%2C+2011."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2B%25E2%2580%2599t%2BKlooster%26aufirst%3DG.%26atitle%3DPreclinical%2520Pharmacology%2520and%2520Early%2520Clinical%2520Evaluation%2520of%2520GLPG0634%252C%2520a%2520Selective%2520JAK1%2520Inhibitor%2520for%2520the%2520Treatment%2520of%2520Rheumatoid%2520Arthritis" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Van Rompaey, L.; Clement-Lacroix, P.; Galien, R.; van der Aar, E.; Nelles, L.; Smets, B.; Dupont, S.; Christophe, T.; Conrath, K.; Brys, R.; van ’t Klooster, G.; Fletcher, S.; Feyen, J.; Menet, C.</span><span> </span><span class="NLM_article-title">GLPG0634, a Janus Kinase Inhibitor for the Treatment of Rheumatoid Arthritis</span>. <span class="NLM_conf-name">WIR</span>, <span class="NLM_conf-date">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Van+Rompaey%2C+L.%3B+Clement-Lacroix%2C+P.%3B+Galien%2C+R.%3B+van+der+Aar%2C+E.%3B+Nelles%2C+L.%3B+Smets%2C+B.%3B+Dupont%2C+S.%3B+Christophe%2C+T.%3B+Conrath%2C+K.%3B+Brys%2C+R.%3B+van+%E2%80%99t+Klooster%2C+G.%3B+Fletcher%2C+S.%3B+Feyen%2C+J.%3B+Menet%2C+C.+GLPG0634%2C+a+Janus+Kinase+Inhibitor+for+the+Treatment+of+Rheumatoid+Arthritis.+WIR%2C+2011."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BRompaey%26aufirst%3DL.%26atitle%3DGLPG0634%252C%2520a%2520Janus%2520Kinase%2520Inhibitor%2520for%2520the%2520Treatment%2520of%2520Rheumatoid%2520Arthritis" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Namour, F.; Galien, R.; Vanhoutte, F.; Wigerink, P.; van’t Klooster, G.</span><span> </span><span class="NLM_article-title">An Active Metabolite Contributes to the Pharmacodynamics and Efficacy of GLPG0634, a Selective JAK1 Inhibitor</span>. <span class="NLM_conf-name">American College of Rheumatology Annual Meeting</span>, <span class="NLM_conf-loc">San Diego</span>, <span class="NLM_conf-name">October 25–30, 2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Namour%2C+F.%3B+Galien%2C+R.%3B+Vanhoutte%2C+F.%3B+Wigerink%2C+P.%3B+van%E2%80%99t+Klooster%2C+G.+An+Active+Metabolite+Contributes+to+the+Pharmacodynamics+and+Efficacy+of+GLPG0634%2C+a+Selective+JAK1+Inhibitor.+American+College+of+Rheumatology+Annual+Meeting%2C+San+Diego%2C+October+25%E2%80%9330%2C+2013."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DNamour%26aufirst%3DF.%26atitle%3DAn%2520Active%2520Metabolite%2520Contributes%2520to%2520the%2520Pharmacodynamics%2520and%2520Efficacy%2520of%2520GLPG0634%252C%2520a%2520Selective%2520JAK1%2520Inhibitor" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">van’t Klooster, G. A. E.; Brys, R. C. X.; Van Rompaey, L. J. C.; Namour, F. S.</span><span> </span><span class="NLM_article-title">Aminotriazolopyridine for Use in the Treatment of Inflammation, and Pharmaceutical Compositions Thereof. UY34855 (A)</span>. WO2013189771 (A1), <span class="NLM_month">January</span><span class="NLM_day">31</span>,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=G.+A.+E.+van%E2%80%99t+Klooster&author=R.+C.+X.+Brys&author=L.+J.+C.+Van+Rompaey&author=F.+S.+Namour&title=Aminotriazolopyridine+for+Use+in+the+Treatment+of+Inflammation%2C+and+Pharmaceutical+Compositions+Thereof.+UY34855+%28A%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%25E2%2580%2599t%2BKlooster%26aufirst%3DG.%2BA.%2BE.%26atitle%3DAminotriazolopyridine%2520for%2520Use%2520in%2520the%2520Treatment%2520of%2520Inflammation%252C%2520and%2520Pharmaceutical%2520Compositions%2520Thereof.%2520UY34855%2520%2528A%2529%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4P7E" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4P7E','PDB','4P7E'); return false;">PDB: 4P7E</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-NOTES-d2158e5598-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i82"><a href="/doi/suppl/10.1021/jm501262q">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_61586"></div></div></div></div></div><hr /></hr><p class="last">Protein crystallography, crystallographic data, and molecular modeling. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm501262q/suppl_file/jm501262q_si_001.pdf">jm501262q_si_001.pdf (119.66 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm501262q&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Barticle%3Aarticle%3A10.1021%2Fjm501262q%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2014.57.issue-22" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm501262q" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679955ac28123dac","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
